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ABSTRACT
Background: Although periodontal disease is depicted as the most common disease affecting 
humankind little is known of the molecular events leading to its initiation and progression. 
The junctional and oral-gingival epithelia are functionally and histologically distinct. The 
junctional epithelium differs from other epithelia in its pattern of maturation and its formation 
of a unique epithelial attachment to the tooth. Apical migration of the jimctional epithelium is 
a centrd feature o f periodontal disease progression. Currently, no fully satisfactory 
explanation exists either for the normal stability of this epithelium at the dento-gingival 
attachment or for its activation to migration with the onset of periodontitis.
Aims: To test the hypothesis that the differences between the junctional and gingival 
epithelial phenotypes result from phenotypic differences between the fibroblast populations of 
sub-epithelial gingival connective tissues.
Materials and methods: Junctional and oral-gingival epithelia were successfully isolated and 
cultured as confirmed by immunohistochemistry using a panel of antibodies specific to the 
junctional phenotype. Similarly, the underlying fibroblast populations, namely the periodontal 
ligament and oral-gingival fibroblasts were isolated and cultured. These unique cellular 
phenotypes were maintained for several passages allowing amplification of cells for 
incorporation into organotypic co-cultures.
The mRNA derived fix>m cell populations was subjected to TaqMan™ quantitative PCR in 
order to quantify expression levels of cytokines known to be involved in epithelial growth and 
differentiation.
Results: Within the homotypic organotypic culture system the underlying connective tissues 
modulated the phenotypic growth, development and differentiation of the overlying 
epithelium. Further, immunostaining demonstrated restoration of the in vitro phenotypes 
comparable to those o f the epithelial tissues of origin. Heterotypic re-combinations showed 
variation in differentiation state o f epithelia dependant on their underlying connective tissue. 
Both histologically and immunohistochemically junctional epithelium was found to revert 
toward the oral-gingival epithelial phenotype on culture upon oral-gingival fibroblasts. Oral- 
gingival keratinocytes cultured upon periodontal ligament fibroblast substrate also 
demonstrated a shift in phenotype toward the junctional-type, although this was less marked.
Q-PCR results for the two-fibroblast populations demonstrated striking differences in 
expression levels o f several cytokines in particular large percentage increases in KGF and 
HGF expression within the oral-gingival type. Interestingly, junctional epithelial samples 
demonstrated statistically significant increases in IL -la  and GM-CSF receptor expression and 
distinct increases in several other cytokine receptor levels when compared with oral-gingival 
epithelium.
Conclusions: The four individual phenotypic cell populations persisted in culture. On 
recombination into the organotypic system, there were discernible growth variations that may 
be attributable to diverse cytokine/receptor levels involved in epithelial-mesenchymal 
interactions. It was apparent that both keratinocytes and fibroblasts have joint control o f the 
phenotype o f an epithelium. Such varying cytokine levels may represent intrinsic differences 
in sub-sets o f the population that are at greater or lesser risk of developing periodontal 
disease.
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CHAPTER ONE 
INTRODUCTION
CHAPTER ONE 
INTRODUCTION
1.1 Background
Although widely cited as being the most common disease affecting humankind little is known 
of the molecular events leading to the initiation and progression of periodontal disease. 
Epidemiological studies indicate that mild to moderate periodontitis affects the majority o f the 
adult population; while studies suggest some 8-20% of highly susceptible individuals within 
the population suffer fix>m a more severe form o f the disease (Loe and Morrison, 1986).
Periodontal disease is an inflammatory condition that results in the loss of the tooth 
supporting structures. In health, there is a dynamic equilibrium between microflora and host 
defences, whereas during disease chronic periodontitis is associated with accumulation of 
bacterial plaque on the tooth surface and subsequent inflammation of the periodontal tissues 
(Page and Schroeder, 1976). Studies of periodontal disease have demonstrated a progression 
from gingivitis through loss o f epithelial attachment to the tooth, alveolar bone destruction 
and ultimately to tooth loss. These processes however are not continuous, but progress in a 
site-specific, episodic manner with bursts of destructive activity alternating with periods of 
quiescence and possibly repair (Haffajee et cd., 1983). There is great individual variation in 
these patterns of destruction, which also varies over time in the same individual (Eley and 
Cox, 1998).
1.2 Periodontal tissues
Clinical attachment of soft tissue to the tooth is facilitated by a unique epithelium, the 
junctional epithelium. This epithelium is functionally and histologically distinct fix)m its close 
neighbour, the gingival epithelium (Mackenzie, 1987). Apical migration of the junctional 
epithelium is a central feature o f periodontal disease progression (Schroeder and Listgarten, 
1971) but currently no satisfactory explanation exists either for the normal stability o f this 
epithelium at the dento-gingival junction or for its activation to migration with the onset of 
periodontitis.
Fibroblasts are the predominant cell type in sub-epithelial connective tissues and are 
responsible for the major part of the production of extracellular matrix and growth factors 
during normal function, development, regeneration and pathologic alteration (Smith, 1997
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and Lekic et aL, 2001). Schor and Schor (1987) suggested that specificity of fibroblast 
phenotype might influence not only the metabolism of connective tissues but also of adjacent 
epithelia.
Oral-gingival and periodontal ligament fibroblasts are the two populations of fibroblasts 
within the periodontium that this study will examine.
13 Control of the epithelial phenotype
It is now clear that the normal maintenance of tissue regeneration following damage, and the 
tissue responses to inflammation, are strongly influenced by various molecules that control 
cell growth and differentiation. O f these, a variety of epithelial mitogens have been identified 
as instigators and maintainers of the epithelial phenotype. Keratinocyte growth factor for 
example, has been shown to selectively induce keratinocyte proliferation and differentiation 
in tissue culture (Rubin et al., 1989). Such molecules form a complex network of autocrine 
and paracrine acting mediators between the epithelia and their underlying connective tissues, 
the so-called epithelial-mesenchymal interactions (McFarlane et al., 1990 and Luger and 
Schwartz, 1994).
Little is known about the molecular basis of apical migration o f junctional epithelium 
observed during the transition fi*om health to disease, but it has been postulated that the 
heterotypic nature o f the underlying coimective tissue fibroblasts could, via diffusible factors, 
modulate the junctional phenotype to a migratory phenotype (Mackenzie, 1987). There is now 
considerable interest in determining the role o f these fibroblast-derived cytokines in 
remodelling of diseased periodontal tissues.
1.4 Aims of the thesis
The aim of this study was to investigate epithelial-mesenchymal interactions that stabilise the 
normal dento-gingival attachment apparatus. Such information appears essential in order to 
elucidate the pathological changes that are associated with activation of the junctional 
epithelium to a migratory phenotype.
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The nature of periodontal disease poses the following questions:
1. What mechanisms result in the normal structural stability o f the dento-gingival 
complex?
2. What occurs during advancing periodontal disease to disturb this stable state?
3. How can marginal gingivitis with coimective tissue inflammation persist for extended 
periods o f time without progression to loss of attachment?
Specifically it was intended to:
1. Confirm expression characteristics of the oral tissues of interest by ex vivo staining 
tissue sections with a panel o f monoclonal antibodies to known differentiation 
markers.
2. To identify, isolate and culture oral-gingival and junctional epithelia together with 
their corresponding connective tissue fibroblasts, namely oral-gingival and periodontal 
ligament fibroblasts.
3. To establish whether their unique phenotypes could be maintained in culture.
4. To develop an organotypic model o f gingival and junctional epithelium.
a. Using this model, assess the ability o f gingival coimective tissues to support, 
maintain and direct the differing oral-epithelial phenotypes by series of cross- 
recombination experiments.
b. To investigate a role for cytokines, in particular keratinocyte and hepatocyte 
growth factor in the maintenance of organotypic epithelial growth and 
differentiation.
5. To provide quantifiable data using polymerase chain reaction techniques, as to 
whether in vitro periodontal tissues have intrinsic differences with respect to their 
biochemical profile of cytokines and receptors that may be accountable for the 
maintenance o f the stable junctional phenotype in health, and its change to a migratory 
phenotype in disease.
6. To attempt to formulate possible biological mechanisms for the onset and progression 
of chronic periodontal disease.
An increased understanding o f the aetiology and pathogenesis of periodontal disease at the
molecular level may help provide the rationale for improved prevention and treatments.
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The literature review of this thesis will consider the structure of the periodontium, particularly 
that of the junctional epithelium, and the aetiology of periodontal disease. It will consider the 
phenotype of the gingival epithelia both in vivo and in vitro and finally the epithelial- 
mesenchymal interactions that are implicated in the control, growth, and differentiation of 
these tissues.
2.1 T he periodon tium
The periodontium consists of the gingiva, junctional epithelium (JE), periodontal ligament 
(PDL), root cementum and the alveolar bone (Figure 2.1). The teeth are supported by the 
alveolar processes of the maxilla and mandible and are surrounded by the periodontal tissues 
that provide the support essential for function.
Figure 2.1: Photomicrograph of the periodontium in health
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2.2 O ra l ep ith elia
The keratinising oral epithelia, much like skin, are arranged into four distinct layers, the strata 
basale, spinosum, granulosum and comeum (Figure 2.2). The stratum comeum is not present 
within the non-keratinising oral epithelia including the oral-sulcular and junctional epithelia. 
The basal cell layer consists of relatively small cuboidal cells in contact with a basal lamina 
that connects them to the underlying connective tissue (CT). The stratum spinosum is the 
major epithelial layer composed of large cells with well-developed arrays of desmosomes. 
The stratum granulosum is generally less well defined than its counterpart in skin consisting 
of 1-5 layers of flattened squamous epithelial cells. The stratum comeum consists of very flat 
cells that have lost their nuclei and cytoplasmic organelles; they have thickened cell 
membranes and inter-cellular junctions that gradually disintegrate as the cells approach the 
surface. Nuclei and isolated organelles may be retained in the most superficial cells when 
keratinisation is incomplete (para-keratinisation).
Fundamentally, the oral mucosae may be classified into three different types: the gingiva and 
the covering of the hard palate (masticatory mucosa) the dorsum of the tongue (specialised 
mucosa) and the remainder of the oral mucous membranes (lining mucosa).
Figure 2.2: The strata of oral epithelium
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2.2.1 The gingiva
The gingivae are formed by the mucosa that covers the alveolar bone and surrounds the 
cervical portion of the teeth. It consist of the “attached gingivae”, which run from the muco- 
gingival junction to the gingival margin and are bound firmly to the underlying alveolar bone, 
and the “free gingivae” which run from the free gingival groove to the attachment to the tooth 
(Figure 2.3). This attachment to the tooth results in a sulcus, a narrow space between the 
gingiva and the tooth. In health, it is minimal in depth maybe even absent under strict normal 
conditions, but it invariably exist under conditions of clinical health to between 0.2 and 
3.0mm. More than 3mm clinically can be regarded as pathological in nature (Schroeder and 
Listgarten 1977).
Figure 2.3: Photomicrograph of the attached gingivae
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2.2.2 Oral-gingival epithelium
The oral-gingival epithelium (OGE) begins at the muco-gingival junction and is continuous at 
the crest of the gingiva with the oral-sulcular epithelium (facing the tooth surface but not 
attached to it). OGE is covered by a keratinised or parakeratinised stratified squamous 
epithelium.
2.23 Dento-gingival junction
The dento-gingival junction (attachment zone) represents a unique structure where there is an 
interruption in epithelial continuity at its attachment to the tooth surface. It consists of two
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epithelial components: oral-sulcular (OSE) and JE, and two CT components: periodontal 
ligament and the gingival lamina propria.
2J2A Oral-sulcular epithelium
Located at the crest of the gingival margin the OSE extends downward into the gingival 
sulcus and is continuous with the JE. Its primary difference with OGE is that it is non- 
keratinised, and when compared to JE it is relatively impermeable to the passage of cells and 
fluid.
2.2^ Junctional epithelium
The JE is a stratified squamous non-keratinised epithelium that attaches gingival soft tissue to 
the tooth surface forming a physical barrier between the extemal environment (oral cavity) 
and the intemal environment of the host (periodontal CTs). However, JE is not a very 
effective permeability barrier as it has widened intercellular spaces (18% of the epithelium is 
occupied by intercellular space) that harbour elevated numbers o f neutrophilic granulocytes 
and sulcus fluid derived ftom the vessels o f the gingival plexus (Ten Cate, 1994, Chapter 14). 
Anatomically it may be located entirely on enamel, on enamel and cementum, or entirely on 
cementum depending on the stage o f dental emption and the degree of gingival recession. It is 
bounded on both sides by a basement membrane, as described by Schroeder and Listgarten 
(1971) with extemal basal lamina overlying the CT and intemal basal lamina forming 
hemidesmosomal attachments against the non-vital tooth substrate (reviewed by Hormia and 
Owaribe, 2001). This results in a collar surrounding the neck of the tooth 15-30 cells wide at 
the floor of the gingival sulcus tapering apically to final thickness of some 3-4 cells.
Basal JE cells are attached, so an “upper” surface available for the elimination of cells is 
limited. The cells streaming fi’om the high tumover of basal cells move to within two or three 
cell layers of the tooth surface and then join a main migratory route in a coronal direction 
eventually being sloughed off into the gingival sulcus (Gould et al., 1983).
The JE has generated much interest due to its unique phenotype, stmcture and because o f its 
involvement in the initiation of periodontal disease. The apical migration of JE attachment to 
the tooth is the primary indicator o f destmctive periodontitis. The nature of these processes 
leading to apical migration and formation of pocket epithelium are not fully understood.
Chapter two. Literature review
23  Connective tissues of the periodontium
23.1 Periodontal ligament
This specialised CT consists of a band of fibrous tissue interposed between the cementum of 
the roots of the teeth and the inner wall of the alveolar socket. In health the PDL functions in 
several capacities including anchorage of the tooth in the jaw, physiological mobility during 
mastication and provision of proprioceptive information on tooth and jaw position (Schroeder 
and Listgarten, 1971 and Somerman et al., 1988). Fibroblasts constitute the major cellular 
population, they flmction to synthesise collagen and the proteoglycan matrix surrounding the 
fibres. They also participate in the resorption of collagen fibrils and are believed to play a role 
in eruption due to their contractile properties (Beertsen et al., 1974). With the onset of 
periodontal disease, pockets develop that are associated with loss of PDL and alveolar bone.
Much hope has been placed upon the ability of the PDL to help reform tissue architecture 
post-periodontal disease. Boyko et a/. (1981) seeded fibroblasts fi'om either PDL or OGF onto 
the surface of tooth roots that were subsequently inserted into artificial sockets. Areas of 
newly formed PDL attached to cementum only where PDL cells were used. So far, no one has 
succeeded in establishing a new and normally fimctioning PDL without PDL cells, indicating 
that these cells have specialised properties in the reformation of the dento-gingival 
attachment.
23.2 Gingival connective tissues
The CT supporting the oral mucosa (including the oral-sulcular and oral-gingiva epithelia) is 
termed the lamina propria. This CT supports both the overlying OSE and OGE. Much like the 
PDL, the principle cell component is the fibroblast, which plays a key role in tissue integrity, 
communication and direction of the behaviour of the overlying epithelimn via a complex 
series o f diffusible factors and matrix effects (Schor and Schor, 1987).
2 3 3  The cementum
Cementum is a hard bone-like material covering the roots of the teeth. Its function is to 
anchor the PDL fibre bundles to the tooth. There are two types: acellular (or primary 
cementum) that contains comparatively few collagen fibrils loosely packed and more or less 
perpendicular to the dento-cemental junction, and cellular (secondary cementum) that is 
deposited over the primary cementum subsequent to occlusal contact. Its matrix consists of a 
denser array of coarse collagen fibrils (Schroeder and Listgarten, 1971).
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23.4 Alveolar bone
This bone is arbitrarily categorised as that bone formed in relation to the teeth. The alveolar 
bone proper consists o f a thin lamella of cortical bone surrounding the tooth root in which are 
embedded fibres of the PDL. The surrounding supporting bone consists of cortical plates and 
cancellous bone between.
2.4 Embryological origins of the epithelial attachment
Very early in tooth development, at the cap stage, three distinct components can be 
recognised: the dental organ, the dental papilla and the dental follicle. The dental follicle is a 
well-defined layer o f cells surrounding the tooth germ that is continuous with, and derived 
fix>m the dental papilla at the cervical loop. It gives rise to the supporting tissues of the tooth 
to include cementum, alveolar bone and PDL, the fibroblasts of the PDL originating shortly 
after root development begins (Ten Cate, 1994, Chapter 4 and Beertsen et al., 1997).
Prior to eruption a tooth is covered by a layer of ameloblasts, having completed then- 
formative fimction develop hemidesmosomes, secrete a basal lamina and become firmly 
attached to the enamel surface (Schroeder and Listgarten, 1971). An outer layer of cells, 
composed of the remnants o f the dental organ then separate the tooth from the overlying oral 
epithelium, the two together are known as the reduced enamel epithelium (REE). As the tooth 
erupts, these cell layers fuse and form a mass of degenerating epithelial cells that provide an 
epithelial-lined canal through which the tooth erupts. A component of the dento-gingival 
junction is now present and undergoes further tissue development after the tip of the erupting 
tooth emerges into the oral cavity. The oral epithelial cells migrate over the reduced enamel 
epithelium and a process o f transformation over the course of 3-4 years then takes place 
whereby the REE gradually becomes the JE. Immediately following the transformation of the 
REE, the development of the dento-gingival junction is considered complete.
It has been demonstrated that JE formation does not require the influences of 
odontogenically-derived CT. OGE has the ability to re-differentiate into the JE phenotype 
without the intervention of PDL, or even a tooth, as verified by Mackenzie and Tonetti (1995) 
with the formation of an anatomically “correct” epithelial attachment to titanium dental 
implants.
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2.5 P erio do n ta l disease
2.5.1 Introduction
Periodontal disease is an inflammatory condition resulting in the loss of the tooth supporting 
structures. In health, there is a dynamic equilibrium between microflora and host defences 
whereas chronic periodontitis is associated with accumulation of bacterial plaque on the tooth 
surface, subsequent inflammation of the periodontal tissues (Figure 2.4), apical migration of 
the epithelial attachment, destruction of the PDL, and loss of crestal alveolar bone (Haffajee 
and Socransky, 1994 and Page, 2002). Together these processes can lead to formation of a 
pathologically deepened gingival crevice or pocket.
Figure 2.4: Photomicrograph of the junctional epithelium during disease
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2.5.2 Gingivitis
The term gingivitis is used to describe inflammatory lesions that are confined to the marginal 
gingiva (Loe et aL, 1965). Marginal gingivitis with CT inflammation can persist for extended 
periods without progression to loss of attachment (Listgarten et al., 1985).
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2^.1 Periodontitis
The early changes associated with the inflammatory gingival response to microbial insult 
were summarised by Page and Schroeder (1976) and form the basis for current understanding 
of the host response in human periodontitis (Haffajee and Socransky, 1994). The progression 
fiom gingivitis to periodontitis is not obligatory but the progression of gingivitis to a 
periodontal lesion with pocket formation is invariably associated with proliferation and apical 
migration of the JE (Schroeder and Listgarten, 1971). Haffajee et al. (1983) first proposed the 
theory that tissue destruction in some lesions occurs during relatively “acute bursts” of 
disease activity followed by “quiescent” periods. Such periods of active destruction may 
represent a period when the host is overwhelmed by organisms capable of evading or 
interfering with the gingival defence systems, or active destruction may be precipitated by an 
overly aggressive or inappropriate response to microbial stimulation. Whether this is a result 
of reaction to microbial by-products and/or changes in the host epithelial-mesenchymal 
signalling remain to be elucidated.
Apical epithelial migration has several important consequences:
• By creating a potential space between the gingiva and the tooth, it enhances the 
possibility of further plaque accumulation and a persistent inflammatory response.
• It effectively prevents reattachment by isolating the tooth surface fi-om regenerative 
CT mechanisms: perpetuation o f small losses of attachment thus results in the 
progressive nature of tissue breakdown (Mackenzie, 1987).
• Activation of JE to a migratory phenotype may be a mechanism that actively destroys 
CT attachment to the tooth via induction and production of proteases (Laiho and 
Keski-Oja, 1989).
Several possible mechanisms may explain the apical migration of JE during disease:
1) As a response to destruction of the underlying CT, there may be a tendency for the JE 
to migrate into the space created on the root surface (Grant et a l, 1979).
2) “Physiological” regulation of epithelium by its imderlying CT prevents apical 
migration, but damage to this CT may remove its inhibitory effect on epithelial down­
growth (Page and Schroeder, 1976).
3) Keratinocytes are stimulated during periodontal disease (by intrinsic host factors 
and/or extrinsic bacterial products) resulting in active destruction of the attachment 
apparatus as the JE cells migrate.
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Nonnally, when surface continuity of an epithelium is disrupted, lateral migration of the 
epithelium is activated and ceases only when the free edges of epithelium meet and continuity 
is restored, the so-called “free edge effect” (Winter, 1972 and Clark, 1991). However, at the 
attachment zone epithelial migration does cease, forming an essentially "free" edge.
It has been suggested that further epithelial down-growth is prevented by the density of PDL 
fibres inserted into the tooth (Goldman and Cohen, 1980) but, interestingly, apical down­
growth does not occur around dental implants despite lack of insertion of such a ligament 
(Listgarten et al., 1991 and Mackenzie and Tonetti, 1995).
Recently, a number o f studies have investigated the ability of keratinocytes to produce tissue- 
degrading mediators, in particular matrix metalloproteinases (MMPs). Studies have foimd 
evidence for production of MMP-7 (matrilysin), MMP-8 (collagenase-2) and MMP-9 
(gelatinase-B) by JE (Uitto et al., 2002; Kivela-Rajamaki et al., 2003 and Smith et al., 2004), 
demonstrating perhaps, an ability to degrade its underlying attachment apparatus.
However, the current literature provides no satisfactory explanation either for the normal 
stability o f epithelium at the dento-gingival junction or for the activation of epithelial 
migration that occurs during the transition from gingivitis to periodontal disease.
2^ .4  Epidemiology
Epidemiological studies indicate that mild to moderate periodontitis affects the majority of the 
adult population; and that some 8-20% of highly susceptible individuals within the population 
suffer from a more severe form of the disease (Loe et al., 1986). Clinical classifications of the 
disease are many and varied. The American Association of Periodontology last updated their 
classification during 1999 (as reviewed by Armitage, 1999). Briefly, periodontal diseases are 
categorised as:
1) Chronic - encompassing previous terms such as adult, juvenile and pre-pubertal.
2) Periodontitis as manifestations of systemic disease.
3) Necrotising periodontal diseases.
4) Periodontitis associated with endodontic lesions.
5) Developmental or acquired deformities or conditions.
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2^.5 Aetiology
Ample evidence has revealed that the initiation and progression of periodontal disease is 
closely associated with quantitative and qualitative changes in the subgingival dental plaque 
flora (Page and Schroeder, 1976; Listgarten, 1986 and Page, 2002). Examples include:
•  Clinical experiments demonstrating that the withdrawal of oral hygiene in healthy 
mouths results in the accumulation of dental plaque paralleled by the onset of 
gingivitis.
•  Institution of oral hygiene restores the tissues to health.
•  A number of topical anti-microbials have been shown to inhibit plaque formation and 
prevent the onset of gingivitis.
•  Animal studies have demonstrated that gnotobiotic rats are free of periodontal 
destruction (Heijl et al., 1980). Bacteria isolated from human dental plaque introduced 
into the mouths of such animals can induce periodontal disease.
• Increasing evidence shows that there are differences in the bacterial flora associated 
with healthy gingival crevices and the various stsiges o f disease (Lovegrove, 2004).
2^.6 Microbiology of periodontitis
Healthy tissues are associated with a scanty flora located almost entirely supra-gingivally on 
the tooth surface. Gingivitis has revealed a complex accumulation 1-20 cells thick comprising 
mainly gram-positive bacteria including: Streptococcus, spirochetes and actinomyces species. 
In developing gingivitis the layers extend to 100-300 cells, actinomyces predominate but there 
is an increase in strict anaerobes and gram-negative organisms such as porphyromonas 
gingivalis and prevotella intermedia. In long-standing gingivitis, gram-negative bacteria may 
account for 35 percent of the total, the majority located subgingivally.
Periodontal bacterial pathogens persist in colonised sites by evading host defence mechanisms 
through the production of factors such as leukotoxins or lymphocyte-suppressing factors. 
Various bacterial products such as toxins (Listgarten, 1987) lipopolysaccharide (Nair et al., 
1983) and proteases (Uitto et al., 1988) have been shown to have an array of deleterious 
effects on host cells. Further, mucosal keratinocytes and fibroblasts are capable o f adapting 
imder the influence o f such products into highly destructive cellular phenotypes capable of 
expression of, or mediating activity of, host enzymes such as MMPs (Birkedal-Hanson,
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1993). Ultimately they are capable of inducing the inflammatory changes clinically observed 
in periodontal lesions (Zambon et al., 1994, Chapter 1).
2.5.7 CoUagenases
Much interest has centred on the ability of periodontal pathogens to secrete collagenases 
capable of degrading human collagen and hence the CTs involved with attachment. Seifter 
and Harper (1970) found that only a small group of bacteria are capable of such a feat, in 
particular Porphyromonas gingivalis appears capable of degrading type I collagen. More 
recent investigations have demonstrated that the majority o f the collagenase activity present in 
gingival fluids is host derived (Uitto et al., 1990). Salonen et al. (1991b) found that oral- 
gingival derived keratinocytes grown in culture were capable of degrading an underlying 
collagen substratum. This only occurred in the absence of a basement membrane, which may 
be the signal for these cells to secrete matrix-degrading enzymes.
2.5.8 Pathogenesis of periodontal disease
Mechanisms involved in the induction and progression of the destructive chronic 
inflammatory lesion are unclear. Although plaque organisms have been demonstrated within 
periodontal tissues there is little evidence that tissue damage is the result of direct bacterial 
invasion. Page and Schroeder (1976) charted histologically the progression of periodontal 
disease following plaque accumulation thus:
Day 2-4 The initial lesion -  This is only detectable histologically, it being localised
around the base o f the gingival sulcus. There occurs vasodilatation, fluid exudate, cellular 
exudation, enhanced transmigration of PMNs and disruption of intercellular spaces.
Day 4-7 The eariy lesion - Exacerbation of the initial lesion with disruption of
intercellular spaces, failure to maintain attachment to enamel, deepening of the sulcus,
subgingival plaque, lymphocytic infiltration, cytopathic changes in gingival fibroblasts, loss 
o f collagen, hyperplasia of JE and rete ridge formation.
2-3 weeks The established lesion - Further disruption and hyperplasia of JE, ulceration
o f pocket epithelium, predominance of plasma cell infiltrate, continued destruction of gingival 
CT and expansion of volume of tissue involved with varying attempts at repair.
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1 month + The advanced lesion - Characterised by the destruction of the CT attachment 
to the root of the tooth, loss of alveolar bone and pocket formation. As the area of 
inflammatory infiltrate increases, there is destruction of collagen in the supra-alveolar CT and 
the fibres lose their attachment to cementum. This is accompanied by the death of 
cementoblasts and apical migration of the JE to cover the denuded root surface to the level of 
the first intact attachment fibres, resulting in true pocket formation. Periods of quiescence 
follow.
2.5.9 The role of host immunity in periodontitis
Activation of humoral immunity leads to the differentiation of plasma cells and the 
production of immunoglobulins, vdiich could be involved in tissue injury through the 
activation of complement and antibody mediated hypersensitivity reactions. Products of 
microbial plaque are also good activators of complement by the alternate pathway. Both 
pathways result in the generation of biologically active molecules, which can induce vascular 
permeability and are chemotactic for PMNs (Travis et al., 2000).
Cell mediated immunity to oral bacteria is active in periodontal disease and type IV delayed 
hypersensitivity reactions could contribute to tissue injury. The potentially damaging effects 
of activation of T-cells by plaque antigens could be mediated by direct cjdotoxic t-cell activity 
or through release o f lymphocytes (Kinane, 2000).
The cells of the human oral epithelium are an active part of the host defence system rather 
than simply an inert barrier to bacteria and other noxious stimuh. Hillman et al. (1995) 
proposed that the gingival epithelium might participate actively in the inflammatory process 
and that keratinocytes secreting cytokines such as interleukin-ip (IL-ip) during inflammation 
may control the activity of epithelial cells and adjacent inflammatory cells of the CT. 
However, it remains unclear if epithelial cells contribute to tissue breakdown in periodontitis 
(Suchett-Kaye et al., 1998).
2.5.10 Clinical treatments
As periodontal disease is characterised by a loss of CT attachment to teeth, the two goals of 
periodontal th er^y  are to halt the attachment loss and to regenerate the lost periodontal 
apparatus (Piche et al., 1989). To date the most common treatment for chronic periodontitis is 
regular dental scaling and root-planning. This requires thorough removal of deposits (plaque.
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calculus and stain) fix)m the tooth and root surface and removal of cementum or surface dentine 
that is rough and impregnated with calculus. This decreases the bacterial load within the 
surrounding periodontal tissues allowing repair of the epithelial attachment. Maintenance of 
good oral hygiene by the patient is then essential to stop disease progression (Cobb, 1996).
These procedures however do not regenerate original tissue architecture. Several surgical 
techniques have been developed to aid in this including guided tissue regeneration, bone 
grafting and the use o f enamel matrix derivatives. These techniques selectively inhibit 
epithelial down-growth allowing proliferation of the PDL to correctly restore the soft tissue 
architecture. Despite much clinical application, there remains an absence of clinical evidence 
that regenerative therapies increase the life span of teeth (Becker, 1999 and Clauser et al., 
2003).
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2.6 The fibroblast phenotype
2.6.1 Introduction
Fibroblasts are the predominant cell type in sub-epithelial CTs and are responsible for the 
major part of the production of extracellular matrix and growth factors. They perform vital 
roles during normal function, development, regeneration and pathologic alterations (Smith, 
1997 and Lekic et al., 2001). In spite of their widespread anatomical distribution and ease 
with which they are grown in culture, fibroblasts remain a poorly defined cell type.
2.6.2 Fibroblasts of the periodontium
The periodontium is composed of a number of discrete CTs: cementum, alveolar bone, PDL 
and gingiva each with a unique architecture, composition and function. This diversity makes 
periodontal wound healing a more complex process than general soft tissue healing, 
particularly because of the interaction between hard and soft tissues as well as epithelium 
(Irwin et al., 1994). The two populations of fibroblasts within the periodontium that this study 
will examine are the oral-gingival fibroblasts derived fix)m the ectoderm and PDL fibroblasts 
derived fi"om the dental follicle (mesoderm) (Ten Cate, chapter 4,1994).
2.6.2.1 Periodontal ligament fibroblasts
Due to their unique location, PDL fibroblasts together with osteoblasts and cementoblasts 
have the responsibility o f producing, maintaining and remodelling the PDL, cementum and 
bone. It has been proposed that only cells fi-om the PDL have the potential to create new CT 
attachment to the root surface (Nyman et at., 1982). Evidence exists that suggests a 
proportion of PDL fibroblasts express osteoblast-like properties that OGFs lack, (Basdra and 
Komposch, 1997) \ ^ c h  would in part explain the ability of PDL fibroblasts to form 
mineralised nodules in culture and produce the enzyme alkaline phosphatase (ALP) (see 
ch ^ ter 2.6.3). Therefore, PDL fibroblasts possess the ability to form and possibly regenerate 
both hard and soft CT extracellular matrices.
2.6.2.2 Oral-gingival fibroblasts
In contrast, OGFs have the relatively simpler task of producing and maintaining the soft tissue 
lamina propria of the gingiva. They are responsible for synthesising and secreting components 
of the extracellular matrix and play an important part in the remodelling of CTs during 
periodontal inflammation (Hassell and Stanek, 1983 and McCulloch and Bordin, 1991).
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2.63 Fibroblast heterogeneity
The apparent similarity of fibroblasts in culture belies the extensive heterogeneity now 
thought to exist among these cells. Although there are no clear phenotypic markers that 
discriminate different types of fibroblasts from each other, evidence from a number of studies 
indicates that fibroblasts residing within CTs including the gingiva and PDL are 
heterogeneous, with a number of cell subpopulations exhibiting different functional activities 
(Hassell and Stanek, 1983; Mackenzie et al., 1993a; Irwin et al., 1994 and Schor, 1995). A 
growing body of literature has shown that when fibroblasts from normal and diseased tissues 
are grown in vitro, there exist large variations in terms of matrix biosynthesis, enzyme 
activities, expression of surface proteins, response to inflammatory mediators and 
proliferative potentials. For example, Hassell and Stanek (1983) observed a considerable 
degree o f stable variations in synthetic properties and proliferative rates amongst six 
morphologically indistinguishable cultures of human diploid fibroblasts derived from a single 
biopsy of a normal gingival papilla tip.
Heterogeneity has been suggested to be of fundamental importance for normal functioning as 
well as wound healing of CTs, in particularly for the periodontium. Studies by Schor and 
Schor (1987) and Mackenzie (1987) suggested that specificity of a fibroblast phenotype might 
influence not only the metabolism of CTs but also of adjacent epithelia. Heterogeneity in 
production of growth factors and in response to cytokines could be important for the regional 
specific differentiation pattem of adjacent epithelium (Gr0 n, 2001). Fibroblasts are capable of 
synthesizing an array of biological mediators that influence epithelial behaviour. Typical 
interactions involve molecules such as keratinocyte growth factor (KGF) that are targeted to 
receptors on epithelial cells (Boukamp et al., 1990). Conversely, keratinocytes can induce 
specific fibroblast gene expression (Smola et al., 1993). Therefore, a feedback system might 
result as an important part in the interaction between the two cell types (Maas-Szabowski and 
Shimotoyodome, 1999). There is now considerable interest in determining the role of 
fibroblast derived cytokines in remodelling o f diseased periodontal tissues.
2.6.4 Fibroblast characterisation in culture
Morphologically, gingival and PDL cells appear to be similar, having the spindle-shaped 
elongated appearance characteristic o f fibroblast-like cells. However, Piche et al. (1989) 
found at confluence the morphology o f PDL cells to differ fix)m those of the oral-gingival 
region. In addition, the two populations have been shown to differ in terms of size.
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proliferative ability and in expression of extracellular macromolecules (Otsuka and Pitaru, 
1988; Somerman et al., 1988 and Mariotti and Cochran, 1990). PDL cells in vitro have been 
found to have osteoblast-like characteristics, \ ^ c h  include high levels of ALP, production of 
predominately type I collagen and production of osteonectin (Wasi et at., 1984). Typically, 
cells derived from attached gingivae have a fibroblastic phenotype while those derived from 
PDL/cementum have been reported to have either fibroblastic or osteoblastic characteristics.
2.6.4.1 Alkaline phosphatase
The term ALP is broad and describes a group of enzymes that have the capacity to remove 
phosphate moieties fix)m organic substrates at an alkaline pH. In humans, at least four ALP 
isoenzymes are coded by separate gene loci: placental, placental-like, intestinal and tissue 
non-specific (the so called liver/bone/kidney type) (Harris, 1990). Nojima et al. (1990) foimd 
that ALP in bovine PDL cells was the tissue non-specific type which as well as bone 
mineralisation has been observed in vascular endothelia of small arterioles in the brain and 
heart. Goseki et al. (1995) first isolated ALP cDNA from PDL and confirmed it was identical 
to that o f the tissue-non-specific type.
When associated with cell membranes ALP is thought to play a role in ion transport, 
providing phosphate ions at mineralisation sites. It has been suggested that hydrolysis of 
monophosphate esters by the enzyme produces a high concentration of phosphates leading to 
supersatuiation and subsequent precipitation of calcium phosphate salts in the collagenous 
substrate (Beertsen and Van den Bos, 1991). In doing so, Beertsen and Everts (1990) have 
suggested that ALP may play a role in the deposition of calcified layers along exposed 
calcified surfaces. The authors found that regional variations of ALP activity in the 
periodontium of the rat molar were associated with regional variations in cementum 
thickness. Groeneveld et al. (1993) has shown that enzyme activity is higher adjacent to more 
recently deposited cellular cementum compared with acellular cementum.
Numerous studies have shown that gingival fibroblasts, like those in most other tissues 
contain relatively low levels o f ALP activity compared to cells derived from PDL or bone 
(Kawase et al., 1986; Somoman et al., 1988 and Piche et al., 1989). Further work by Gao et 
al. (1999) foimd that ALP activity was highest in osteoblasts, moderate in PDL and lowest in 
OGF cells.
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Abe et al. (1996) conducted ultrahistochemical investigation of chronically inflamed hxraian 
gingiva and found differential expression of ALP activity by OGF depending on tissue 
location. The majority o f fibroblasts located in the inflamed gingival CT, an area with dense 
infiltration of inflammatory cells and scant collagen fibrils, exhibited intense membrane ALP 
activity, whereas the majority of fibroblasts in the adjacent non-inflamed gingival CT showed 
little or no membrane ALP activity. Groeneveld et al. (1996) found that in the CTs of the 
outer part of the free gingiva and that o f the attached gingiva there was hardly any detectable 
activity except for the walls of the blood vessels. In the inner part of the gingiva, which 
underlies the JE, higher levels were foimd. This sudden transition from ALP-rich to ALP-poor 
fibroblasts suggests differing phenotypes localised to their own domain. This finding supports 
a hypothesis that the fibroblasts of the PDL and the inner part of the gingivae are involved in 
the processes leading to cementum formation and possible regeneration. It is feasible that 
those fibroblasts bordering the apical termination of the JE might also influence the 
phenotype of this epithelial tissue.
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2.7 The epithelial phenotype
2.7.1 Introduction
During embryologic development, the phenotype of an epithelium is developmentally 
determined by interactions with its adjacent CT (Kollar and Baird, 1970) and such 
interactions persist in later life to influence epithelial maintenance and repair (Schweizer et 
al., 1984; Hill and Mackenzie, 1984; Mackenzie, 1984 and Cunha et al., 1985). These 
interactions have been considered as either directive (instructive) or permissive in nature 
(Saxen, 1977). Directive influences are distinguished by the “commitment” or permanent 
change that occurs in responding tissues, whereas permissive influences do not determine the 
phenotype but are necessary for its expression. This “developmental” phenotype can however 
be experimentally redirected into new phenotypic patterns by recombination with other CTs 
(Hill and Mackenzie, 1984; Mackenzie, 1984 and Cunha et al., 1985).
The structure o f human oral mucosa exhibits marked regional variations encompassing 
parakeratinised, orthokeratinised, keratinised, and non-keratinised epithelia. This histological 
variation across such a smaU anatomical distance makes the oral-gingival epithelia 
particularly important in the study o f epithelial cell characteristics versus mesenchymal 
instruction in determining epithelial differentiation (Lindberg and Rheinwald, 1990).
2.7.2 Connective tissue influences
Breathnach (1971) found that human oral mucosa acquires its adult pattem of differentiation 
and keratinisation at the fifth month post-conception, approximately the same time as human 
skin. This goes some way in dictating that regional differences in epithelia are not brought 
about purely by demands placed upon them by fimction.
The gingival sub-epithelial CT (the lamina propria) provides instructive influences for the 
normal maturation of gingival stratified squamous epithelia and these influences are said to be 
absent fix>m deep CT (Mackenzie and Hill, 1984; Fusenig et al., 1991 and 1994 and 
Mackenzie et al., 1993). Evidence for this was provided by Mackenzie and Hill (1981). Full 
thickness mouse oral mucosa was grafted to deep CT in an in vitro model system. The 
epithelium differentiated normally over its own lamina propria however, there was a small 
outgrowth of epithelium onto the deep CT that did not migrate to epithelialise the whole graft 
bed. This outgrowth was proliferative, formed a basal lamina, shared a passive non-migratory
Chapter two: Literature review 2 3
behaviour and acquired a differentiation pattem similar to JE (See chapter 2.7.6.4). It was 
characterized by co-expression of the basal cell markers of a stratifying epithelium (CK4 and
5) with suprabasal expression of markers typical of a simple epithelium (CK8, 18, 19 and 
Lewis blood group antigens).
2.73 The junctional phenotype
Although very little is known about the interactions involved in the formation and 
maintenance o f JE in vivo, evidence indicates that two basic processes are in operation:
1) Cell-cell interactions
The anatomical arrangement of the sulcular region is such that the gingival CT supports OGE, 
\^4iereas the JE is spatially related to PDL. As discussed in chapter 2.6.3 evidence from a 
number of studies indicates that fibroblasts residing within CT, including the periodontium, 
are heterogeneous. The PDL being odontogenically derived differs in its developmental 
history to gingival CT and thus, possibly exerts varying levels of, or indeed different 
instructive and permissive influences on its overlying JE. Altematively, if periodontal CT is a 
functionally “deep” CT it may lack both directive and permissive influences. Therefore, the 
pattem of differentiation of JE could be viewed as a regionally specific phenotype influenced 
by the periodontal CTs lack of signalling molecules.
The regenerative properties of the attachment zone provide further evidence of this 
phenomenon. When the JE is surgically removed a fimctionally and stmcturally identical 
tissue reforms from the residual, phenotypically different OGE (Schroeder and Listgarten, 
1971). This suggests that the new epithelium, although derived from OGE, re-differentiates 
into JE on appositional growth against the PDL.
2) Epithelium-dental surface interactions
Biopsies of the “gingiva” reformed around oral implants stained for cytokeratins (CK) in a 
pattem that was phenotypically indistinguishable from those of natural teeth (Mackenzie and 
Tonetti, 1995). This being the case despite there being no involvement of odontogenic 
tissues. This provides evidence that the formation of JE, although possibly directed by 
underlying CT does not necessarily require its developmental odontogenic CT, the PDL. 
More likely an explanation is that teeth (and osseointegrated implants) create a “geometry” 
of apposition of epithelium to a deep CT.
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Oral epithelial cells have the capacity to attach and migrate on mineralised root surfaces, 
deposit a basal lamina and stratify. This indicates that contact with tooth mineral and/or 
proteins adsorbed onto its surface affect epithelial cell attachment, migration and 
differentiation. This finding indicates that cell-to-tooth surface contact induces the polarised 
secretion o f extracellular matrix proteins, which in tum may affect cell differentiation. Keratin 
typing and immunohistochemical (IHC) staining of the intemal and external basal laminae of 
JE indicate that the basal cells by virtue of their tooth contact are different from those facing 
the CT (Salonen et al., 1989).
In summary, regional variations in epithelial phenotype may thus reflect phenotypic 
differences between fibroblast subpopulations in the sub-epithelial CT (McKeown et al., 
2003).
2.7.4 Inflammatory influences
If non-permissiveness of periodontal CT is accepted as a working hypothesis, the question 
arises as to why apical migration of the epithehum occurs at all during periodontal disease. 
The epithelium adjacent to mucosal transplants fails to epithelialise the adjacent deep CT 
despite the absence of any physical barrier to its outgrowth (Listgarten et al., 1991). Thus, 
loss of attachment of CT to the tooth would not in itself be sufficient to initiate epithelial 
down-growth.
The CT associated with the dento-gingival junction is often inflamed and it has been 
suggested that factors associated with inflammation can substitute for permissive factors 
produced by dermal cells, or can perhaps act to favour selective outgrowth of fibroblasts of 
the permissive phenotype. Kristofferson et al. (1983) proposed that it is for this reason the 
OSE and OGE phenotypes are markedly different (non-keratinised versus keratinised) yet 
both are supported by the gingival lamina propria. A direct role for inflammation in 
stimulating epithelial growth and differentiation is suggested by the behaviour of the rests of 
Malassez in periapical granulomas (Gao et al., 1988). In their quiescent state within healthy 
PDL these rests strongly express only CK5 and 19, however, under the influence of 
inflammation they become activated to a proliferative state and express additional keratins 
characteristic of both stratifying and simple epithelia. Normally the CT is responding to 
signals fix)m the epithelium itself, but similar signals are also generated by inflammation, 
which may alter epithelial growth and migration as discussed below.
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2.7^ Characterisation of the oral epithelial phenotypes
Although continuous with OSE and OGE, JE differs from them histologically and 
ultrastmcturally (Schroeder and Listgarten, 1971). It has been distinguished in terms of 
expression of the cytokeratins (Morgan et al., 1986; Shabana et al., 1991 and Mackenzie et 
al., 1991) blood group antigens (Steffensen et al., 1987 and Mackenzie et al., 1989) integrins 
(Hormia et al., 1990) intracellular adhesion molecule-1 (Crawford and Hopp, 1990) type VIII 
collagen (Salonen et al., 1991a) lectin reactivity (Bampton et al., 1991) desmoplakins I+II 
(Carmichael et al., 1991) MMP-7 (Uitto et al., 2002) and MMP-9 (Smith et al., 2004). 
Differences in expression patterns can therefore be used to demarcate the epithelia of the 
gingiva, particular the JE, by staining ex vivo sections and cells cultured in vitro.
2.7.6 Cytokeratms
2.7.6.1 Introduction
Cytokeratins are 7-llnm  tonofilaments composed of polypeptides o f a wide range of sizes 
(from about 40,000 to over 200,000 Mr) that vary both between different cell types and in the 
same cell type and between different species. They are the products of two distinct gene 
families (Fuchs et al., 1981) composed o f smaller acidic type-I filaments and the larger, more 
basic type-II filaments. They are assigned numbers depending upon their relative migration 
by charge and molecular weight on a two-dimensional polyacrylamide gel. The basic proteins 
numbered 1-8 and the acidic proteins ntimbered 9 through 20.
2.7.6.2 Keratin expression patterns
Development of monoclonal antibodies (mABs) to individual keratin polypeptides has 
enabled in-situ studies to be carried out. It has been found that keratins are expressed in size- 
ranked pairs containing one of each type o f keratin except keratins 15 and 19 that appear to be 
unpaired (Sun et al., 1985 and Waseem et al., 1998). These are summarised in table 2.1.
Table 2.1: Epithelial type and paired keratin expression
Acidic Basic Markers of:
10 I Suprabasal cells of stratifying keratinised epithelia
13 4 Suprabasal cells of stratifying non-keratinised epithelia
14 5 Basal layers of stratifying epithelia (and suprabasal in culture)
16 6 Suprabasal cells of rapidly proliferating stratifying epithelia
18 8 Simple epithelia
15 Basal cells of stratified epithelia (sporadic distribution in culture)
19 Simple and transitional epithelia
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Cytokeratin expression in any epithelimn is one of its most invariable characteristics, so much 
so that keratin mapping is now considered to be a very sensitive and specific method for 
following the development and differentiation of epithelial tissue (Moll and Franke, 1982; 
Ouhayoun and Gosselin et al., 1985 and Gosselin and Magloire, 1990). There have been a 
number of studies of keratin expression by the different oral epithelia: alveolar mucosa 
(Ouhayoim and Gosselin, 1985) buccal mucosa, tongue and hard palate (Clausen et al., 1986) 
cheek and hard palate (Morgan et al., 1987) and gingiva (Shabana et al., 1991; Mackenzie et 
al., 1991 and Mackenzie and Gao, 1993).
First Ouhayoun and Gosselin (1985) and then Morgan et al. (1986) using a panel of mABs 
specific for single or small defined groups of keratin peptides, showed that the three epithelia 
o f the human gingiva each have a distinct pattem of expression of keratin polypeptides 
reflecting their histologic type and differentiation state. In general, basal cells in all stratified 
oral epithelia express similar keratins, CK5, 14 and 15, while the suprabasal cells express a 
specific set of markers indicating commitment to a distinct program of differentiation. CK4 
and 13 relate to non-keratinising stratified epithelia, CKl and 10 keratinising epithelia and 
CK6 and 16 indicating a proliferative phenotype. These differences are summarised in table 
2 .2 .
Table 2.2: Regional expression of cytokeratins throughout human gingivae
Phenot3i>e Basal keratin expression Suprabasal keratin expression |
OGE CK5, 14 and 15 (19 at tips o f rete (Morgan et 
a l,  1987))
CKl and 10 (described as patchy) [ 
CK5 and 14 
CK6 and 16
OSE CK5, 14 and 15 (8,18,19 described by some 
(Ban^>ton et a/., 1991))
C K 4andl3
C K 6andl6
JE CK5, 14, 15 and 19 throughout all levels (CK8 and 18 variable and faint) 
(CK6 and 16 present in die developing JE (Feghali-Assaly and Sawaf, 1994))
2.7.63 Oral-gingivai and oral-sulcular epithelium
OGE and OSE express different sets of keratins in the suprabasal layers. The suprabasal 
compartment above the level of rete pegs to include the upper part of stratum spinosum and 
stratum granulosum of OGE expresses CKl and 10. Expression is less pronounced in the 
stratum comeum. These cytokeratins characterise the orthokeratinising, terminally 
differentiating epidermal type. OSE expresses CK4 and 13, characteristically expressed 
suprabasally by non-keratinised stratified squamous epithelia. Sporadic suprabasal cells
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within OGE samples also exhibited CK4/13 possibly as a response to inflammation (Morgan 
et al., 1987). Cytokeratins 6 and 16 stain suprabasal cells predominately in keratinised regions 
of OGE and to include focal staining of OSE.
2.T.6.4 Junctional epithelium
Ultrastructural studies initially characterized the JE as an undifferentiated epithelium 
(Schroeder and Listgarten, 1971) and immunohistochemical studies showed its lack of 
expression of the major differentiation products that characterise other oral epithelia (Morgan 
et al., 1986 and Steffensen et al., 1987). However, it is now clear that JE is far fi-om 
undifferentiated; several studies have shown that JE has a highly unusual pattem of 
differentiation in which markers typical o f stratifying and simple epithelia are co-expressed. 
The JE is unique with respect to expression o f CKl 9 and the simple cytokeratins 7, 8 and 18 
(Mackenzie et al., 1991). Cytokeratin 19 expression is differential across the distribution of 
the JE; within the coronal portion of the JE tissue, it strongly expresses CKl9 in the basal 
cells adjacent to the CT and in the cells attached to the tooth surface, but more weakly within 
the interior. This differential staining would also imply that the cells are undergoing 
differentiation as they move away fix>m the tooth surface or the CT (Salonen et al., 1989). 
Interestingly, JE cells in vivo have not been found to express CK6 or 16, despite these being 
associated with tissues of rapid tumover. Feghali-Assaly et al. (1994 and 1997) investigated 
the CK profile within the developing JE of partially empted teeth and found characteristics of 
a transitional epithelium, developing fix>m a simple to stratified epithelium expressing not 
only CK5 and 19, but C K 4,13 and 16 also.
2.7.7 Lectins
Lectins are non-enzymatic proteins or glycoproteins of non-immune origin that bind 
carbohydrates and can agglutinate cells and/or precipitate glycoconjugates. They are involved 
in a variety of cellular processes including enzyme trafficking and immune function. Lectins 
have been used extensively to study skin keratinocytes, both in-situ and as isolated cells, and 
to study normal differentiation and pathological conditions (Goldstein and Hayes, 1978 and 
Schaumburg-Lever, 1990). Although there have been studies describing their reactivity within 
oral mucosa there have been few studies of their expression in gingiva. Rittman et al. (1982) 
demonstrated that the lectin binding intensity of the JE in the mouse differed fi-om that of the 
OSE and OGE. Bampton et al. (1991) devised a panning technique to separate the JE 
phenotype dependant on lectin reactivity in normal human junctional, sulcular, and attached
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gingival epithelia. They then confinned the identity o f the epithelia by parallel staining with 
cytokeratin antibodies. It was established that the reactivity of the lectin dolichos biflorus 
agglutinin with JE was specific.
2.7.8 Matrix metalloproteinase-T
Uitto et al. (2002) recently revealed that Matrilysin, an MMP that is expressed in exocrine 
and mucosal epithelia, is expressed in suprabasal cells of the JE facing the teeth and in the 
epithelial cell rests of Malassez. Monoclonal antibodies to MMP-7 proved successful in 
identifying JE cells in a tissue culture model mimicking JE (Uitto et al., 2002).
2.7.9 Intercellular adhesion molecule-1
Intercellular adhesion molecule-1 (ICAM-1) is a widely distributed cell adhesion molecule 
involved in interactions with epithelial cells. Crawford and Hopp (1990) found ICAM-1 to be 
selectively expressed by JE cells in healthy gingivae at detectable levels. Moughal et al. 
(1992) confirmed this expression and found that there was a gradient, with the strongest 
staining at the crevicular aspect. ICAM-1 expression by keratinocytes is induced by biological 
mediators such as IL-1 and lipopolysaccharide (EPS); it is therefore likely that the variation in 
ICAM-1 expression in gingival tissues reflects that variation in the distribution of biological 
response modifiers to bacterial load.
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2.8 Cell culture
2.8.1 Keratinocytes in culture
Mlineck and Buchner (1975) first developed a simplified method for growing gingival 
epithelium by explant outgrowth. However, it was Rheinwald and Green (1975), using a 
feeder layer of irradiated mouse fibroblasts, who first established the technique of growing 
human epidermal keratinocytes that allowed them to be successfully sub-cultured.
2.8.2 Junctional epithelium in culture
Salonen and Santti (1985) were the first to attempt to construct an in vitro JE model by 
simulating the JE attachment zone by growing oral epithelial cells on a membrane. It was 
Altman et al. (1988) who first successfully cultured and characterised true JE derived cells 
albeit from the rat.
As discussed in chapter 2.7.5 woik then concentrated on finding markers that differentiate 
between OGE and JE and that were retained in vitro. Bampton et al. (1991) using DBA in a 
panning technique successfully isolated and cultured keratinocytes fiom human JE and 
compared their phenotype in vitro with that of cells grown fi"om the oral-sulcular and attached 
OGE. All cells expressed CK4, 7, 14, 18 and 19 indicating, at least with respect to their 
keratin expression, that cells fi’om the three regions of the gingiva may revert to one 
phenotype in culture.
Gao and Mackenzie (1992) demonstrated that during standardized in vitro culture conditions 
OGE lost expression of the differentiation markers CKl and 10 and acquired some expression 
of CKl 9, but less so than that of JE.
Matsuyama and Izumi (1997) established a culture o f human JE cells derived from gingival 
tissue attached to the tooth surface, and characterised these cells immunocytochemically and 
ultra-structurally. Again, the expression pattem of CK l9 was observed not only by cells from 
junctional tissue but also by cells from gingival tissue. However, as with Bampton’s work, 
DBA was specific in only reacting with cells from the junctional tissue.
Studies have been conducted into possible modulators of cytokeratin expression by 
keratinocytes in culture, specifically retinoic acid. This has shown minor effects on the
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marker expression of JE but markedly enhanced expression of cytokeratins 8, 18, 19, 
vimentin and ICAM-1 in OGE. These observations indicate that the response to retinoic acid 
can affect the phenot)^s expressed by epithelia in vitro and suggest that such mechanisms 
may be related to the different phenotypic patterns expressed by gingival epithelia in vivo 
(Gao and Mackenzie, 1996).
These results support the hypothesis that epithelial phenotype is influenced by the sub- 
epithelial mesenchyme, and therefore may be partly responsible for the unique phenotype of 
the JE (Mackenzie, 1987). It is likely that epithelial-mesenchymal interactions act to direct 
and maintain epithelial differentiation in vivo however, there are also likely to be intrinsic 
differences between epithelia that help maintain their phenotype. This has been demonstrated 
by phenotypic maintenance of epithelia under in vitro culture conditions despite the removal 
of their specific underlying mesenchymal tissues (Asselineau et al., 1986 and Delcourt-Huard 
etal., 1997).
2.83 Media
Complex supplemented media have been formulated to allow epithelial growth (Wu et al.,
1982). Generally, to a basal medium such as DMEM is added serum, hydrocortisone 
(promotes cell attachment and proliferation, can induce cell differentiation) EGF (mitogen for 
epithelial and fibroblast cells that delays terminal differentiation) and cholera toxin (mitogen 
for normal epithelia, promotes growth and induces differentiation). Vitamin A and retinoids 
have also been shown to have mariced effects on cultured keratinocytes, higher levels 
increasing proliferation, promoting desmosome formation and increasing CKl9 expression 
(Eckert and Green, 1984 and Kautsky et al., 1995).
2.8.4 Holoclones, meroclones and paraclones
Epithelial renewal depends ultimately on a subpopulation of stem cells present within the 
proliferative cell population (Cotsarelis et al., 1999). Within epithelial culture systems, 
colonies are formed fi*om individual cells resulting in “clonal colonies”. Barrandon and Green 
(1985 and 1987) predicted that once such clones have been derived fi’om a single keratinocyte 
their growth potential can be estimated from the resulting morphology:
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Holoclones - that have the greatest reproductive capacity, fewer than 5% of the colonies 
formed by holoclones abort and terminally differentiate. They typically consist of small, 
rounded cells that may be repeatedly amplified and are believed to contain the stem cell 
component.
Paraclones - that contain exclusively cells with a short replicative lifespan after which they 
uniformly abort and terminally differentiate. They appear somewhat dissociated, are 
generally larger and irregularly shaped and fail to passage successfully.
Meroclones - that appear as intermediate colony forms containing cells of different growth 
potential.
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2.9 Oi^anotypic culture
2.9.1 Introduction
Keratinocytes and fibroblasts are the most prominent ceil type in epidermal and dermal tissue 
compartments respectively; therefore, cellular interactions during epithelial development are 
thought to incorporate both:
1) Direct keratinocyte-fibroblast contact and
2) Exchange o f soluble mediators that fimction in either an autocrine or paracrine 
manner.
Given the complex nature of the developmental microenvironment, it has been difficult to 
determine the exact nature and timing of these interactions in vivo.
Stratifying squamous epithelia differ regionally in their suprabasal expression of 
differentiation markers but these characteristic patterns of in vivo marker expression are at 
least partially lost when isolated epithelial cells are grown in vitro (Mackenzie and Fusenig,
1983). Using the in vitro model systems that follow, many aspects of tissue homeostasis and 
control have been investigated.
2.9.2 Collagen lattice systems
Fibroblast populated collagen lattices represent a model system that addresses some of the 
limitations of monolayer cultures. It was Bell et al. (1981) who constructed the first lattice 
systems using grafts consisting of fibroblasts cast in collagen and seeded with epidermal cells. 
Later advances in this technique have allowed growth on various substrates and membranes 
(Nishikawa e /a /., 1987).
2.93 Organotypic models or "skin equivalents”
The closest in vitro physiological conditions for epithelial differentiation are reproduced 
within organotypic culture systems in wfiich epithelial cells are grown on fibroblast 
containing collagen matrices. Asselineau et al. (1986) and Lenoir and Bemard (1990) have 
demonstrated more normal in v/vo-like patterns of stratification and cell morphology. More 
ordered proliferation, expression of differentiation markers and reformation of a basal lamina 
has been demonstrated within these systems (Smola et al., 1998). Keratinocytes have been 
shown to express integrins, ICAM-1 and suprabasal differentiation markers typical of the 
epithelia of origin (Tomakidi et a l, 1999; Gao and Mackenzie, 1996 and Gron and
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Andersson, 1999). In such cultures, other epithelia including oral mucosa similarly express 
more normal phenotypic patterns (Shabana et al., 1991). It has been suggested by several 
parties that growth of keratinocytes on CT equivalents is a valid procedure for investigating 
the spatial organisation of physiological processes, the role of cell-to-cell interactions, and 
gene expression (Garlick and Taichman, 1994 and Stark and Baur, 1999).
The latest research in skin organotypics, in particular that by Mass-Szabowski et al. (1999, 
2000 and 2001) have begun to dissect intricate growth factor mediated processes and 
autocrine loops involved in epithelial growth and differentiation, in particular a role for KGF 
in normal epithelial growth and development (Costea et al., 2003).
2.9.4 The gingivai organotjqiic culture
Gosselin et al. (1989) first used gingival keratinocytes within an organotypic method 
consisting of human dermal fibroblasts. Odioso and Doyle (1995) used homotypic 
combinations of gingival fibroblasts to support gingival epithelial cells within a submerged 
model. Garlick et al. (1996) and Delcourt-huard and Corlu (1997) further refined the 
technique to allow epithelial maturation at the air-liquid interface. Tomakidi et al. (1997) 
using a similar raised configuration, found formation of non-keratinising stratified squamous 
epithelium with morphological and biochemical characteristics of non-keratinised gingiva and 
basement membrane formation containing type IV collagen and laminin. Latest 
methodologies have led to the construction of large area organotypic cultures of oral mucosa 
that may prove usefiil in intra-oral grafting procedures (Igarashi et al., 2003).
2.9.5 The junctional organotypic culture
Several in vitro models have been developed for studying the structure and function of the JE. 
Salonen and Santti (1983) examined ultrastructural and immunohistochemical similarities in 
the attachment of human oral epithelium to the tooth in vivo using micro-porous filters and 
decalcified dentin matrix slices as culture substratum. Further, Salonen and Santti (1985) 
attempted to develop a JE model using gingival explants cultured on a protein-binding 
membrane. Epithelial cells migrated fix>m the cut edge of epithelium and CT forming a sheet 
of tissue between the explant and the membrane substratum. The resultant epithelium, 
although not directly derived from the JE was phenotypically similar to JE cells in vivo by 
nature of its cytokeratin expression.
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Pan and Firth (1995) were the first to describe an organotypic model using cultured JE cells 
albeit porcine derived. Papaioannou and Cassiman (1999) were the first to describe a human 
JE organotypic culture system using “pocket epithelium” grown on a polyester trans-well 
system with a keratinocyte serum -fi^ medium. Although multi-layered epithelium was 
successfully cultured, immunohistochemically it confusingly resembled both junctional and 
“pocket” (sulcular) epithelia. An organotypic in vitro model that mimics the dento-epithelial 
junction was proposed by Oksanen and Hormia (2002) using rat enamel to provide the added 
physiological copy of a hard tissue surface and thus the internal basement membrane.
To date all JE based organotypic culture studies have involved the use of oral keratinocytes 
and a substrate (either polycarbonate membrane or dentinal tooth slice) to induce re- 
differentiation of the OGE into the JE phenotype.
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2.10 Cytokines and their maintenance of epithelium
2.10.1 Introduction
Cytokines are small (glyco)proteins produced by cells and are capable of affecting the 
activities o f the same (autocrine) or other cell types (paracrine). They have been implicated in 
the pathogenesis of many diseases (Kreuger et al., 1990; Alexander and Damoulis, 1994 and 
Dinarello, 2002). They are ubiquitous; being produced by all cells and deliver signals over 
relatively short distances by binding to high affinity receptors at extremely low concentrations 
(Meager, 1991). A given cytokine may have different (pleiotropic) effects on different types 
of cells, and there are often overlapping effects (redundancy) with several different cytokines 
having a similar effect on the same cell type (Howells, 1995). Resting cells produce low 
levels of cytokines but production is upregulated when they are activated, typically by the 
actions of other cytokines. Cytokines thus function in networks with the actions of individual 
cytokines being controlled by positive and negative feedback from other cytokines 
(McFarlane et al., 1990; Luger and Schwartz, 1994 and Hanada and Yoshimura, 2002).
Cytokine networks influence the growth and differentiation of stratified squamous epithelia. 
Cytokines produced by the epithelium itself influence epithelial homeostasis; for example 
TGFa stimulates proliferation (Derynck, 1988) and TGFp inhibits it and enhances 
differentiation (Massague, 1990). The epidermis also produces cytokines that influence the 
immime response, for example epidermal synthesis of the interleukins (Krueger et al., 1990). 
The complexity o f these interactions makes it difficult to determine which cytokines are of 
particular importance to the epithelial prohferative and migratory responses seen in 
periodontal disease (Alexander and Damoulis, 1994) or even woimd healing (Stephens and 
Thomas, 2002 and Thomas and Harding, 2002). However, the results of both transgenic and 
functional studies indicate a central role for KGF both in developmental interactions and in 
the normal maintenance and wound healing responses of adult epithelia (Guo et al., 1993).
Many reports exist in the literature describing the spatial distribution of cytokines and their 
receptors in various tissue types. The skin, a close approximation of the gingivae, has been the 
subject o f numerous in vivo and in vitro studies performed regarding certain cytokine 
networks (Schroeder, 1995 and Wemer and Grose, 2002). However, evidence for other 
cj^okines, in particular their presence within periodontal tissues is either conflicting or absent, 
summaries of which are presented below.
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2.10.2 Keratinocyte growth factor
Rubin et al. (1989) first isolated KGF fi-om medium conditioned by growth of a human 
embryonic fibroblast cell line and demonstrated its potent mitogenic activity for 
keratinocytes. KGF, alternatively designated FGF-7, is a member of the fibroblast growth 
factor family of related proteins (Finch et al., 1989) that contains at least 23 related genes 
(Mason, 1994 and Shimada et al., 2004). In vivo, KGF is described as a paracrine acting 
growth factor produced by mesenchymal cells to stimulate epithelial cell proliferation via 
KGF receptors expressed exclusively on epithelial cells (Rubin et al., 1989; Miki et al., 1992 
and Wemer et al., 1992). There is no corresponding mitogenic activity of KGF on fibroblasts, 
endothelial cells or other non-epithelial targets of FGF action (Rubin, et al, 1989 and Finch et 
al., 1995a). Of particular interest are recent observations that KGF expression is upregulated 
early after full thickness skin injury to a much greater extent than other FGFs and remained 
elevated thought the first 7 days after injury, implicating KGF as a potentially important 
physiological mediator of wound repair (Wemer, 1998).
KGF gene expression can be induced by a number of cytokines and growth factors such as 
IL-6, TGFa and platelet derived growth factor (PDGF). IL-1 in particular has been shown to 
induce raised KGF mRNA within dermal fibroblasts (Braulche et al., 1994 and Chedid et a l
1994). The strong inductive response of fibroblasts to IL-1 appears relevant to the normal 
expression of KGF in the sub-epithelial stroma. The epidermis normally contains levels of 
IL-1 that are 100 to 1000-fold higher than most other tissues and it secretes biologically- 
active IL-1, predominantly as IL-1 a  (Cork et al., 1996). By this paracrine mechanism the 
epithelium itself appears to induce local fibroblasts to produce the KGF required for its 
maintenance (Chedid et a l, 1994).
Many studies have reported KGF expression within both OGF and PDL fibroblasts 
(Dabelsteen and Wandall, 1997; Gr0 n et al., 2001; Mackenzie and Gao, 2001 and Mckeown 
et a l, 2003). Analysis of mRNA fix)m fibroblasts from different tissues suggests that KGF in 
adults is produced by a subpopulation of fibroblasts located in superficial CT adjacent to 
epithelium (Gao and Mackenzie, 1996); and may in this way regulate epithelial 
differentiation (Finch et a l, 1995b and Wemer, 1998). This in conjunction with recent in-situ 
hybridisation studies fix>m oral mucosa indicates that KGF is limited to fibroblasts in the 
lamina propria with no expression in deeper CT. This has led to the hypothesis that the
Chapter two: Literature review 3 7
specific phenotype of JE is due to its position adjacent to the PDL, which may be regarded as 
a deep CT not expressing KGF (Gao and Mackenzie, 1992).
2.103 Keratinocyte growth factor receptor
KGF actions are dependant on its binding to a specific cell surface receptor, keratinocyte 
growth factor receptor (KGFR). KGFR is a membrane-spanning tyrosine kinase, which is a 
splice variant of the FGF receptor 2/bek gene, FGFR-2 Illb. It has high affinity for KGF as 
well as for acidic-FGF but not basic-FGF (Miki et al, 1992). It differs from the FGFR-2, 
which has high affinity for acidic and basic-FGF but no affinity for KGF (Bottaro et al., 
1990). The bek gene encodes both receptors with alternative splicing of exons that determine 
expression of immunoglobulin-like loops giving differential receptor specificity for FGF- 
related ligands (Cheon et al, 1994). Whereas epithelial cells express transcripts containing 
only the exon sequence specific for KGFR, mesenchymal cells express transcripts for the 
exon sequence specific for FGFR-2. The KGFR and FGFR-2 sequences are structurally 
identical but for a stretch of 49 amino acids of the extracellular domain (Miki et a l, 1992).
KGFR is expressed predominately in the basal layer of most types of epithelial cells in vivo 
(Guo et a l, 1993) and in vitro (Rubin et a l, 1995). The receptor has been located in gingival 
epithelium by Das et al. (2001) and Ohshima et al. (2002a). There exists no published work 
relating to KGF receptor in JE tissue.
2.10.4 Keratinoeyte growth factor-2
Keratinocyte growth factor-2 (KGF-2 or FGF-10) is a homologue of FGF-7. It binds with an 
equal affinity to the FGF-7 resident epithelial cell receptor FGFR-2 Illb, but unlike FGF-7 
also binds the Illb splice variant of FGFR-1. Evolutionary relationships of human FGFs 
indicated that KGF-2 is closest to FGF-7 in both structure and biologic activity (Emoto et al., 
1997). Recombinant human KGF-2 shows mitogenic activity for foetal rat keratinising 
epidermal cells, but essentially no activity for fibroblasts. Murine KGF-2 appears to be a 
primary factor in the process of wound healing in conjunction with other growth factors such 
as TGFa and KGF (Jimenez and Rampy, 1999). There even exists a commercially available 
preparation, designated Repifermin (Human Genome Sciences) available for wound healing 
purposes.
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There exist few articles on the distribution of KGF-2 within tissues, even less so within the 
periodontium. Using Northern blot analysis and IHC Sanale et al. (2002) detected expression 
of KGF-2 in the fibroblasts of the lamina propria.
2.10.5 Hepatocyte growth factor
HGF was isolated initially fi’om the serum of partially hepatectomised rats, it being produced 
predominantly in the liver and the pancreas. Gherardi and Stoker (1990) foimd that HGF is 
structurally similar to scatter factor (SF), a molecule shown to stimulate the dissociation and 
scattering of epithelial cells. Later, Weidner et a/. (1991) presented structural and fimctional 
evidence that human scatter factor and human HGF are identical proteins encoded by a single 
gene.
As well as being hepatotrophic HGF is a classical paracrine mediator of stromal-epithelial 
interactions and is expressed by mesenchymal cells in close vicinity to epithelial structures 
(Gherardi and Stoker, 1990). It is considered a possible mediator of epithelial-mesenchymal 
interaction during organogenesis and organ regeneration (Birchmeier and Gherardi, 1998). It 
disrupts desmosomal junctions between epithelial cells and induces a motile, fibroblast-like 
phenotype in individual cells. The factor therefore also influences the invasive growth of 
tumour cells derived fix>m epithelial cells (Birchmeier et al., 1996), and may be involved in 
the processes o f wound-healing and early embryonic development (Sonnenberg et al., 1993). 
In human skin, both molecular forms of IL-1 induce fibroblast synthesis of HGF. HGF is 
therefore a multifimctional cytokine that acts as a mitogen, motogen and a morphogen 
(Sonnenberg et al., 1993).
Bottaro et a/. (1991) demonstrated that the beta-subunit of the c-Met proto-oncogene product 
is the cell-surface receptor for HGF. c-Met is over-expressed in a significant percentage of 
human cancers and is amplified during the transition between primary tumours and 
metastasis.
Essentially, studies have shoAvn distribution of HGF/KGF to mirror those of KGF/KGFR 
with expression of the cytokine demonstrated within OGF (Gr0 n et al., 2001; Ohshima et al., 
2002a and McKeown et al, 2003) and its receptor identified within OGE by Ohshima et al 
(2002a).
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2.10.6 Granulocyte macrophage-colony stimulating factor
Colony-stimulating factors (CSFs) are proteins necessary for the survival, proliferation and 
differentiation of haematopoietic progenitor cells (Metcalf, 1992). GM-CSF also plays a 
significant role in keratinocyte proliferation in vitro and speeds healing of skin wounds 
(Hancock et al., 1988). GM-CSF is secreted together with other factors by T-cells and 
macrophages following cell activation by antigens or mitogens. Epithelial cells and fibroblasts 
respond to IL-1 a  by producing GM-CSF in a dose dependant fashion (Cubitt et al., 1994). 
The synthesis of GM-CSF by various other cell types, for example endothelial cells and 
fibroblasts, is inducible by TNFa, TNFp and IL-1 (Fitzgerald et al., 2003). GM-CSF can be 
associated with the ECM of cells as a complex with heparin sulphate proteoglycans. This 
allows storage of the factor in a biologically inactive form. GM-CSF can be expressed also as 
an integral membrane protein. The membrane-bound or matrix-associated forms of the factor 
can interact with receptors on other nearby cells, establishing cell-to-cell contacts that may 
induce biological activities in juxtaposed cells (Montagnani et al., 2001).
Sugiyama et al. (2002) identified GM-CSF within cultured gingival keratinocytes by both 
ELISA and PCR methods. For fibroblasts however there exist conflicting results; Nixon et al. 
(2000) did not find GM-CSF within cultured OGF, likewise the only paper relating to PDL 
was by Yamaji et al. (1995) who also did not identify GM-CSF by RT-PCR methods. Some 
studies have demonstrated GM-CSF induction in stimulated (woxmded) epithelia (Mann et 
a l, 2001).
Under in vitro conditions GM-CSF receptor has been demonstrated in both CT and epithelial 
components of the skin (Montagnani et a l, 2001 and Maas-Szabowski et a l, 2001) but no 
papers relate specifically to oral tissues.
2.10.7 Transformmg growth factor alpha
Transforming growth factors (TGFs) are biologically active polypeptides that reversibly 
confer the transformed phenotype on cultured cells. TGFa shows about 40% sequence 
homology with epidermal growth factor (EGF) (Derynck, 1988). The biological activities of 
these two growth factors are very similar and both bind to the same receptor. The 
transmembrane precursor of TGFa can bind to EGF receptors on near-by cells. This enables it
Chapter two: Literature review
to establish specific cell-to-cell contacts and to elicit developmentally important responses in 
neighbouring cells (Derynck, 1992).
TGFa is produced by keratinocytes, macrophages, hepatocytes and platelets, and its synthesis 
can be stimulated by infection with viruses (Christensen and Poulsen, 1996). The 
physiological role of TGFa is probably the control of epidermal development during 
differentiation of cells as it has a known autocrine action within the skin (Mass-Szabowski et 
al., 2001). An increased production of TGFa is commonly associated with neoplastic 
transformation of various cell types (Ju, 1991).
Concerning the periodontium, TGFa levels have been found to be lower in the gingival 
crevicular fluid of patients with chronic periodontal disease (Mogi et al., 1999), which may 
result in delayed periodontal regeneration during the progression of the disease. TGFa has 
been identified within fi*eshly isolated oral keratinocytes by Formanek et al. (1999) using 
both ELISA and PCR, and by Momose et al. (2002) using ELISA.
Several references state that TGFa is released by embryonic fibroblasts and plays an 
important role in the developing foetus (Locci et al., 1993). Xu et al. (2000) recognised 
TGFa by IHC within interfacial membranes retrieved at revision total hip arthroplasty, 
whereas Rotaru et al. (2003) found TGFa localised to the basal epithelial layer and adjacent 
fibroblast layer in a series of oral fibromas. Li et al. (1997) detected TGFa in the walls of 
odontogenic cysts by IHC. Yamaji et al. (1995) however could not detect TGFa within PDL 
fibroblasts by means of PCR, and Tyler et al. (1999) did not detect TGFa in periapical 
granulomas again using PCR.
2 .10.8 Interleukin-l alpha
IL-1 was previously described as lymphocyte-activating factor and was thought to be 
produced only by monocytes, however it is now known to be synthesized by a variety of cell 
types including activated macrophages, keratinocytes, stimulated B-lymphocytes and 
fibroblasts, and is a potent mediator o f inflammation and immunity (Dinarello, 2002). There 
are two structurally distinct forms of IL-1: IL-1 a , wiiich is the acidic form and IL-ip the 
neutral form. Both are 17KD proteins coded by separate genes (Dinarello, 1989). Synthesis is 
controlled by a complex feedback loop since IL-1 is capable also of inhibiting or promoting
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its own synthesis depending on conditions and ceil types. Maas-Szabowski et al. (1999) 
demonstrated that TGFa expression by skin keratinocytes upregulated KGF production by 
dermal fibroblasts that in-tum stimulated keratinocyte growth. Similar signalling pathways 
may be responsible for the normal differentiation patterns of OGE. The synthesis of IL-1 can 
be induced by other cytokines including TNFa, IFNa, IFNp and by bacterial endotoxins, 
viruses, mitogens and antigens.
Reports providing evidence of IL-1 production by fibroblasts are however confusing, with 
mention of its production only by wounded skin fibroblasts and in some pathological CT 
disorders such as systemic sclerosis (Kawaguchi et al., 1999).
Komman et al. (1997) suggested that genetic polymorphisms of the IL-1 gene might be 
associated with severity of periodontitis. In their study, carriage of allele ‘2’ of the IL-IA 
gene and allele ‘2’ of the IL-1 B gene was associated with increased severity of periodontitis 
in non-smokers. Further, Shirodaria et al. (2000) demonstrated an increase in IL-1 a  within 
gingival crevicular fluid in patients with the IL-1 A genotype.
Lossdorfer et al. (2002) using both IHC and in-situ hybridisation techniques demonstrated 
IL-1 a  within OGE and PDL tissues of the rat. Miyauchi et al. (2001) demonstrated its 
expression within JE cells by IHC assay.
Two kinds of IL-1 receptor bind with different affinities. Both IL -la  and IL-lp can bind to 
the same receptors with equal affinity and therefore show closely similar biological activities. 
The type-1 receptor, isolated fi’om T-cells, is expressed predominantly on T-cells and cells of 
mesenchymal origin and has been designated CD121a. The type-2 receptor has been 
designated CD121b and has been isolated from B-cells, granulocytes and macrophages. It is 
expressed predominantly on B-cells and cells of the myelomonocytic lineage.
Few reports exist with regard to IL -la  receptor distribution within the periodontium, most 
notable is work conducted by Chou et al. (2000) who found trace amounts of IL-1 receptor 
mRNA within gingival fibroblasts.
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CHAPTER THREE
HYPOTHESES
CHAPTER THREE 
HYPOTHESES
The proposed woric is based on three general hypotheses:
H37>othesis 1. That differences between junctional and oral-gingival epithelia are associated 
with dififering influences of their sub-epithelial fibroblasts.
Hypothesis 2. That periodontal and gingival fibroblasts differ in their constitutive and 
induced levels of expression of cytokines required for maintenance of epithelial growth, and 
for activation of epithelial migration.
Hypothesis 3. That junctional epithelial cells are less readily stimulated than oral-gingival 
epithelial cells by factors that normally activate epithelial maintenance.
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CHAPTER FOUR 
MATERIALS AND METHODS
Unless otherwise stated reagents and chemicals used diroughout this study were obtained 
from Sigma-Aldrich, cell culture consumables from Invitrogen™, polymerase chain reaction 
constituents from Promega and TaqMan™ quantitative-PCR products from Applied 
Biosystems.
This chapter presents methods required for: -
a) Tissue culture, fixation and immunohistochemical investigations.
b) ELISA protein level assays for three cytokines: KGF, GM-CSF and TGFa.
c) Bromodeoxuridine (BrdU) keratinocyte proliferation studies and;
d) Quantitative-polymerase chain reaction investigations.
4.1 Media
Cultured cells require a sterile environment and a supply of nutrients for growth and in 
addition, the culture environment should be stable in terms of pH and temperature. Various 
defined basal media types have been developed, modified and enriched with amino acids, 
vitamins, fatty acids and lipids. This study required the maintenance of human and mouse 
fibroblasts and human oral keratinocyte cell lines. The following media formulations were 
filter sterilised through 0.22pm filters (Stericup™, Millipore) and stored at 4°C. Media were 
warmed to 37°C prior to use.
4.1.1 Fibroblast medium
The fibroblast medium used was high glucose Dulbecco’s modified Eagle’s medimn 
(DMEM) with phenol red, containing 2mM L-glutamine, antibiotic/antimycotic 
(Penicillin/streptomycin/amphoteracin B) and supplemented with 10 % foetal bovine serum 
(FBS).
4.1.2 Mouse Swiss 3T3 fibroblast medium
3T3 medium was as for fibroblast medium but with newbom calf serum (NBCS) substituting 
for the FBS.
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4.13 FAD oral keratinocyte medium
FAD medium was first derived by Wu et al. (1982) as a supplemented medium for the culture 
of epithelial cells. To prepare a 500ml batch of medium firstly produce “solution A” \^iiich 
consists of 3 parts DMEM to 1 part Ham’s F-12, dissolved in which is 9.1mg of adenine. To 
450ml of solution A is added 50ml FBS, 500pl hydrocortisone, 500pl cholera toxin, 500pl 
epidermal growth factor (EGF), 250pl insulin and 5ml antibiotic/antimycotic.
Final concentrations of supplements were: -
• Adenine 0.089mM • Hydrocortisone 400ng/ml • Cholera toxin 10’^ ^
• EGF lOng/ml • Insulin 5pg/ml
• Penicillin G sodium lOOU/ml, streptomycin sulphate lOOpl/ml, Amphoteracin B 0.25pg/ml.
4.13 FAD washing medium
A washing medium was devised for the initial collection and incubation of potentially 
infected human specimens, \ ^ c h  had the same formulation as FAD with the addition of 
triple the concentration of antimycotic/antibiotic (Penicillin G sodium (300U/ml), 
streptomycin sulphate (300pl/ml), amphoteracin B (0.75pg/ml)), nystatin (24ml/l) and 
Plasmocin™ (Autogen-Bioclear, 25pg/ml) a commercial mycoplasma inhibitor.
4.2 Cell culture
Cells were cultured in Heraeus function line incubators set at 37°C and 5% CO2. They were 
humidified with a water bath containing Sigmaclean® germicide treatment. Sterile work was 
undertaken in a Bioquell Microflow Class 2 safety cabinet.
4.2.1 Primary Cultures
These were derived directly fi-om excised, normal human tissue and grown either as explant 
cultures or following dissociation into a single cell suspension by enzyme digestion. 
Epithelial cultures occasionally became over-grown by fibroblasts and as these contaminating 
fibroblasts proved impossible to remove, these cultures were discarded.
4 3 3  Continuous Cultures
A 3T3-Swiss albino fibroblast line (American Type Culture Collection (ATCC) Cat no. CCL- 
92) was serially propagated in culture indefinitely. In order to retain original growth 
characteristics these were sub-cultured before confluence.
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4.2.3 Consent
Informed consent was obtained from patients attending the Oral Surgery department at the 
University of Wales, Dental School, Cardiff as approved by the local research ethics 
committee (see appendix I).
4.2.4 Specimens and collection
Experimental material was obtained from 18 individuals with an age range of 13 to 44 years. 
Patients underwent tooth extraction primarily for caries or orthodontic reasons during which 
samples of buccal gingiva of approximate dimensions 5mm by 4mm were collected whilst 
still attached to the tooth. Care was taken to obtain specimens from sites clinically unaffected 
by periodontal disease. Atraumatic tooth extraction was achieved using a series of elevators, 
avoiding the damaging introduction of extraction forceps. Samples were immediately 
transported to the laboratory in sterile containers containing FAD washing medium.
4.2.5 Isolation
Keratinocytes and fibroblasts were isolated from biopsies as described in detail by Gao and 
Mackenzie (1992). After carefully separating the tooth from the gingiva, part of each soft 
tissue specimen was frozen and sectioned for immunocytochemical staining. The remaining 
gingival sample was then micro-dissected using a dissection microscope (Nikon SM2800) to 
free the JE complex. The remaining portion was treated enzymatically with 0.25% trypsin 
overnight to separate the OGE from the underlying CTs.
Figure 4.1: Molar tooth with soft tissue attached/dissected from ACJ
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4.2.5.1 Oral-gingival fibroblasts (OGF)
The CT fragment was minced thoroughly with a scalpel, gathered in a little medium, placed in 
a sterile 20ml universal container and centrifuged at SOOrpm (50x g) for 5 minutes (ALC® 
PK120R refrigerated centrifuge). The pellet was resuspended in a collagen gel within a 6-well 
plate (for preparation see chapter 4.4.2). As confluence approached fibroblasts were harvested 
fix)m gels by treatment with a 0.1% collagenase solution at 37®C for 15 minutes before being 
re-plated in T75 flasks (Iwaki, Bibby Sterilin Ltd) for amplification.
4.2^.2 Periodontal ligament fibroblasts (PDL)
PDL tissue was obtained by scraping the mid-third portion of the tooth root and fibroblasts 
isolated using the method for OGF described in chapter 4.2.5.1.
4.2.53 Oral-gingival epithelium (OGE)
The separated epithelial sheets were minced thoroughly with a scalpel and transferred to a 
sterile 15ml centrifuge tube. 1ml trypsin/EDTA (0.05% (w/v) trypsin/0.53mM 
ethylenediaminetetraacetic acid; Gibco) was added and warmed to 37°C, gentle pipetting 
provided a single cell suspension that was pelleted at lOOOrpm (80x g) for 10 minutes.
43.5.4 Junctional epithelium (JE)
The dissected JE tissue was minced thoroughly, 1ml trypsin/EDTA added and kept at 37®C 
for 15 minutes to help dissociation into a single cell suspension. 5ml of FAD was added, 
transferred to a 15ml tube and the cells pelleted at lOOOrpm for 10 minutes. Applying the 
basic techniques of Rheinwald and Green (1975) OGE and JE keratinocytes were plated onto 
a mitomycin-C-treated 3T3 layer that had been produced one day in advance (see chapter 
4.2.9). Cultures were maintained in FAD.
4.2.6 General culture morphology
Both fibroblast and epithelial cell cultures formed monolayers attached to the tissue culture 
flask. Epithelial cells formed small rounded colonies that conformed to the cobblestone 
descriptions stated in the literature (Fig 3.2a). Fibroblasts formed typical elongated spindle 
shapes (Fig 3.2b).
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Figure 4.2a: Epithelial morphology Figure 4.2b: Fibroblast morphology
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4.2.7 Cell quantification
In order to standardize cell procedures such as cryopreservation and subculture routines it was 
necessary to quantify numbers. This was achieved using cell-counting chambers (ISL Fast 
Read, Cat No. BUS 100) during trypsinisation, a single drop of cell suspension is placed into a 
chamber, counted in triplicate and averaged. This provided an amount equivalent to “number 
of cells” xlO" /^ml.
4.2.8 Amplification and sub-culture of 3T3 cells
The medium was removed, cells washed with PBS (without Ca2+/Mg2+), 2.5ml of 
Trypsin/EDTA added and the flasks incubated for 10 minutes at 37°C or until the cells 
became detached and rounded. The cells were removed from the flask in 5ml medium, 
centrifuged at SOOrpm for 5 minutes and the pellet re-plated at a 1:10 dilution ratio.
Prior to use as feeder cells, 3T3 cells were growth arrested by exposure to mitomycin-C. 
Mitomycin-C is cytostatic and has the ability to covalently bind to DNA inhibiting its 
synthesis and hence cell replication. Its action is most prominent during the late GI and early 
S-phases of the cell cycle; this allows just one further replication cycle to occur.
4.2.9 Mitomycin-C treatment
All procedures involving mitomycin-C required complete darkness as exposure to light 
readily decomposes it, inactivating its growth arresting properties (Sigma-Aldrich, product 
information sheet, M4287). A 2mg vial of mitomycin-C was added to 4ml of DMEM producing
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a working solution of 0.5mg/ml, this was aliquotted and stored at -20®C for up to 6 months. T75 
flasks were covered in foil and 0.1ml of mitomycin-C solution introduced in 5ml 3T3 medium 
(final mitomycin-C concentration of O.Olmg/ml). Cultures were incubated for 2.5 hours, washed 
4 times in PBS, medium replaced and left overnight to undergo final replicative cycles. After 24 
hours, the treated 3T3s could be trypsinised, counted and re-plated at required densities for 
epithelial growth (6x10^/175 flask equivalent to 8000 cells per cm^).
4^.10 Amplification and sub-culture of human fibroblasts
When visualised to be at 80-90% confluency fibroblasts were treated as for 3T3s and re­
plated into flasks at a dilution ratio of 1:6. Cells were utilised in experiments between passage 
(P) 2 and P4.
4^.11 Amplification and sub-culture of keratinocytes
Prior to confluence, primary keratinocyte colonies were passaged onto mitomycin-C treated 
3T3 cells. 5ml of 0.02% EDTA solution was added to T75 culture flasks and incubated for 5 
minutes or until 3T3 cells had detached and could be removed by aspiration. Then 5ml of 
trypsin/EDTA was added and left for 10 minutes at 37°C or until the cells became detached 
and rounded. Keratinocytes were centrifuged at lOOOrpm for 10 minutes and passaged at a 1:4 
dilution ratio.
Some flasks of epithelial and fibroblast cultures were fixed for IHC assays. Remaining flasks 
provided fix)zen cell stocks for experimental use between second and fifth passage.
4.2.12 Cryopreservation
Fibroblast, and epithelial populations were limited in the number of successful passages they 
could undergo, and for this reason it was essential to establish a system of master and working 
banks in order to maintain such lines at low passage for repeated experimentation. The basic 
principle of successful cryopreservation is a slow fi^ z e  and quick thaw, as a general guide 
cells should be cooled at a rate o f - l°  to -3°C per minute. Cultures should be healthy and in 
log-phase of growth before preservation (this was achieved by using pre-confluent cultures 
and by changing the culture medium 24 hours before fi:eezing). Cells were brought into 
suspension in a volume of fi:esh medium and a cell count performed if necessary. The 
remaining suspension was pelleted and resuspended in fi^ ze  medium (90% FBS, 10%
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Dimethyl sulphoxide (DMSO)). 1ml aliquots of cell suspension were placed into 
cyroprotective ampoules inside a passive freezer (Mr Frosty®, Nalgene) containing isopropyl 
alcohol that is in turn stored at -80°C. After 24 hours, cells were cryopreserved for indefinite 
periods by immersion in liquid nitrogen that maintained a temperature of -196°C.
4.2.13 Thawing of cells recovered from liquid nitrogen
The cryoprotectant DMSO is toxic above 4°C therefore; it was essential that cultures were 
rapidly diluted in culture medium to minimize toxic effects. This was achieved by placing 
ampoules in a water bath at 37®C. The outside of the ampoule was wiped with 70% alcohol 
and the contents pipetted drop-wise into pre-waimed growth medium.
4J2.14 Screening for Mycoplasma contamination
Mycoplasmas are the smallest free-living self-replicating prokaryotes. The effects of 
mycoplasma infection are more insidious than those of bacteria and fimgi. They can induce 
several long-term effects that include: reduced growth rate, morphological changes and 
chromosome aberrations. An in-house technique was used to test derived samples indirectly 
using the DNA stain Hoechst 33258.
Sample and control cells were grown on chamber slides (Falcon; Stone, UK) for 48 hours at a 
density of 10"* cells per well. They were fixed in freshly prepared fixative (1:3 glacial acetic 
acid: absolute methanol) for 5 minutes. This was repeated for a fiirther 5 minutes, the slide air 
dried for 30 minutes and 2ml Hoechst 33258 stain (Sigma; Ipg/ml) applied for 5 minutes 
whilst being shielded from direct light by aluminium foil. The slides were washed four times 
with water, mounted in an anti-fade mountant and a coverslip placed. Cells were observed 
under ultra-violet light at x40 magnification.
Samples infected with mycoplasma were seen as fluorescing nuclei plus extra-nuclear 
fluorescence of mycoplasma DNA (small cocci or filaments). These infected cultures were 
discarded.
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43  Characterisation of epithelial and fibroblast cultures
Characterisation methods involved staining fibroblast and epithelial populations with a panel 
of diflferentiation markers (Table 4.1). Cell smears; cryosections and cells grown directly on 
plastic substrate were used.
43.1 Fixation methods
Cells were prepared in several ways prior to immunological staining;
a) Cells were stained \^iile attached to T75 flask substrate. Ice-cold methanol/acetone in 
equal parts was added for 10 minutes, rinsed with several changes of PBS and flasks 
stored at 4®C containing lOmM azide. Pieces of flask base were removed and stained in a 
similar maimer to glass slide preparations.
b) Preparation o f cell smears involved enzymatically removing the cells fi*om their flasks, 
resuspending in a little FBS and smearing onto poly-l-lysine coated slides (Polysine™, 
Menzel-Glaser Cat. No. 041400).
4 3 3  Enzymatic nnmaskmg and blocking of antigenic sites
Formalin fixed, paraffin embedded specimens required unmasking of antigenic sites and were 
deparaffinized in 100% xylene for 2 minutes, hydrated through a graded alcohol series (100% 
for 2 minutes x3, 70% for 2 minutes x3 and 50% for 2 minutes x3) and brought to double 
distilled water (DD H2O).
Slides were then immersed in a retrieval solution: (Glycerine 90ml, 10ml of 10 mM citrate 
buffer (pH6.0)), micro-waved at 600 Watts on high power for 1.0 minute, on low power for 
10.0 minutes and cooled to room temperature. After cooling, endogenous peroxidase activity 
was quenched by immersing the slides in 0.3% H2O2 diluted in TBS (0.05M Tris-HCl, 0.15M 
NaCl, pH 7.6) for 5 minutes and washed in PBS before continuing with the IHC technique.
4 3 3  Fibroblast characterisation
For the most part, the PDL and OGF cultured fix>m explants were heterogeneous populations 
of cells (Hassell and Stanek, 1983; Schor and Schor, 1987 and McCulloch and Bordin, 1991).
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Efforts to characterise PDL cells biochemically and so differentiate them from OGF cells 
have been reported (Kawase et at., 1988; Somerman et a l, 1988 and Piche et a l, 1989).
433 .1  Morphology and growth characteristics
Fibroblasts in monolayer culture were photographed at various time points at increasing 
passage numbers up to PIO using a Nikon Eclipse TSIOO inverted phase microscope and a 
Nikon Coolpix 950 digital camera. Simple growth-rate studies were conducted; equal 
numbers of OGF and PDL fibroblasts (1x10'*) of the same passage number were plated into 
T75 flask and the number of days until confluence recorded.
4 3 3 3  Alkaline phosphatase detection
Fibroblasts, both grown on plastic substrate and as cell smears, were used for histochemical 
differentiation by examining the presence of ALP. Preparations were fixed in 4% 
paraformaldehyde for 10 minutes and washed 3 times in IxTRIS buffer (see stock solution 
preparation - appendix II). 5-Bromo-4-chloro-3-indolyl phosphate p-toluidine salt (BCIP) 
substrate was made as per manufacturers instructions, applied to the sections and incubated at 
room temperature for up to 2 hours. The reaction was stopped by briefly washing in H2O. 
Where counterstaining was required, sections were immersed in Harris’s haematoxylin 
(Lamb, Cat No. 4975) for 2 minutes and placed under running water for 20 minutes. Slides 
were mounted in an aqueous mountant. Crystal/mount™ (Biomeda Corp, Cat No. M 03) 
viewed, photogr^hed and digital images captured.
43.4 Epithelial characterisation
43.4.1 Morphology, growth characteristics and cell size
For later comparison, keratinocytes in monolayer culture were photographed at various time 
points and at increasing passage numbers up to P5.
43.4.2 Immunohistochemistry protocol
IHC staining was performed on cell smears, on colonies cultured on plastic substrate and on 
cryosections of gingival whole mounts and organotypic gels. Specimens were fixed in ice- 
cold acetone/methanol for 10 minutes and washed in PBS for 5 minutes and where necessary 
circled with a PAP pen (Dako). Specimens were treated with a blocking agent (PBS, 2% BSA 
and 0.2% Triton-X) for 1 hour at room temperature. This was shaken off and primary 
antibodies applied directly and incubated overnight in a humid chamber at 4°C. After 24
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hours, specimens were washed in 3 changes o f PBS over 30 minutes and the appropriate 
fluorescein isothiocyanate (FITC) conjugated secondary antibody applied for 2 hours at room 
temperature. Following a fiirther 3 washes, all samples were incubated in Hoechst 33258 dye 
(Ipg/ml) for 30 minutes to aid location of cellular nuclei, then mounted in an anti-fade 
mountant (Johnson and Nogueira-Araujo, 1981 (see appendix II)). Commercial antibodies 
were tested for optimal concentrations before use and supernatants used neat (see table 4.1). 
Controls included omission of the primary antibody, secondary antibodies alone, comparison 
of staining patterns between the different antibodies used and conformity of staining to known 
patterns of antigen distribution. Samples were viewed on an Olympus Provis AX70 
fluorescent microscope and photographed using a Nikon DXM1200 digital camera. Separate 
images for FITC and Hoechst were obtained, and where necessary to illustrate tissue 
morphology, combined in Photoshop 5 (Adobe).
Table 4.1: Antibodies, suppliers, and working concentrations
Monoclonal antibody Clone number Concentration
Cytokeratin 1 LHKl® Supernatant
Cytokeratin 4 6B10'’ 1:50
Cytokeratin 5 AF138‘= 1:500
Cytokeratin 6 HK6’ Supernatant
Cytokeratin 7 LP5K* Supernatant
Cytokeratin 8 LE41* Supernatant
Cytokeratin 10 LHP2* Supernatant
Cytokeratin 13 1C7/2D7" 1:50
Cytokeratin 14 LL002“ Supernatant
Cytokeratin 15 LHK15* Supernatant
Cytokeratin 16 LL025* Supernatant
Cytokeratin 17 E3*’ 1:50
Cytokeratin 18 LE61” Supernatant
Cytokeratin 19 LP2K* Supernatant
Cytokeratin 20 IQ20.8'’ 1:10
DBA e 5pg/ml
ICAM-1 0054“ 1:40
MMP-7 (Matrilysin) Ab-3* 1:100
Desmoplakin I+II DP2.15* lOpg/ml
TGFa Ab8610" 1:40
a = Gift of Prof L L e ^  
b = Neomakers 
c = Berkeley Antibody 
d = Dako
e = Vector labs 
f  = Oncogene 
g = Cymbus Biotech 
h = Abeam Limited
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43.5 Assay of epithelial ceU proliferation
To identify differences in cell proliferative capacity between JE and OGE, populations were 
subjected to S-Phase labelling by addition of 50pg/ml 5-bromo-2’-deoxyuridine (BrdU) to the 
medium for 2 hours prior to fixation. Populations were pulsed with BrdU separately on days 
1, 2, 3, 4, 5 and 6. The cells were then fixed in 70% ethanol for 10 minutes, washed in PBS, 
treated with 4M hydrochloric acid (HCl) for 10 minutes and washed in PBS of pH 8.5 then 
pH 7.4.
43.5.1 Blocking of endogenous peroxidase activity and antibody application
Endogenous peroxidase was blocked using 3% hydrogen peroxide (H2O2) in PBS containing
0.2% Triton-X for 5 minutes before £q)plication of an anti-BrdU primary antibody (Dako) at a 
dilution of 1:100. After overnight incubation at 4°C, cells were washed and rabbit anti-mouse 
horseradish peroxidase (HRP) conjugated secondary antibody applied at a dilution of 1:200 
for 2 hours (Vectastain® elite ABC kit. Vector Labs, Burlingame, CA).
4 3 3 3  Colour visualisation
Visualisation of binding was achieved by using a 3,3’-diaminobenzidine tetrahydrochloride 
(DAB) substrate kit (Vector Labs) that produced a brown colour insoluble in alcohol. The 
DAB substrate was applied for up to 10 minutes and the reaction terminated by washing in tap 
water. Haematoxylin counter-stain was provided \^ e re  necessary and Ciystal/mount™ 
applied. Fifty colonies were identified per flask per day, classified morphologically (see 
chapter 2.8.4 for colony classification) and labelled cells counted.
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4.4 Organotypic culture
4.4.1 Preparation of coUagen solution
Rat-tail collagen was extracted as previously described by Rowling et al. (1990). Freshly 
removed rat tails were washed in two changes of 70% alcohol for 15 minutes each at -20°C. 
Tails were washed in two changes of DD H2O for 5 minutes at 4°C, each is then broken, the 
skin removed and tendons extracted. 0.8g -  0.9g of tendon and 35ml 0.1% acetic acid was 
then placed in 50ml centrifuge tubes on a shaker platform at 4°C for 24 hours. Tubes were 
then centrifuged at 10,000rpm (8000x g) for 2 hours at 4°C and the supematant poured into a 
sterile bottle. This process was then repeated with the remaining pellet.
4.4.1.1 Dialysis of Colh^en
Collagen gel solution was placed into a length of dialysis tubing in a 4-litre beaker o f sterile 
water and stirred at 4°C for 3 days, changing water every other day. Dialysis of the gel 
continued until the correct consistency was obtained, bubbles should rise gently, and then the 
gel was placed in 50ml tubes at -80°C to fteeze-dry. The lyophilised collagen was weighed 
into 160mg batches and irradiated at 50,000 Grey and stored at 4°C. 160mg of collagen was 
reconstituted using 40ml 0.1% acetic acid providing a 4mg/ml final concentration. To assess 
sterility, enough collagen gel to cover the bottom of a small petri dish was incubated at 37°C 
for 3 days and examined microscopically for evidence of bacterial or fungal growth.
4.4.1.2 Protein determination
The protein concentration of samples o f the prepared rat-tail collagen was assessed using a 
Total Protein Kit (Sigma). A protein concentration standard curve was set up by mixing 500pl 
of BSA standards (0-1 mg/ml in DD H2O) with 2.2ml of Biuret reagent. This was incubated 
for 10 minutes at 20®C, lOOpl of Folin and Ciocalteu’s phenol reagent added to each tube, 
mixed well and incubated for a further 30 minutes. lOOpl of sample was transferred to a 96- 
well microtitre plate. The absorbance was read at 550nm in a Dynex MRX microplate reader. 
To estimate the protein concentrations of samples 500pl of sample was analysed in place of 
the BSA standard and compared against the standard curve.
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4.4.2 Organotypic culture protocol
4.4.2.1 Day 1 - Fibroblast impregnated collagen gel
Two methodologies were used to construct the collagen gels. The support for organotypic 
culture was either provided by:
A) Purchased 3.0pm pore size insert system contained in a deep 6-well culture 
plate (Falcon, Beckton Dickinson) (Figures 4.3a) or
B) A ‘mesh’ structure constructed fix>m stainless steel contained in a 6-well culture 
plate as described by Igarashi et al. (2002) (Figures 4.3b).
Under ice-cold conditions, a standard ratio of constituents was used to produce a collagen gel 
that provided uniform setting. 8ml of collagen solution was added to a sterile 50ml centrifuge 
tube, 1ml of lOx DMEM and 1ml FBS added, mixed and neutralised with drop-wise addition 
of IN NaOH until light pink in colour. 1ml of fibroblast medium containing the appropriate 
number of fibroblasts was added and the gels poured.
Sub-confluent fibroblast cultures were trypsinised, counted, pelleted and resuspended in the 
collagen gel mix. Method A required 3ml collagen containing 3x10^ fibroblasts to be poured 
into a 3pm pore cell culture insert. Method B required 1x10^ fibroblasts in 1ml collagen to be 
poured into each well of a 24-well plate. Once set, the fibroblast-populated gels or 
‘cormective tissue equivalents’ were maintained in an excess of fibroblast medium overnight.
4.4.2.2 Preparation of nylon mesh
Nylon meshing of 100pm pore size was used as a support device for the collagen lattices 
(Nitex Nylon Cat No. 3-100/35, Tetko Inc). Sterile nylon discs ~ 2 cm in diameter were 
placed in a petri dish and lightly coated in collagen gel. After draining excess collagen, the 
petri dishes were incubated at 37°C and collagen allowed to solidify. Once set, collagen- 
coated discs were cross-linked by fixation in 1% glutaraldehyde for 1 hour at 4°C, before 
washing with four 20-minute changes of PBS and two 20-minute changes of FAD washing 
medium. Following the wash procedures, treated meshes were stored in FAD at 4°C imtil use.
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4.4.2.3 Day 2 - Addition of keratinocytes to gel surface
To provide equal densities of keratinocytes used in the two methods the surface area of the gel 
was calculated for each: -
Method A - Insert: Diameter 24mm, Surface area = 452mm^
Method B - 24 well plate: Diameter 18mm, Surface area = 254mm^ (approximately half)
Keratinocytes to be used were trypsinised, counted, resuspended and plated at a concentration 
of 0.5x10^/24well or IxloVinsert (= 200,000cells/cm^) in FAD. Gels were incubated 
overnight to allow epithelia to become established and adherent. For gels prepared in 24-well 
plates the medium was aspirated, gels raised using spatulas and placed onto the nylon 
mesh/steel grid support system. FAD was added to all wells to just touch the underside of the 
mesh/porous polycarbonate membrane, the cultures being maintained at the air/liquid 
interface for 14 days before processing (Figure 4.3a^).
Figure 4.3a: Method (A) demonstrating porous polycarbonate insert within deep-well plate
0.22^ni pore 
membrane
Deep well plate
Figure 4.3b: Method (B) demonstrating stainless steel mesh set-up
Stainless steel 
mesh support
Collagen coated 
nylon mesh
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4.4.3 Processing organotypic gels
Following the culture period half the organotypic cultures were fixed in 4% paraformaldehyde 
at 4°C overnight and paraffin embedded. Sections were cut at a setting of 5pm and de-waxed 
in xylene, hydrated through graded alcohols to water and stained in Harris’ haematoxylin for 
15 minutes. After a five-minute wash, they were differentiated in 1% acid alcohol (1% HCl in 
70% alcohol) for 5-10 seconds. Following a further wash, sections were eosin stained for 10 
minutes before rinsing under warm running water. Finally, sections were dehydrated through 
alcohols and mounted for viewing with a light microscope.
The remaining half was orientated and mounted onto cork discs (Lamb) using embedding 
medium (Cryomatrix™, Thermo Shandon) and snap-frozen in isopentane chilled via liquid 
nitrogen (Figure 4.4). 7pm sections were cut perpendicular to the epithelial surface in a 
cryostat (Shandon Cryotomb) and positioned onto poly-l-lysine coated slides.
Figure 4.4: Orientating gels onto cork discs
Sample embedded 
within cryomatrix
Plastic coverslip
I
Completed 
specimen ready for 
cryosectioning
a) Plastic coverslip embedded within cork disc
b) Sam ple orientated and contained within embedding medium
c) Coverslip removed
d) Final sam ple ready for sectioning on cryostat
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4.5 Polymerase chain reaction (PCR)
The PCR is an in vitro procedure for the amplification of DNA molecules. The technique uses 
two oligonucleotide primers that flank the targeted DNA and amplification occurs following 
repeated cycles of heat denaturation of the DNA, primer annealing and extension of annealed 
primers by the thermostable enzyme tag polymerase. TaqMan™ quantitative-PCR is an 
accurate method of detecting mRNA even when expressed at low levels.
4.5.1 Inventory
PCR products were supplied by Promega vdiilst TaqMan™ Q-PCR products, software 
(Primer Express® v2.0) and hardware (ABI PrismTOOO sequence detection system) were 
supplied by Applied Biosystems. Water was rendered nuclease-fi*ee by treatment with 0.1% 
diethyl pyrocarbonate (DEPC), as were plastic tissue culture components.
4.5.2 RNA isolation
Total RNA was extracted fi*om cells cultured in monolayer using the guanidinium-thiocyanate 
method (Chomczynski and Sacchi, 1987). Medium was changed 48 hours pre-extraction. 1ml 
of RNAwiz™ (Ambion; Austin, USA) was added to each T75 flask, incubated for 30 minutes 
and then homogenised by vigorous pipetting before being transferred to a 1.5ml microtube. 
200pl of chloroform was added to the homogenate, shaken vigorously for 20 seconds and 
incubated for 10 minutes. This was then transferred to a heavy phase-lock gel micro-tube 
(Eppendorf) before centrifiigation at 13,000rpm (13,000x g) for 25 seconds (Sorvall® 
Biofiige Fresco). On completion the upper aqueous phase was transferred into a clean tube, 
500|il of H2O, 1ml of isopropanol and Ipl glycogen added before incubating for a further 10 
minutes. The RNA was pelleted by centrifuging at 13,000rpm for 15 minutes, washed with 
1ml ice-cold 75% (v/v) ethanol, supernatant discarded and the pellet air-dried for 10 minutes. 
The RNA was resuspended in 20pl of H2O before purification.
4.5.2.1 RNA purification
Contaminating DNA was removed fi*om the RNA by treatment with DNA-Free™ Dnase I 
treatment (Ambion). A 0.1 volume of the lOx buffer was added together with Ipl of Dnase I 
(2U/pl) and incubated for 30 minutes at 37®C. A 0.1 volume of Dnase I Inactivation Reagent 
was added to each sample, mixed and the solution incubated at room temperature for 2 
minutes. The samples were then centrifuged at 6000rpm (2800x g) for 1 minute to pellet the
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Dnase I Inactivation Reagent. The supernatant containing the DNA-free RNA was then 
removed to fresh eppendorf tubes before quantification.
43J2J2 RNA quantification
RNA samples were quantified by diluting 2pl of RNA solution with 98pl H2O and the 
absorbance read on a luminometer (GeneQuant II; Amersham Pharmacia Biotech, St Albans) 
at 260 and 280nm. The ratio of Abs260nm/Abs280nm gave the purity of the sample, 2.0 delineates 
pure nucleic acids, less than 1.6 indicated contamination with proteins (Sambrook et al, 
1989). The concentration and purity were calculated using the formula:
Abs260nin X dilution factor (50) x RNA factor (40) = X pg/ml
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4.6 Reverse-transcriptase polymerase chain reaction (RT-PCR)
4.6.1 First-strand complementary (cDNA) synthesis
First strand cDNA was synthesised by reverse-transcription, firstly 2pg of previously 
extracted mRNA was made up to 18pl in H2O. To the 18pl of RNA solution was added 20 pi 
of reverse-transcription amplification buffer master mix (see appendix V). This was incubated 
at 95°C for 4 minutes then immediately quenched on ice for 2 minutes to relax any RNA 
secondary structures. 2.0pl o f RNase inhibitor (40U/pl) and 2.5pl Moloney murine leukaemia 
virus reverse-transcriptase (MMLV-RT) (200U/pl) was added before incubating at 25°C for 
10 minutes, 42°C for 60 minutes and 95 °C for 5 minutes.
4.6.2 Primer amplification
Preliminary experiments determined the optimum PCR conditions. 2pg of previously 
transcribed cDNA was used as template for the PCR reaction, placed in a 200pl microtube 
and made up to 48pl with PCR amplification buffer master mix (see appendix V) adding the 
taq polymerase last.
The mixture was incubated as follows:
One cycle - 94°C for 2 minutes
40 cycles (Amplification) - 94°C for 30 seconds
(Denaturation) - 60°C for 30 seconds
(Annealing) - 68°C for 75 seconds
Final extension step of - 68°C for 15 minutes
To monitor the efficiency of amplification and assess the quality of the cDNA 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeeping gene was included in 
each reaction. Amplification of the gene verified that the target nucleic acid and reaction 
components were of acceptable quality.
Negative controls included the substitution of H2O in place of the template RNA, omission of 
the primers and the omission of the reverse-transcription step before PCR amplification. 
Reactions performed with omission of either sample RNA or the primers failed to amplify 
product.
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Primer design software was used to design both forward and reverse primers and matching 
TaqMan™ Probes. The primers were initially bought from Invitrogen™, tested, examined via 
agarose gel electrophoresis and if the appropriate weight band was visualised then the more 
costly TaqMan™ probes were ordered from Applied Biosystems.
4.63 Analysis of PCR products
Agarose gel electrophoresis and ethidium bromide staining was used to assess the presence 
and size of PCR products. 5pl of final PCR product was added to lOpl of loading buffer. In 
addition, a lOObp incremental DNA ladder and H2O controls were added to the lanes. (For 
constituents o f agarose gel, THE buffer and loading dye, see appendix V). Gels were placed in 
an electrophoresis tank (MiniCuve 8.10 Electrophoresis Unit; Qbiogene, Livingstone) and run 
at a potential o f 75V until the gel front was past halfway point. The bands were then 
visualised under a UV light documentation system (Gel Doc 2000; Bio-Rad Laboratories) and 
digital images captured. For the size of the PCR products see appendix VI.
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4.7 Quantitative (Real-time) polymerase chain reaction
Pioneered by Higuchi et a l (1992) Q-PCR analysis detects specific nucleic acid amplification 
products as they accumulate in real-time. This real-time analysis is characterised by the point 
during amplification when the accumulation of product is first detected rather than the amount 
of product accumulated after a fixed number of cycles. The higher the starting amount of 
nucleic acid target the sooner a significant increase in fluorescence is observed. The cycle 
number at \ ^ c h  the reporter fluorescence generated is detectable above background noise is 
termed the threshold. The system uses fluorescently labelled oligonucleotide probes that 
eliminate the need for post-PCR processing and it is capable of screening gene expression 
within hours, using a minimal amount of sample material, and can detect a single molecule of 
DNA or RNA.
4.7.1 TaqMan™ chemistries
Q-PCR using the Applied Biosystems Prism 7000 Sequence Detector is based on detection of 
a fluorescent signal produced proportionally during the amplification of a PCR product. 
Probes are designed to anneal to the target sequence between the traditional forward and 
reverse primers, they are labelled at the 5' end with a reporter fluorochrome, 6- 
carboxyfluorescein (6-FAM) and a quencher fluorochrome, 6-carboxy-tetramethyl-rhodamine 
(TAMRA) added at any T position or at the 3' end. The probe is designed to have a higher Tm 
than the primers, and during the extension phase the probe must be 100% hybridised for 
success of the assay. As long as both fluorochromes are on the probe, the quencher molecule 
stops all fluorescence by the reporter, however as taq polymerase extends the primer, the 
intrinsic 5’ to 3' nuclease activity degrades the probe releasing the reporter fluorochrome. The 
amount of fluorescence released during the amplification cycle is proportional to the amount 
of product (amplicons) generated in each cycle. The intensity of the fluorescence signal 
increases proportionally in real-time as PCR cycles continue. At any point during the 
exponential phase of a reaction the amoimt of DNA can be calculated, then through a simple 
mathematical calculation the initial concentration of DNA in that reaction can also be 
determined (Figure 4.5).
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Figure 4.5: A schematic of the Q-PCR reaction sequence
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1. When the probe is intact, the proximity of the reporter dye to the quencher dye results in 
suppression of the reporter fluorescence primarily by Fdrster-type energy transfer (Lakowicz and 
Maliwal, 1983).
2. During PCR, if the target of interest is present, the probe specifically anneals between the 
forward and reverse primer sites.
3. The 5' to 3' nucleolytic activity of the AmpliTaq Gold DNA Polym erase cleaves the probe 
between the reporter and the quencher only if the prot>e hybridizes to the target.
4. The probe fragments are then displaced from the target and polymerization of the strand 
continues. The 3' end of the probe is blocked to prevent extension of the probe during PCR. 
This process occurs in every cycle and d o es not interfere with the exponential accumulation of 
product.
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4.7.2 Designing the TaqMan^*^ Probes
There are strict criteria that are adhered to by the Primer Express® software:
• G-C content must be in the 20-80% range.
• Tm 10°C higher than primer.
• Length between 25-32 base pairs.
• Avoid runs of identical nucleotide (3+).
• No G base at the 5’ end.
• Select the strand that gives the probe more C’s than G’s.
4.73 Designing the TaqMan''^’^  Primers
The primers were chosen after the probes using the following parameters:
• Design the primers as close as possible to the probe without overlapping.
• Amplicon 100-350 base pairs in length.
• Tm (annealing) of 59-60°C with less than 2°C difference between the two primers.
• Length 18-33 base pairs.
• Keep the G-C content in the 20-80% range.
• Avoid runs of identical nucleotide.
• The five nucleotides at the 3’ end should have no more then two G and/or C bases.
Although all products of interest had conventional primer pairs documented within the 
literature, it was rare to find those that achieved all the exacting criteria outlined above. As a 
result, primers were designed independently using Primer Express® software. Cytokine base 
sequences used in the study were obtained from GenBank® at the National Centre for 
Biotechnology Information database at http://www.ncbi.nlm.nih.gov/Genbank.htmI. Primers 
were specifically designed to cross an exon-exon boundary ensuring that genomic DNA was 
not being amplified. BLAST searches confirmed the specificity of primers for the respective 
cytokines. TaqMan™ GAPDH housekeeping primers and probes were also constructed. To 
ensure successful amplification of the appropriate product, traditional PCR and gel 
electrophoresis was undertaken to ensure products of the correct weight were realised. On 
delivery, probes and primers were reconstituted in H2 O to a stock concentration of lOpM, 
aliquotted and stored at -20°C in darkened vials to prevent photo-bleaching.
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Primer probe pairs were designed for the following cytokines (see appendix VI):
1. Keratinocyte growth factor (FGF-7/KGF).
2. Keratinocyte growth factor receptor (KGFR) (which is encoded by the fibroblast 
growth factor receptor type II gene - FGFR-2 Illb).
3. Keratinocyte growth factor-2 (FGF-10/KGF-2).
4. Granulocyte macrophage-colony stimulating factor (GM-CSF).
5. Granulocyte macrophage-colony stimulating factor receptor (GM-CSFR).
6. Interleukin-1 -alpha (IL-1 a).
7. Interleukin-1 -alpha receptor (IL-1 oR).
8. Hepatocyte growth factor/Scatter factor (HGF/SF).
9. Hepatocyte growth factor receptor or c-met (HGFR).
10. Transforming growth factor alpha (TGFa).
11. GlyceraIdehyde-3-phosphate dehydrogenase (GAPDH).
4.7.4 Standard curve generation
As comparisons were to be made between differing cell populations an end-point copy 
number or “absolute” copy number was required. This was achieved by constructing a 
standard curve for each PCR run fi’om 10-fold serial dilutions of a purified DNA sample of 
known amount A PCR product that included the quantified amplicon was used (prepared by 
“conventional” PCR fix>m cDNA positive for the concerned target mRNA). These PCR 
products were purified fi*om agarose gels.
The cDNA produced was validated in the reverse-transcription and PCR reactions to 
determine if it transcribed and amplified at the same efficiency as the sample RNA present in 
a mixture of extracted RNAs. A standard curve was generated by plotting the loglO of control 
template (absolute copy number or nanograms) on x-axis against the threshold (Q) value on 
the y-axis. The Q  value being the cycle at which a statistically significant increase in product 
yield is first detected. Standard curve, linear equation and correlation coefficient (R2) are 
automatically computed with the ABI PRISM® software. The standard curves were found to 
be linear over 6 logs (10  ^ to 10  ^dilutions) with R2 of 0.998. A four-cycle difference was 
foimd to approximately equal a 10-fold difference in initial target concentration.
Chapter four; Materials and methods 08
4.7.5 GAPDH housekeeping
GAPDH primers were used as an internal reference of housekeeping gene transcription for 
normalisation between different cDNA samples.
4.7.6 No template controls (NTCs)
These were used to determine the limits of PCR sensitivity and test reactions for possible 
background that may occur during amplification. They also provided a test as to whether 
contamination of RNA by genomic DNA had occurred and that no genetic material had been 
transferred during pipetting. NTCs also assessed any generation of primer-dimer PCR artefact 
or amplicon contamination that should have been eliminated by the software.
4.7.7 TaqMan'^ primer amplification
Q-PCR master mix was prepared (equilibrated at room temperature) using Ipg of previously 
transcribed cDNA as template, placed in an optically clear 96-well plate and made up to 25pl 
with Q-PCR amplification buffer master mix (see appendix V) adding the taq polymerase last. 
Ehie to the large numbers of manual pipetting sequences, (up to 96 reactions per plate) there 
was the possibility o f introducing errors; in an effort to combat this, all reaction-wells were 
repeated in triplicate. This offered the opportunity of identifying and omitting erroneous data. 
To further confirm Q-PCR efficiency agarose gel electrophoresis was undertaken on products.
Q-PCR program:
One cycle (denaturation) - 95®C for 2 minutes
40 cycles (amplification) - 95°C for 30 seconds
One cycle (anneal) - 60°C for 1 minute
One cycle (extend) - 72°C for 1 minute
4.7.8 Data acquisition and analysis
The detection system consists of a 96-well thermal cycler connected to a laser and charge- 
coupled device (CCD) optics system. An optical fibre inserted through a lens is positioned 
over each well, and laser light is directed through the fibre to excite the fluorochrome in the
PCR solution. Emissions are sent throxigh the fibre to the CCD camera where they are
analysed by the software’s algorithms. Emissions are measured every 7 seconds. The 
sensitivity of detection allows acquisition of data when PCR amplification is still in the 
exponential phase. This is determined by identifying the cycle number at which the reporter
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dye emission intensities rises above background noise - the threshold cycle (Q). The Q  is 
determined at the most exponential phase of the reaction and is more reliable than end-point 
measurements of accumulated PCR products used by traditional PCR methods. The Ct is 
inversely proportional to the copy number of the target template; the higher the template 
concentration, the lower the threshold cycle measured. Measuring the Ct values and 
comparing with the standard curve accomplish absolute quantification of the amount of target 
in the unknown samples.
All statistical analyses were performed using the statistical fimctions of the MS Excel 
computer programme or SPSS® software package.
4.7.9 Normalisation
Normalisation was necessary to correct for fluorescence fluctuations due to changes in 
concentration or volume. It was accomplished by dividing the emission intensity of the 
reporter dye by the emission intensity of a passive reference to obtain a ratio defined as the 
normalised reporter (Rn) for a given reaction well. The passive reference is a dye 
automatically included in the TaqMan™ buffer and does not participate in the 5’ nuclease 
PCR.
4.7.10 Primer/probe optimisation
Optimisation of the PCR reaction was required for each primer and probe set. The purpose of 
this procedure is to determine the minimum primer concentrations giving the maximum yield, 
and to determine the minimum probe concentrations that give the minimum Ct for each probe 
target As the optimal concentration may not be the same for both this was achieved by 
varying the concentration of one primer relative to the other (manufacturers suggested range 
lOOnM to 800nM). Optimal primer concentration was calculated to be 300nM. Probe 
concentration was suggested to range fl*om 50nM to 200nM and found to be optimal at 
ISOnM. The Mg^ "^  concentration was also optimised at 5.5mM.
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4.8 Enzyme-linked immunosorbent assay (ELISA)
To check whether gene expression levels were similar at the protein level ELISA quantitation 
was undertaken. R&D Systems, Europe, supplied kits for the determination of human KGF, 
GM-CSF and TGFa concentrations in cell culture supernatant.
4.8.1 Principle of the assay
This assay employs the quantitative sandwich enzyme immunoassay technique. Briefly, a 
mAh specific for the cytokines o f choice had been pre-coated into the wells of a 96-well 
microplate. Standards and samples were pipetted into the wells so that the immobilized 
antibody can bind any proteins present. After washing any unbound substances, enzyme- 
linked antibodies specific for the proteins were added. Following a wash to remove any 
unbound antibody-enzyme reagent, a substrate solution was added, colour developing in 
proportion to the amount of protein bound in the initial step. The colour development is 
stopped with an acid solution and the intensity measured spectrophotometrically.
4.8.2 Limitations of the procedure
Cytokine protein concentrations measured at any one-time point could reflect the concurrent 
processes of cytokine secretion, cytokine uptake by cells, and cytokine protein degradation 
and not correlate directly with the levels of bioactive cytokine protein. As a result of these 
processes, the measured level of cytokine protein may significantly underestimate the actual 
cytokine-producing potential o f cells.
4.83 Sample collection
Cell culture supernatants - Particulates were removed by centrifugation and supernatant 
assayed immediately.
Cell lysates - In order to liberate any boimd protein cells were lysed using a 5% Triton-x 
solution. Cells fi-om a pre-confluent T75 flask were used (» 3x10^ cells).
4.8.4 Reagent preparation
Cytokine standards were reconstituted in H2O producing stock solutions of varying 
concentrations depending on kit (KGF 20,000pg/ml, TGFa 10,000pg/ml, GM-CSF 
500pg/ml). These were allowed to sit for a minimum of 15 minutes with gentle agitation prior
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to making dilutions. 900[i\ of calibrator diluent was pipetted into the most concentrated tube. 
500pl was then pipetted into the remaining tubes producing a dilution series (Figure 4.6). The 
most concentrated standard served as the high standard and calibrator diluent served as the 
zero standard (Opg/ml).
Figure 4.6: Example TGFa standard dilution series
10.000
pg/mL
500 pL 500 nL 500 mL 500 hL 500 |LiL 500 pL
i i i
1000
pg/mL
500 2 5 0  125 62 .5  31.2  15.6
pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL
4.8.5 Assay procedure
Manufacturers instructions were followed. All samples and standards were assayed in 
duplicate after equilibration to room temperature. Briefly:
1. lOOpl of assay diluent was added to each well.
2. lOOpl of standard or sample was added per well ensuring reagent addition was 
uninterrupted and completed within 15 minutes. Wells were covered in foil and 
incubated for 2 hours at room temperature.
3. Wells were aspirated and washed with wash buffer and this process was repeated three 
times for four washes.
4. 200pl of cytokine conjugate was added, covered and incubated for a further 1 hour.
5. The aspiration/wash procedure of step 3 was repeated.
6. 200pl of substrate solution was added to each well and incubated for 20 minutes
whilst being protected from light.
7. The reaction was halted using 50pl of stop solution.
8. The optical density (OD) of each well was determined within 30 minutes using a
microplate reader set to 450nm. To ensure wavelength correction, the wavelength was 
set to 540nm and readings repeated. This subtraction allowed correction for optical 
imperfections in the plate.
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4.8.6 Calculation of results
An average of the duplicate readings for each standard, control and sample was calculated and 
the average zero standard optical density subtracted. Using Microsoft Excel software, a 
standard curve was generated by plotting the mean absorbance for each standard on the x-axis 
versus the standard concentrations on the y-axis. The data was linearised by plotting the log 
concentrations versus the log of the OD and the best-fit line through the points of the graph 
determined by regression analysis.
4.8.7 Sensitivity
The detection limits of the kits were 3-500pg/ml for GM-CSF, 15-2000pg/ml for KGF and 
2.5-lOOOpg/ml for TGFa.
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CHAPTER FIVE 
RESULTS
This chapter presents results of an: -
a) Extensive histochemical staining analysis performed on fresh tissue cryosections, cell 
smears and colonies grown on a plastic substratum.
b) ELISA protein level assays for three cjdokines: KGF, GM-CSF and TGFa.
c) Biomodeoxuridine (BrdU) keratinocyte proliferation studies.
d) Quantitative-polymerase chain reaction investigations.
Spreadsheets containing raw numerical data are within the appendices.
5.1 Fibroblast cultures - designation and morphology
Fibroblasts were derived from two anatomically separate regions, the superficial lamina 
propria, (named oral-gingival fibroblasts) and PDL connective tissues. In addition, explant 
culture of JE tissue samples regularly provided a third fibroblast population. These 
populations probably arose because o f the difficulty in dissecting the JE complex fiom its 
imderlying CT. It is unlikely that they originated from periodontal ligament as the JE sample 
is easily dissected fioe of the tooth surface. In addition, due to the extremely thin nature of a 
JE sample, the fibroblasts are unlikely to originate from directly beneath the OGE, it being 
some 2-3mm distant The origin of these fibroblasts was therefore assiuned to be beneath the 
physical attachment of JE as demonstrated in figure 5.1. The possibility of contamination 
during the micro-dissection procedure could not be ruled out but this population named 
junctional zone fibroblasts (JZF) was included in fiirther investigations.
All three populations formed homogenous monolayer cultures that conformed to the classical 
spindle-shaped appearance described throughout the literature. Although Piche et al. (1989) 
documented subtle morphological changes between PDL and OGF in culture; this was not 
evident in our cultures, certainly not to the extent necessary to differentiate them with any 
authority by phase-contrast microscopy.
Cell types were assigned numbers. The same number across different cell types (epithelial or 
fibroblastic) indicate those cultures were derived from the same patient i.e. a matched pair.
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5.1.1 Oral-gingival fibroblasts
Eight OGF lines were successfully derived namely: - OGFl, 2 ,9 ,11 ,13 ,14 ,15  and 16.
5.1.2 Periodontal l^ament fibroblasts
Seven PDL lines were successfully derived namely: - PDLl, 2 ,9 ,14 ,15 ,16  and 23.
5.13 Junctional zone fibroblasts
Four JZF lines were obtained namely: - JZFl, 9,17 and 21.
5.2 Keratinocyte cultures - designation and morphology
In co-culture with 3T3 feeder layers proliferating JE and OGE colonies consisted of small, 
rounded, tightly packed cells conforming to the classical “cobblestone” appearance, which 
had the ability to push their surrounding 3T3 fibroblasts away as they expanded. Applying the 
classification proposed by Barrandon and Green (1985) (see chapter 2.8.4 for description), 
these most proliferative colonies initially correspond to the “holoclone” type. However, as 
time progressed and with repeated passage a larger number of colonies lost their 
“neat/rounded” appearance. They became scattered and irregular consisting of larger, 
flattened cells. These colonies therefore conformed to the meroclone/paraclone types. At no 
point during culture were morphological features evident that would enable distinction 
between JE and OGE populations.
53.1 Junctional keratinocytes
Eleven JE lines were derived namely: - JE l, 2 ,4 ,6 , 7, 8 ,9 ,17 ,18 ,21  and 22.
5.2.2 Oral-glngival keratinocytes
Six OGE lines were derived namely: - OGE5, 6, 7, 8 ,9  and 14.
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Figure 5.1: Anatomical regions from which cell populations were derived
Oral-gingival
keratinocytes
Junctional epithelial 
keratinocytes
Presumed location of 
junctional zone  
fibroblasts Oral-gingivalfibroblasts
Periodontal ligament 
fibroblasts
5.3 F ib ro b last ch arac te risa tio n
5.3.1 Growth-rate studies
Sub-cultured fibroblasts divided rapidly and replating from a sub-confluent T75 flask at a 1:6 
dilution ratio resulted in confluence within 5-7 days. At low passage number (below P4) OGF 
and PDL fibroblasts, whether matched or unmatched, took similar periods to reach 
confluency, there being no differences apparent to allow discrimination between populations. 
The graph over page shows growth rate potential of OGF, PDL and JZF fibroblast cultures 
using cell number as an indicator of proliferation. Mariotti and Cochran (1990) and Ogata and 
Niisato (1995) have performed more accurate population doubling-rate experiments and
discovered that PDL fibroblasts proliferated at a slightly higher rate when compared with
OGF.
With further passaging, (P5+), there was a noticeable decrease in the ability of cells to 
proliferate and colonise the flasks. Growth rapidly deteriorated and PDL fibroblasts were
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rarely able to continue growth beyond P7 whilst OGF cells similarly faltered several passages 
later. Altered morphology accompanied these changes with the cells becoming larger, 
flattened, and blunt-ended with multiple cell-processes (Figures 5.2a-b). Other groups have 
reported these “high passage” features. In particular, Somerman et al. (1990) has referred to 
unpublished data demonstrating lower proliferation rates for PDL beyond P7. They attributed 
such characteristics to the phenomenon of senescence.
Figure 5.2: Growth curve for fibroblast cell lines
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Fibroblasts were plated at 100,000 cells per T75 flask and cells counted using counting 
chambers on days 1 through 7. Triplicate a ssa y s of five fibroblast strains were used. Data are 
expressed a s  the mean + the standard error mean.
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Figure 5.3a: OGFl at low passage (PI) Figure 5.3b: OGFl at high passage (P9)
T>pical spindle-shaped morpholog>' o f low passage 
or^-gingival fibroblasts as they approach sub- 
confluence.
mmmm
Toward the end o f their replicative life, the same 
oral-gingival fibroblasts exhibit a flattened 
morphology w ith granular cytoplasm and m ultiple 
cell processes. At this passage number, the cells did 
not reach confluence.
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53.2 Histochemical staining for alkaline phosphatase
5.3.2.1 Ex vivo staining
Previous studies suggest that the most consistent difference observed between PDL and OGF 
is their differential expression of ALP. Cryosections of gingival tissue samples were stained 
to demonstrate the in vivo location of ALP positive zones. As can be seen in figure 5.3 
staining was at its most intense adjacent to the tooth root and the PDL attachment zone (and 
possible region of derivation of JZF). This expression extended halfway through the gingival 
width with diminishing intensity. Toward the external surface, beneath the OGE rete pegs, 
was a zone apparently devoid of ALP activity. This region was interspersed with pinpoint 
positive cell clusters that corresponded to endothelial cells of the gingival capillary plexus.
Figure 5.4: Gingival cryosection stained for alkaline phosphatase
This figure dem onstrates the reduction in intensity of ALP expression from the root surface toward 
the extem al oral-gingival surface.
External oral epithelial surface 
Approximate position of ADJ 
Oral-gingival fibroblast zone
Vascular endothelium
Periodontal ligament zone
Incision biopsy line
In order to investigate whether these staining characteristics were maintained throughout the 
isolation and culture procedures, cells growing in monolayer and smears developed from 
them were similarly stained.
533.2 In vitro stainmg - cultures
There were few stained cells within OGF populations whereas PDL cultures showed an 
abundance of positive cells (Figures 5.4a-d). Due to difficulties in visualising fibroblast 
boundaries in culture, cell smears were produced and stained in order to provide numerical 
data.
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Figure 5.5a: OGFl at sub-confluence 
stained for ALP
There were only occasional cells 
demonstrating ALP expression within the eight 
OGF lines tested.
Figure 5.5b: OGFl at confluence stained 
for ALP
To test whether ALP expression w as not a 
time-dependant function, staining was 
repeated at confluence. Again, OGF was 
negative for ALP expression.
\ w i \
W  ‘
Figure 5.5c: PDLl at sub-confluence 
stained for ALP
Demonstrating numerous positively stained 
cells.
Figure 5.5d: PDLl at confluence stained 
for ALP
Maintenance of ALP expression at confluence.
5.3.3.4 In vitro staining - smears
Despite photographic appearances (see figures 5.5a and b), cell smears were made with 
approximately equal cell densities as judged by eye under phase-contrast microscopy. PDL 
cell smears exhibited far higher numbers of positive cells (51-88%) compared with OGF (0- 
11%). Figures 5.5a and b show four paired samples.
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Figure 5.6a: ALP staining PDL smears Figure 5.6b: ALP staining OGF smears
PDL1 PDL2 OGF1 OGF2
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PDL9 PDLl 4 OGF9 OGF14
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5.3.4 Effects of increasing passage number on ALP expression
In order to elucidate if the differing phenotypes, as dictated by ALP expression, were stable 
through increasing passage number, cultures were fixed and stained in situ over as many 
passages as possible. A palatal fibroblast line PF4, that exhibits no ALP activity, was run in 
tandem as a negative control. Cultures were scored as positive for ALP expression if any 
positive cells were present.
No OGF cultures beyond P3 exhibited ALP activity. All PDL lines expressed ALP up to P5 
some as far as P7, however this expression was either lost in subsequent passages or the cells 
reached the end of their replicative potential. A summary of passage number versus ALP 
activity is shown in table 5.1.
It was likely that there would be less loss of in vivo phenotype during early passage; therefore, 
cells for subsequent experimentation were used at passage number 3 or below.
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Table 5.1: Alkaline phosphatase activity with increasing passage number
+ = Positive staining 
-  = No positive cells
o = Cells stocks unavailable at this passage number
Blank boxes indicate inability of cell line to continue to divide and achieve this passage number.
Cel! line 1
PASSAGE NUMBER
5 6 7 8 9 10
O G F l
O G F l O +
OGF 7
OGF 9 +
OGF 11 + +
OGF 13 o +
OGF 14 +
OGF 15 +
P D L l o + + + + + + —
PDL 2 o + + + + — —
PDL 9 + + + + + + +
PDL 14 o + + + + —
PDL 15 o + + + + — —
PDL 16 o o + + + + +
J Z F l + + + + — — — —
JZF9 o o + + + — — — —
JZF 17 o o + +
PF4 -I-I-
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5.4 Epithelial characterisation
5.4.1 Growth-rate studies
Up to passage 3, all keratinocyte populations proliferated rapidly. On passaging at a dilution 
ratio of 1:10, keratinocytes reached confluence in approximately 8 days. Due to the unequal 
quantities in starting sample size between JE and OGE tissues, the time taken for JE to come 
to confluence appeared greater than that of OGE. In subsequent passages similar numbers of 
cells were plated into T75 flasks, however, JE colonies continued to show less growth and 
greater numbers of abortive, paraclone-like colonies became apparent. These results are in 
keeping with those of Gao and Mackenzie (1993) \^ o  found that JE showed relatively high 
rates of cell turnover in vivo but in vitro showed slower rates of growth than OGE. Beyond P3 
JE lines showed a rapid decrease in their ability to divide and colonise the dishes. Similarly, 
OGE lines began to differentiate and rarely provided the rapidly proliferating holoclone-type 
colonies whilst paraclones became more apparent at later passages beyond P5. This increase 
in proportion in paraclone colonies would imply that keratinocytes were differentiating and 
entering into their terminal differentiation pathway. This may in part be attributable to the 
lack of a stem cell fiaction obtained from initial explant growth, or may represent a deficiency 
in factors within the co-culture system required for sustainable growth.
5.4 BrdU labelling protocol
In order to examine the lower rate of proliferation of junctional keratinocytes, BrdU uptake 
was used to assess the number of dividing cells entering S-phase for a given time period. 
BrdU was introduced to five JE and five OGE PI cultures on days 2, 4 and 6 post-plating. 
Within each flask, fifty colonies were then randomly selected and categorised as being 
holoclones, meroclones or paraclones. For each colony the total cell number and the number 
of BrdU-positive cells allowed the percentage BrdU positive cells to be calculated. This 
provided information about the proliferative differences between holoclones, meroclones and 
paraclones and differences in proliferative capacity between JE and OGE in culture. Beyond 
day-6, colonies were too large for manual counting and had begun to merge with each other. 
Raw numerical data is shown in appendix VII. Figures 5.6a-d show example staining patterns.
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Figure 5.7a: BrdU staining of an OGE holoclone-type colony
Typical example of a holoclone with small, 
rounded keratinocytes forming a compact 
colony with orderly margin. BrdU-positive 
cells tend to be positioned toward the 
periphery of the colony.
Figure 5.7b: BrdU staining of an OGE meroclone-type colony
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Typical example of a meroclone with som e  
small, rounded keratinocytes and larger, 
flattened cells toward the periphery. 
Generally, the larger cells do not 
demonstrate BrdU incorporation, probably 
as they are non-replicative, terminally 
differentiated cells.
Figure 5.7b: BrdU staining of an OGE meroclone-type colony
Typical example of a paraclone containing 
almost no small, round keratinocytes. The 
cells appear large, irregular and flattened. 
Very few cells take up the BrdU. T hese  
colonies represent the terminally 
differentiated fraction.
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5.4.2.1 Colony cell numbers
Figures 5.7 and 5.8 demonstrate the increasing cell number within the three colony 
morphology classifications over a 6-day period. Holoclones show considerable growth and 
expansion reaching an average colony size of 96 cells for JE and 177 cells for OGE. 
Predictably, there were lesser increases for meroclones and paraclones.
Figure 5.8: Average junctional epithelium colony cell number
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Figure 5.9: Average oral-gingival epithelium colony cell number
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S.4.2.2 BrdU labelling of JE and OGE colonies
Figures 5.9 and 5.10 show the percentage of cells within each colony type that incorporated 
the BrdU substrate for junctional and oral-gingival samples respectively.
Figure 5.10: Average percentage BrdU-positive cells per colony 
type - junctional epithelium
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Figure 5.11: Average percentage BrdU-positive cells per colony 
type - oral-gingival epithelium
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5.43. Summary
Holoclones demonstrated a considerable growth advantage over meroclones and paraclones. 
Further, OGE keratinocytes demonstrated a higher growth-rate within the holoclone fraction 
when compared to JE keratinocytes, producing colonies of, on average, double the number of 
cells. Meroclones and paraclones showed little differences between the two-keratinocyte 
populations.
Over each two-hour period, BrdU uptake in holoclones showed a persistently increased 
number of proliferating cells incorporating the thymidine analogue compared with 
meroclones or paraclones.
The percentage o f actively dividing cells remained similar between the two-keratinocyte types 
with JE and OGE holoclones maintaining activity in approximately one third of cells over the 
6-day period (JE -  33%, OGE -  30%).
Both meroclones and paraclones showed lower percentages of actively dividing cells and a 
gradual drop-off in uptake over the 6 days. Only 10-15% of meroclones and 4-11% of 
paraclones were incorporating the BrdU at the end of the experimental run. This would 
suggest that the meroclones and paraclones do indeed consist of a higher number of abortive, 
terminally differentiated cells that undergo little or no fiirther proliferative activity.
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5.5 Immunohistochemical staining patterns
Initial studies were undertaken to identify differences in the patterns of mAB binding 
throughout the periodontal epithelia in vivo using ex vivo tissue sections. Antibody panels 
were then applied to all 17 derived epithelial types when grown as colonies on plastic and cell 
smears. Organotypic cultures were constructed using five JE and five OGE samples and the 
same antibody panel applied to cryosections. Images were captured using 4x, lOx or 20x 
magnification. Occasionally for clarification, multiple images of the same section were taken, 
and composites produced using the Photoshop® 6.0 software (Adobe®). The nuclear dye 
Hoechst 33258 was used with some samples principally to aid location and highlight tissue 
architecture. The same UV intensity settings and image resolution were used throughout.
5.5.1 Ex vivo staining patterns 
Cytokeratin I (Figure 5.12)
Antibody staining identified cytokeratin 1 throughout the suprabasal region of OGE extending 
into the stratum comeum. Staining intensity was lost toward the crestal/oral-sulcular interface. 
There were however sporadic suprabasal cells staining throughout the OSE.
Cytokeratin 10 (Figure 5.13)
Cytokeratin 10 staining was similarly distributed to that of CKl, throughout the suprabasal 
layers of the OGE and patchy suprabasal staining of oral-sulcular/crestal regions.
Cytokeratin 4 (Figure 5.14)
Cytokeratin 4 staining was localised to the suprabasal layers of the crestal/oral-sulcular zones 
with occasional patches of stain visible along the OGE.
Cytokeratin 13 (Figure 5.15)
CKl 3 had a similar distribution to CK4 with the entire crestal portion of the sample strongly 
positive. Sporadic suprabasal patches along the OGE were also visible, but to a lesser degree 
compared with CK4.
Cytokeratin 6 (Figure 5.16)
Suprabasal cells of the keratinised OGE showed reactivity with staining gradually fading 
toward the crestal zone.
Chapter five: Results 89
Cytokeratin 16 (Figure 5.17)
Cytokeratin 16 was expected to produce a pattern similar to that of CK6, however staining 
was more widespread with strong positive results throughout suprabasal cells of the OGE and 
OSE but no staining of the JE.
Cytokeratin 8 (Figure 5.18)
Cytokeratin 8 expression was greatest throughout the layers of the JE; there was also evident 
patchy staining o f basal cells of the rete tips at the junction between the OGE and crestal 
zone.
Cytokeratin 18 (Figure 5.19)
In agreement with previous studies, CKl 8 stain was localised to the JE zone only (Morgan et 
al., 1986; Shabana er a/., 1991 and Mackenzie ef a/., 1991).
Cytokeratin 14 (Figure 5:20)
Cj^okeratin 14 was present at great intensity of fluorescence throughout all layers of all 
epithelia.
Cytokeratin 15 (Figure 5.21)
Cytokeratin 15 has been reported to be a potential marker of stem cell zones (Waseem et al., 
1998); within the gingival section, only the basal cells of the OGE and OSE regions were 
positive with intensity diminishing toward the JE.
Cytokeratin 17 (Figure 5.22)
There are few literature reports regarding CKl 7 expression within epithelia. Interestingly its 
distribution appeared to correlate with the basal cells of JE, however this was extremely weak.
Cytokeratin 19 (Figure 5.23)
As expected CKl 9 staining was identified, at high intensity, throughout the JE zone. Staining 
was also identified within basal cells at the rete tips o f the OGE. Merkel cells adjacent to the 
rete tips were also positive for CK l9.
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Intracellular adhesion molecule-1 (Figure 5.24)
Work by Crawford and Hopp (1990) and repeated by Moughal et al. (1992) demonstrated 
distribution of ICAM-1 throughout the JE and partial expression within OSE. 
Disappointingly, any reactivity to the ICAM-1 mAB within the JE was at an extremely low 
intensity. It was unlikely that this would provide a useful differentiation tool.
Desmoplakin I+n (Figure 5.25)
Desmoplakin expression within JE tissues was first identified by Carmicheal et al. (1991). 
Later Matsuyama and Izumi (1997) identified differential staining characteristics between 
cultured JE and OGE populations. However, intra-cellular mAb staining showed similar 
intensities and patterns throughout the gingival section with no differentiating features 
evident.
Dolichos bijlorus agglutinin (Figure 5.26)
DBA was strongly located throughout the JE zone. There was evidence of weak staining of 
the suprabasal cells throughout the remaining section but this was regarded as background 
effects.
Matrix metalloproteinase-T (Figure 5.27)
Recently identified by Uitto et al. (2002) as being differentially expressed by JE, MMP-7 
antibody produced a pattern similar to CKl 9 with the internal basal compartment of JE and 
sporadic basal cells at the rete tips reacting positively.
Chapter five: Results
Figure 5.12: Cytokeratin 1 Figure 5.13: Cytokeratin 10
Figure 5.14: Cytokeratin 4
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Figure 5.15: Cytokeratin 13
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Figure 5.16: Cytokeratin 16 Figure 5.17: Cytokeratin 17
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Figure 5.18: Cytokeratin 8 Figure 5.19: Cytokeratin 18
Figure 5.20: Cytokeratin 14 Figure 5.21: Cytokeratin 15
Figure 5.22: Cytokeratin 17 Figure 5.23: Cytokeratin 19
Imni
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Figure 5.24; ICAM-1 Figure 5.25: Desmoplakin I+II
Figure 5.26: DBA
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Figure 5.27: MMP-7
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Table 5.2: Siraimary of mAB staining of gingival cryosections
+++ Strong positive staining
++ Positive staining
+ Weak positive staining
Negative
1 mAR 1 Location:
1 1 OGE/OSE/JE
Basal
compartment
1 " " 1 
Suprabasal
compartment
1 Cytokeratin 1 OGE
- +++
OSE - ++ (Sporadic cells)
Cytokeratin 10 OGE
- +++
OSE - ++ (Sporadic cells)
Cytokeratin 4 OGE - + (Patches)OSE - +++
1 Cytokeratin 13 OGE
- + (Patches)
OSE - ++
Cytokeratin 6 OGE
- ++
OSE - + (Sporadic cells)
Cytokeratin 16 OGE - ++  1OSE - ++ 1
Cytokeratin 8
OGE + (Rete tips) -
OSE + (Rete tips) -
JE ++
Cytokeratin 18
OGE - -
OSE - -
JE ++
Cytokeratin 14
OGE +++ +++
OSE +++ +++
JE +++
Cytokeratin 15
OGE + -
OSE + -
JE + (Very faint)
Cytokeratin 17 JE +
Cytokeratin 19
Merkel cells ++
OGE ++ (Rete tips) -
OSE ++ -
JE +++
ICAM-1 JE + (Very faint) + (Very faint)
Desmoplakin i+li Ail strata Intracellular +
DBA JE ++
MMP-7
OGE ++ (Rete tips) -
OSE ++ (Rete tips) -
JE +++
In summary, the histochemical staining resulted in distributions similar to those published 
within the literature (Morgan et al., 1986; Shabana et at., 1991 and Mackenzie et al., 1991). 
Obvious departures would include the homogenous staining patterns with desmoplakin and 
disappointingly low intensity binding of ICAM-1. Several mABs showed promise in their 
specificity for the JE phenotype including CK 8,17,18,19, DBA and MMP-7.
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5.5.2 In  vitro staining patterns
To investigate the epithelial phenotype vdien in co-culture with 3T3s the panel of mAB 
staining was repeated on both epithelial colonies cultured on plastic substrate and cell smears 
prepared from them.
Potential differentiation markers that distinguished JE from OGE in culture {in vitro) as well 
as in vivo were:
• CK8 and 18 that showed marginal increases in staining intensity for JE (Figures 5.34
and 5.35).
• CKl9 that demonstrated significant increase in staining intensity for JE (Figure 5.37).
• ICAM-1 that was weakly positive for JE and negative for OGE (Figure 5.38).
• DBA that showed positive JE staining but no reactivity for OGE (Figure 5.40).
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Figure 5.28: Cytokeratin 1 
OGE -  Colony OGE -  Smear
Suprabasal cells stain strongly for 
CK1.
Figure 5.29: Cytokeratin 10 
OGE -  Colony
Larger, flattened cells 
corresponding to the stratum 
corneum stain positively.
OGE -  Smear
-;%te;;
‘  v -
' /
Similar staining pattem as for CK1 
with larger, irregular, differentiated 
cells staining most intensely.
CD
The larger, flattened cells 
corresponding to the stratum 
corneum stained positively 
within OGE sm ears.
JE -  Smear
Few, large differentiated cells 
within JE colonies stain positively 
forCKI.
Occasional large cells within JE 
sm ears were also found to be 
positive.
Very few cells within JE colonies 
stain positively for CK10.
Very weak staining of a small 
fraction of JE cells within sm ears
stained for CK10.
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Figure 5.30: Cytokeratin 4 
OGE ~ Colony OGE -  Smear JE -  Colony JE -  Smear
lO O itm
In vivo, cells at the gingival crest stained positively for CK4 whereas OGE 
did not. it is possible that som e of these crestal ceils were included into the 
OGE fraction during the micro-dissection procedures and are visible here 
sporadically in both colonies and cell smears.
Figure 5.31: Cytokeratin 13 
OGE -  Colony OGE -  Smear
Cytokeratin 4 was not detected within JE tissue in vivo, and very little 
staining is evident throughout the colony and smear preparations.
JE -  Smear
CD
00
Staining in vitro sam ples for CK13 produced similar patterns to that of CK4 
with very weak staining of sporadic cells within colonies and smears.
There was no CK13 staining evident within JE preparations. This mirrors 
the ex vivo IHC (Figure 5:14).
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Figure 5.32: Cytokeratin 6 
OGE — Colon OGE -  Smear JE -  Colony JE -  Smear
Strong positive CK6 staining of all 
keratinocytes within the OGE 
colonies.
Figure 5.33: Cytokeratin 16 
OGE — Colons
intense positive staining forCK16 
by OGE colonies.
Variation in intensity of staining is 
apparent in smears. Larger, 
flattened, differentiated cells tend 
to stain more intensely.
OGE -  Smear
»x20 m
• * »
CO
CD
Within sm ears larger, 
differentiated cells tend to stain 
more intensely for CK16 in a 
similar manner as CK6.
The JE zone did not stain for CK6 
in vivo however, staining of 
colonies in vitro was present. This 
may represent a shift in phenotype 
of JE keratinocytes in culture.
JE -  Colony
Strong, uniform colony staining of 
JE sam ples for CK16.
Similar staining was evident within 
sm ears although smaller cells 
tend to stain less intensely.
JE -  Smear
As seen  with OGE smears there is 
variation in staining intensity with 
larger cells more strongly positive.
o Figure 5.34: Cytokeratin 8
OGE ~ Colony OGE -  Smear
In concordance with in vivo expression patterns, there was no CK8 
localisation within OGE preparations.
Figure 5.35: Cytokeratin 18
O G ^ ^ m e a i ^ ^ ^ ^
CK18 mAB provided a very weak background stain only within OGE 
samples.
JE -  Colony JE -  Smear
CK8 staining was evident 
throughout JE colonies; more 
intensely staining cells tend to be 
clustered
JE -  Colony
A range of fluorescence intensity 
was evident within JE smears. 
Greater intensity appeared to be 
associated with larger cells.
JE -  Smear
lO O n n t
There was widespread, uniform staining for CK18 within JE colonies and 
cell smears. This mAB staining pattern provides evidence for phenotypic 
variation between OGE and JE that is maintained in culture.
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Figure 5.36: Cytokeratin 14 
OGE -  Colony -  Smear JE -  SmearJE -  Colon
Strong positive staining for CK14 of aii celis throughout OGE coionies 
and smears.
Strong positive staining throughout ail ceiis of JE colonies and smears.
Figure 5.37: Cytokeratin 19
OGE -  Colony OGE -  Smear
OOun^ (H)uin
Weak CK19 staining of som e ceils within OGE colonies and smears. 
This w as not seen  to this extent in ex  vivo sections. There numbered too 
many cells to be the sporadic basal OGE or Merkel celis seen  in ex  vivo 
sections. It may indicate a shifting in the phenotype from OGE toward 
the JE-type.
JE -  Colon JE -  Smear
Strong positive CK19 staining of entire JE coionies and smears.
Figure 5.38: ICAM-1
OGE -  Colony OGE -  Smear
■
1
As demonstrated within ex vivo sections, there was no ICAM-1 staining 
within OGE samples.
Figure 5.39: Desmoplakin I+II
JE -  Smear
As with ex vivo sections there was weak ICAM-1 staining of JE 
coionies and sm ears, providing a potential differentiating marker for 
the JE phenotype.
JE -  Smear
Weak intracellular staining for 
Desmoplakin I+II within OGE 
coionies.
OGE sm ears show very weak 
membrane staining of som e cells.
Marginally stronger intracellular 
Desmoplakin staining of JE colonies 
compared with OGE.
More intense cell membrane 
staining of JE keratinocytes 
compared with OGE. This 
difference was not evident within 
ex vivo sections.
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Figure 5.40: Dolichos biflonis agglutinin
OGE -  Colony OGE -  Smear JE -  Colony JE -  Smear
Background staining oniy of OGE sam ples stained for DBA.
Figure 5.41: Matrix metalloproteinase-7 
OGE -  Colony OGE -  Smear
Positive MMP-7 staining in OGE coionies and larger, differentiated ceils 
of smears. Within ex v/Vo sections MMP-7 was localised to basal cells at 
the rete tips and the JE zone only. This may again represent a shift in 
phenotype of the OGE toward the JE-type.
Positive DBA staining of JE 
colonies.
All JE keratinocytes stain for DBA 
within smears. DBA provides a 
positive differentiating marker for 
the JE phenotype in culture.
JE -  Smear
More intense MMP-7 staining of 
JE coionies compared with OGE, 
suprabasal ceils appearing the 
most intense.
JE sm ears exhibit a variation in 
intensity of staining for MMP-7, 
with larger ceiis appearing more 
fluorescent.
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o Figure 5.42: Vimentin
OGE — Colons OGE -  Smear
x?0
.5
-  •  •  • ^
f  l OOi ini
JE -  Colon JE -  Smear
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Vimentin is an intermediate filament protein (57kD) present in cells of mesenchymal origin. In normal tissues, cell types that express vimentin include 
endothelial cells, fibroblasts, smooth muscle cells and lymphoid cells. The im ages above show positive staining of both mesenchymal derived 313 fibroblasts 
and epithelial colonies. Within the cell smear the larger keratinocytes tend to show a reduced expression level, this is an in vitro characteristic that has been 
identified in several other studies (Gao and Mackenzie, 1992 and Matsuyama etai., 1997).
o
Table 53: Summary o f mAB staining of epithelial colonies/smears
+ + +
++
+
Strong positive staining 
Positive staining 
Weak positive staining 
Negative
mAB Junctionai epitheiiai coionies Orai<^ingivai coionies Differentiai
Cytokeratin 1 - (Sporadic differentiated cells) ++ Yes
Cytokeratin 10 - (Sporadic differentiated cells) ++ Yes
Cytokeratin 4 - + (Almost negligible) No
Cytokeratin 13 - + (Almost negligible) No
Cytokeratin 6 + to +++ + to +++ No
Cytokeratin 16 + to +++ + to +++ No
Cytokeratin 8 + to++ + (Almost negligible) Yes
Cytokeratin 18 ++ -i- (Almost negligible) Yes
Cytokeratin 14 +++ +++ No
Cytokeratin 19 +++ -to + Yes
iCAiM-1 + - Yes
Desmopiakin i+ii + + (Almost negligible) Yes
DBA + to++ - Yes
iMiMP-T + to +++ + to++ No
Vimentin +++ +++ No
'hapter five: Results 1 0 5
5.6 Organotypic cultures
5.6.1 Histology
Organotypic cultures were used to compare the differing abilities of periodontal ligament 
fibroblasts and gingival fibroblasts to support the growth of epithelium. In five series of 
experiments, matrices were prepared containing either periodontal ligament or gingival 
fibroblasts and then plated with JE or OGE. Homotypic cultures constructed with OGE 
supported by OGF, and JE supported by PDL simulated the in vivo spatial arrangement. 
Heterotypic combinations, OGE supported by PDL and JE supported by OGF allow 
fibroblasts ability to direct growth and differentiation to be assessed.
Throughout experimentation, OGE showed good patterns of growth, maturation and 
stratification (Figure 5.43a and c). Mucosal architecture included a layer of cuboidal cells 
positioned basally and many spinous cell layers demonstrating that both matrix and 
mesenchymal factors were effective in the reorganisation and differentiation of the 
epithelium. OGE supported by OGF produced a substantial, stratified layer with some 
features resembling the in vivo histology (Figures 5.43a) whilst OGE cultured with PDL 
showed less growth and development (Figure 5.43c). It was apparent however, that JE had a 
decreased growth capacity when compared with OGE. In culture with PDL, it remained 
flattened and atrophic; there was just a small improvement in the number of stratified layers 
when cultured with OGF (Figures 5.43b and d).
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Figure 5.43a: Oral-gingival keratinocytes 
supported by oral-gingival fibroblasts
x 2 0
lOOum
Figure 5.43b: Junctional keratinocytes 
Supported by periodontal ligament 
fibroblasts
x 2 0
100(jm
Figure 5.43c: Oral-gingival keratinocytes 
supported by periodontal ligament fibroblasts
x 2 0
* * *  ' T
- ■  • • '•  '■
' < -----------►
100  p m
Figure 5.43b: Junctional keratinocytes 
Supported by oral-gingival fibroblasts
x 2 0
1 0 0 |j jn
5.6.2 Immunohistochemical staining patterns
All four cultures were stained using the mAB panel in order to determine how the epithelial 
phenotype was retained or modulated within the organotypic system.
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Figure 5.44:
OGF/OGE
Cytokeratin 1
OGF/JE PDL/JE PDL/OGE
Homotypic recombination of 
OGF/OGE demonstrates CK1 
staining of sporadic superficial 
cells of the stratum corneum.
Figure 5.45: 
OGF/OGE
Cytokeratin 10
Sporadic superficiaiiy stained cells 
of JE cultured upon OGF staining 
for CK1, suggesting terminal 
differentiation of som e JE 
keratinocytes.
OGF/JE
JE does not produce keratinised 
stratum corneum in vivo yet som e  
celis have stained for CK1 in 
homotypic culture.
PDL/JE
OGE demonstrating staining for 
CK1 within heterotypic culture.
PDL/OGE
O
00
CK10 Staining a p p e a rs  diffuse and  
w idesp read ; it is not ju s t located  to 
th e  m ost superficial cells.
CK10 staining is barely evident 
within OGF/JE culture.
Individual JE keratinocytes 
unexpectedly stain positively for 
CK10. CK10 not normally being 
present within JE in vivo.
Weak staining of upper half of the 
epidermis for CK10 within PDUOGE 
heterotypic culture.
Figure 5.46:
OGF/OGE
Cytokeratin 4
OGF/JE PDL/JE PDL/OGE
There was no staining for CK4 evident throughout all organotypic recombinations.
Figure 5.47: Cytokeratin 13 
OGF/OGE OGF/JE PDL/JE PDL/OGE
Very weak staining for CK13 
throughout the superficial OGE 
epidermis.
Within OGF/JE culture CK13 
expression was localised to the 
superficial cells only.
Homotypic recombination of 
PDUJE was negative for 
CK13 stain.
Similar staining pattern as 
OGF/OGE with CK13 localised to 
the superficial epidermis.
o<D
o■2.<D
Figure 5.48:
OGF/OGE
Cytokeratin 6
OGF/JE PDL/JE PDL/OGE
CK6 expression w as present throughout the entire epithelium in all organotypic cultures
ozrO)
"S.O)
Figure 5.49; Cytokeratin 8
OGF/JE
H
Unexpectedly, CK8 expression 
w as found within sporadic 
superficial cells of the OGE within 
homotypic culture.
Strong positive CK8 staining of 
entire JE layer within heterotypic 
combination.
Figure 5.50: Cytokeratin 18
O G m E ^ ^ ^
PDL/JE PDL/OGE
All JE cells were expressing CK8 
within homotypic culture upon PDL 
fibroblasts.
Similar appearance to OGF/OGE 
gel, with sporadic superficial 
keratinocytes expressing CK8.
P D L / O G ^ ^ ^ ^ ^ ^ ^ ^
■
CK18 followed a similar staining 
pattern as CK8 above, with 
superficial OGE cells being 
positive.
Weak, positive CK18 staining of 
the entire JE.
Within homotypic culture JE 
keratinocytes were strongly 
stained for CK18.
Positive CK18 staining of OGE 
keratinocytes cultured in conjunction 
with PDL fibroblasts.
o
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Figure 5.53: Dolichos biflorus agglutinin 
OGF/OGE OGF/JE PDL/JE PDL/OGE
DBA was unexpectedly, weakly 
expressed by the superficial half of 
the OGE homotypic cultures.
Within heterotypic culture, the entire 
JE layer stained for DBA.
DBA staining the entire JE layer 
within PDL/JE homotypic culture.
Entire OGE layer weakly staining for 
DBA when cultured upon PDL 
fibroblasts.
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Table 5.4a: Antibody staining of homotypic recombined cultures
+++ Strong positive staining
++ Positive staining
+ Weak positive staining
Negative 
SB Suprabasal
Note: - PDUJE homotypic cultures were regarded as only having a single epithelial 
layer not distinguished by distinct strata.
Comments highlighted in red indicate atypical staining patterns com pared with those of 
ex vivo sections and previous literature studies.
mAB
HOMOTYPIC CULTURES
OGF/OGE PDUJE
Basal SB Comments Single layer Comments
Cytokeratin 1 - +++
Conforms to ex vivo staining pattems
+++
Unexpected CK1 staining of 
JE  cells, may represent 
differentiation induced by 
culture parameters
Cytokeratin 10 - +++ As for CK1 +++ As for CK1
Cytokeratin 4 - - Conforms to ex vivo staining pattems - Conforms to ex vivo staining pattems
Cytokeratin 13 - +
Faint SB staining for CK13 conforms 
with patchy SB cell staining at crestal 
tip of ex vivo sections
-
Conforms to ex vivo 
staining pattems
Cytokeratin 6 +++ +++
Conforms to ex vivo staining pattems
+++
CK6/16 staining was not 
seen  in ex vivo sections, 
again may represent 
differentiation induced by 
culture parameters
Ipytokeratin 8 - + to  +++
Positive SB staining for CK8 likely 
represents differentiating cells found at 
rete tips in sections
+++
Conforms to ex vivo 
staining pattems
lytokeratin 18 - + to ++
Positive SB staining for CK18 likely 
represents differentiating cells found at 
rete tips in sections
++
Conforms to ex vivo I 
staining patterns 1
lytokeratin 14 +++ +++ Conforms to ex vivo staining pattems +++ Conforms to ex vivo staining pattems
Cytokeratin 19 - ++ CK19 staining of CX3E within sections was localised to the rete tips +++
Conforms to ex vivo 
staining pattems
m A - + No DBA staining was seen within OGE of ex vivo sections ++
Conforms to ex vivo 
staining pattems {
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Table 5.4b: Antibody staining of heterotypic recombined cultures
+++ Strong positive staining
++ Positive staining
+ Weak positive staining
- Negative
SB Suprabasal
mAB
HETEROTYPIC CULTURES \
OGF/JE PDUOGE 1
Basal SB Comments SB Basal Comments 1
keratin 1 - +++
Within heterotypic culture JE 
t>ehaves in a similar m anner as  OGE 
seen in homotypic culture -  (see 
table 5.4a)
- +++
OGE keratinocytes retain their in vivo 
characteristic staining pattems for CK1 
when cultured upon PDL
keratin 10 - +++ As for CK1 - +++ As for CK1
keratin 4 - -
Conforms to ex vivo staining 
pattems where neither OGE or JE 
stains positively for CK4
- -
Conforms to ex vivo staining patterns 
where neither OGE or JE stains positively 
for CK4
keratin 13 - ++
JE staining positively for CK13 is 
more characteristic of OGE 
phenotype -  possible redirection of 
differentiation by the underlying CT
- +
This faint but positive staining would imply 
that OGE has retained its original 
phenotypic characteristics despite culturing 
upon heterotypic PDL CT
keratin 6 +++ +++
Conforms to ex vivo staining 
pattems as t>oth OGE and JE stain 
positively for CK6/16
+++ +++
Conforms to ex vivo staining patterns as 
both OGE and JE cultures stain positively 
for CK6/16
keratin 8 +
++
to
+++
JE keratinocytes stain positively for 
CK8 in a similar m anner as  within 
homotypic cultures - + to  +++
Too many OGE keratinocytes stain 
positively for CK8 to represent basal rete 
tip cells alone, more likely is that cells have 
taken on a more JE-like phenotype on 
culture with PDL CT
ceratin 18 + +
As for CK18
- + to ++
As for CK8
ceratin 14 +++ +++ Conforms to ex vivo staining pattems +++ ++ +
Conforms to ex vivo staining pattems
ceratin 19 +++ +++
Within heterotypic culture JE has 
retained the positive staining pattern 
for CK19 seen in ex vivo and 
homotypic cultured JE
++ ++
Although less intense, staining of OGE for 
CK19 may indicate a shift in phenotype 
toward the JE-type
-■
++ ++
Within heterotypic culture JE has 
retained the positive staining pattern 
for DBA seen in ex vivo and 
homotypic cultured JE
++ ++
Although less intense, staining of OGE for 
DBA may indicate a shift in phenotype 
toward the JE-type
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5.7 Reverse-transcription polymerase chain reaction data
5.7.1 Primer specificities
RNA was successfully extracted for 7 PDL, 8 OGF, 4 JZF, 11 JE and 6 OGE lines. Quality 
and quantity was assessed spectrophotometrically and the RNA stored at -80°C until required. 
To confirm successful mRNA extraction each sample was incorporated within a PCR run 
along with housekeeping primers for the gene GAPDH. The GAPDH target DNA region was 
successfully amplified and a distinct product size of 176bp (Table 5.5) obtained for all 
isolates (Figure 5.54).
Figure 5.54: GAPDH products for 10 mRNA samples
176bp
GAPDH
500bp
G A P D l
RT-PCR reactions were undertaken to ensure successful amplification of the appropriate sized 
product by all primer pairs. No product was detected using H2O controls or on omission of the 
reverse-transcription stage. The following agarose gels demonstrate primer efficacies.
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Table 5.5: PCR product sizes
PCR target Product size
KGF 199bp
KGF2 248bp
KGFR 104bp
HGF 181 bp
HGFR 203bp
GM-CSF 181 bp
GM-CSFR 181bp 1
IL-1a 181bp 1
IL-1aR 181 bp
TGFa 226bp
GAPDH 176bp
Figure 5.55: GelDoc image demonstrating KGF and KGFR mRNA
199bp
KGF
500bp
K G F R
104bp
KGFR
For five fibroblast RNA samples KGF was confirmed as being transcribed successfully, 
KGFR proved to be negative. This negative result was not attributable to failure of the 
primers as further amplifications within an epithelial derived RNA sample confirmed the 
presence of KGFR (figure 5.59).
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Figure 5.56 GelDoc image demonstrating KGF2 and HGF mRNA
248bp
KGF2
500bp 5
K G F 2
ISlbp
HGF
Demonstration that HGF successfully amplified within all five fibroblast populations. KGF2 
primers also provided a product for all fibroblast samples, however only one sample (OGF 13) 
was of significant intensity, other samples although evident were extremely weak. This may 
have been because KGF2 levels were genuinely low; later RT-PCR techniques demonstrate 
KGF2 presence at similar levels throughout fibroblast populations.
Figure 5.57: GelDoc image demonstrating IL-laR and GM-CSF mRNA
181bp
[L-IaR
500bp
G M C S FL- (jrR
181bp
GM-CSF
Demonstration that IL-laR and GM-CSF primers were detecting correctly sized product 
within fibroblast RNA samples, GM-CSF being particularly weak. Later RT-PCR data 
confirmed that GM-CSF mRNA expression levels were consistently lower than those of other 
cytokines.
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Figure 5.58: GelDoc image demonstrating HGFR mRNA
\ G \ R
203bp
HGFR
SOObp
Figure 5.58 provides demonstration of HGFR amplification at 203bp within the epithelial 
samples. There was a lower intensity signal for JEl and JE9 samples that was mirrored within 
the Q-PCR data, there being a 5-fold and 3-fold respective decrease when compared to the 
average HGFR mRNA values.
Figure 5.59: GelDoc image demonstrating various mRNA products
104bp
KGFR
203bp
HGFR
181bp
IL -la
iSlbp
GMCSFR
SOObp
This agarose gel confirmed successful amplification of KGFR, HGFR, IL la  and GM-CSFR 
products from epithelial RNA samples.
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Figure 5.60; GelDoc image demonstrating TGFa mRNA
176bp
GAPDH
SOObp S
G A P D H rOFa
226bp
TGFa
Confirmation of TGFa constructs from four epithelial lines. There was a very weak signal 
provided by the JE9 sample which was mirrored by the Q-PCR data, there being a 10-fold 
decrease in mRNA expression level compared with average for TGFa.
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5.8 Quantitative-polymerase chain reaction data
Cytokine mRNA was quantified using the TaqMan™ PCR technique, an accurate method of 
detecting mRNA even when expressed at low levels. There was a considerable volume of data 
produced by the Q-PCR software. Manufacturer’s literature suggested that end-point data are 
reproducible from as low as 1000 copy numbers, and a two-fold difference being of 
recognisable significance. Occasionally small copy number results were obtained toward the 
end of the PCR cycling -  as with all PCR, this was likely to be attributable to cross-binding of 
primers with contaminant genomic DNA.
For the full table of results, example standard curve, and typical Q-PCR-run data see 
appendix VUI. Presented below are high, low and average values for each fibroblast or 
epithelial population. Data relating to the four JZF fibroblasts populations that underwent Q- 
PCR investigations are also included. Statistical differences were evaluated using the 
student’s t-test (two samples assuming unequal variances). Due to the high variability within 
sample groups data was transformed to the logarithmic scale (base 2). The null hypothesis 
was that there was no difference between the mean of any populations (OGF/PDL, JE/OGE). 
A “p” value of less than 0.05 was regarded as statistically significant. Raw data plots 
demonstrate the mean, range of data and 95% confidence intervals.
Three mRNA samples, OGF 15, PDL 15 and OGE8 underwent PCR investigations but data 
were eliminated due to a large number of undetectable results. This was likely due to 
imperfect mRNA extraction procedure; evidence for this exists in the optical quantification 
values for the mRNA samples (See highlighted within appendix III).
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Table 5.6: Summary o f Q-PCR data
Shaded values repiesent samsdes for vdifoh results were of a  value below the manufadurer 
recommended ttiie^iold. t f^ s e s  a e  legsKded as taddng expres^n  of product 
a = Value too low - regarded as a negative result.
b = Abnormally high value for KGF expression within epithelial population is likely due to known 
fibroblastic contamination of individual cultures OGE6 and JE2 pre-RNA extraction. These values 
have t>een dismissed from statistical analyses.
Fibroblast Keratlnocyte
1 Amplicon 1 PDL JZF OGE JE
Low 2595 3700 4508 18(0)* 0(0)*
KGF High 39903 9787 12558 12939 (0)^ ’ 2822 (O)*’
Average 17668 6555 7548 2728(0)*’ 407(0)**
Low 4 {Of 0 0 4271 2784
KGFR High 697 (0)^ 251 (0)" 78 (0)* 18406 37174
Average 300(D)* 81 (0)* 31(0)* 10761 12199
Low 34429 15041 4209 0 0
KGF2 High 57938 58701 49685 0 0
Average 48729 34972 32045 0 0
Low 10342 3740 90454 0 0
HGF High 229047 131511 200670 0 0
Average 104095 49685 140158 5 0
Low 55 (0)* 13(0)^ 122 (0)* 26242 54396
HGFR High 1751 (0)" 650 (0)* 360 (0)^ 270031 471758
Average 416(0)* 250(0)* :^ (0 )* 109111 253998
Low 1095 240 3110 27 (0)* 8(0)*
GM-CSF High 33189 12014 52243 266 (0)* 1598 (0)*
Average 8861 5771 16286 139(0)* 266(0)*
Low 0 0 0 2569 12754
GM-CSFR High 38 (0)" 0 0 7122 152528
Average |5(0)* 0 0 5112 40906
Low 0 0 0 20442 52036
IL-la High 405 (0)" 539 (0)^ 21 (0)^ 156487 573139
Average 68(0)* 103(0)* 5(0)* 73406 274476
Low 8004 1700 12365 1(0)* 15(0)*
IL-laR High 15891 37821 47940 24 (0)* 413(0)*
Average 9768 10497 25585 14(0)* 191(0)*
Low 6472 90539 128366 15297 17040
TGFa High 761756 665647 645141 143152 650595
Average 371979 250825 299261 79635 233702
Amplicon 1 PDL JZF OGE JE
Fibroblast Keratlnocyte
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Table 5.7: Q-PCR data expressed as percentage change between populations
OGF
1 (Avmg*)
PDL
(AvMga) % Change OGE(Average) JE(Average) % Change
KGF 17668 6555 OGF 169% t
KGFR 10761 12199 JE 13% t
KGF2 48729 34972 OGF 39% t
HGF 104095 49685 OGF 109% t
HGFR 109111 253998 JE 132% t
GM-CSF 8861 5771 OGF 54% t
GM-CSFR 5112 40906 JE 700% t
IL-la 73406 274476 JE 274% t
IL-laR 9768 10497 PDL 7% t
TGFa 371979 250825 OGF 48% t 79635 233702 JE 193% t
Table 5.7 displays data as percentage change of the average expression values 
between the four population subsets. It was apparent that with the exception of 
TGFa, fibroblast samples expressed cytokine molecules exclusively and 
keratlnocyte samples solely expressed the cytokine receptor molecules. OGF was 
seen to express, on average, consistently more of the measured cytokines 
compared with PDL samples. Interestingly JE samples were seen to express 
greater levels of receptor molecules compared with OGE samples. Statistical 
analyses of these data are presented in table 5.8.
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Table 5.8: Statistical analyses of Q-PCR log2 transformed data
1 FIBROBLASTS iog2 data
Number of 
samples (n) 
(OGF/PDL)
t-test log2 
data unequal 
variances: p- 
value
Estimated 
difference In 
means: OGF - 
PDL
log2 data
fold-change
(=2^dlfference)
95%
Confidence
Interval
Cytokine
Lower
limit
Upper
limit
KGF 7/6 0.09 1.1 2.1 -0.2 2.3
KGF2 7/6 0.10 0.6 1.5 -0.1 1.3
HGF 7/6 0.10 1.7 3.2 -0.4 3.7
GM-CSF 7/6 0.61 0.6 1.5 -2.0 3.2
IL-laR 7/6 0.36 0.7 1.6 -1.0 2.4
TGFa 7/5 0.48 1.4 2.6 -3.0 5.7
There were noticeable fold-changes in expression levels for several cytokines, OGF being 
2.1-fold greater for KGF, 1.5-fold for KGF, 3.2-fold for HGF, 1.5-fold for GM-CSF, 1.6-fold 
for IL-la receptor and 2.6-fold greater for TGFa, although no differences between OGF and 
PDL populations were statistically significant at the 0.05 level.
EPITHELIA log2 data
Number of 
samples (n) 
(OGE/JE)
t-test log2 data 
unequal 
variances: p- 
value
Estimated 
difference In 
means: JE - 
OGE
log 2 data
fold-change
(=2^dlfference)
95%
Confidence
Interval
Cytokine
Lower
limit
Upper
limit
KGFR 5/10 0.97 0.0 Nil -1.5 1.4
HGFR 5/11 0.09 1.3 2.5 -2.8 0.2
GM-CSFR 5/11 *0.00 2.7 6.5 -3.6 -1.8
IL-la 5/11 *0.01 2.0 4.0 -3.4 -0.5
TGFa 5/11 0.26 1.1 2.1 -3.0 0.9
* = Statistically significant (p<0.05)
There were also large differences between OGE and JE, with JE demonstrating a 2.5-fold 
higher level of HGFR, and 2.1-fold increase in TGFa when compared to OGF. Of statistical 
significance was the increased IL-la levels (4.0-fold, p=O.OI) and 6.5-fold greater GM-CSF 
levels (p=0) within JE keratinocytes compared with OGE.
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Table 5.9: Raw data plot -  fibroblast:KGF
OGF V PDL (KGF)
45000
40000
35000
30000
25000
20000
15000
10000
5000
0
■  OGF mean
■  PDL mean 
X OGF values 
X PDL values
X
X
X *
OGF
18904 Mean 17668
11441 Standard Error 5070
2595 Miramuni 2595
13909 Maximum 39903
30755 Confidence Level(95.09t) 12405
39903
6170
POL
numbets
3700 Mean 6555
8227 Standard Error 958
9787 Minimum 3700
5539 Maximum 9787
7547 Confidence Level(95.0%; 2462
4528
OGF PDL
Table 5.10: Raw data plot -  fibroblast:KGF2
OOP V PDL (KGF2)
70000
60000
50000
I
«0)
£Q.
liJ
Ia:
40000
30000
20000
10000
■  OGF mean
■  PDL mean 
X OGF values 
X PDL values
V ><
X 11
><
CX3F
numbere
42804 Mean 48729
34429 Standanl Error 3411
56411 Minimum 34429
44544 Maximun 57938
57938 Confidence Level(95.0<)(>) 8346
47038
57938
PDL
numbers
24596 Mean 34972
27973 Standard Error 6365
58701 Minimum 15041
15041 Maximum 58701
40016 Confidence Level(95.0%l 18361
43506
OGF PDL
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Table 5.11: Raw data plot -  fibroblastrHGF
OGF V PDL (HGF)
250000
200000
■g 150000
s
£a.
XlU
I
100000
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Table 5.12: Raw data plot — fibroblast:GM-CSF
OGF V PDL (GM-CSF)
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Table 5.13: Raw data plot -  fibroblast:IL-1 aR
OGF V PDL (IL-laR)
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Table 5.14: Raw data plot -  fibroblastiTGFa
OGF V PDL (TGFa)
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Table 5.15: Raw data plot -  epitheliaiKGFR
OGE V JE (KGFR)
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Table 5.16: Raw data plot -  epitheliarHGFR
OGE V JE  (HGFR)
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Table 5.17: Raw data plot -  epithelia:GM-CSFR
OGE V JE (GM-CSFR)
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Table 5.18: Raw data plot -  epithelia:IL-la
OGE V JE (IL-1a)
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Table 5.19: Raw data plot -  epithelia:TGFa
OGE V JE (TGFa)
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5.9 Enzyme-linked immunosorbent assay data
KGF, GM-CSF and TGFa protein levels were measured using both conditioned medium and 
a cell lysate solution. Five PDL and five OGF fibroblast lines were used. For raw data-tables, 
see appendix XI.
5.9.1 Keratinocyte growth factor
KGF protein was detected in all PDL and OGF samples. Initial results were obtained from 
cell culture media samples only (Figure 5.61a). When applying the student’s t-test assuming 
unequal variances, non-lysed samples demonstrated that OGF expressed statistically 
significant increased protein levels when compared with PDL (p=0.050). This finding is 
apparent when examining means data, PDL being 182pg and OGF being 591pg of KGF 
protein on average. This represents a 224% increase in KGF protein expressed by OGF 
compared with PDL.
Figure 5.61a: KGF protein levels in 5 PDL and 5 OGF lines (non-lysed)
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Figure 5.61b demonstrates similar results to those of figure 5.60a except lysed-cell samples 
produced considerably higher expression levels. Without exception, OGF fibroblasts 
produced more KGF protein than PDL fibroblasts, which is in agreement with Q-PCR data. 
When applying the student’s t-test to the lysed-sample data differences were again 
statistically significant (p=0.036). This difference between populations is more clearly 
demonstrated by the mean value data; PDL being 588pg and OGF samples 1845pg of KGF 
protein. This represents a 277% increase in KGF protein expressed by OGF compared with 
PDL.
Figure 5.61b: KGF protein levels in 5 PDL and 5 OGF lines (lysed)
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5.9.2 Granulocyte macrophage-colony stimulating factor
ELISA analysis of five paired samples of OGF and PDL fibroblasts for GM-CSF produced 
variable data; some showed high levels not related to a particular cell type (OGF9 and 
PDL 14). Table 5.62a shows results for cell culture media only. The protein levels are 
considerably less than those for KGF, in excess of 10-fold lower between matching 
populations. This is different to the Q-PCR mRNA data that suggest only a 2-fold difference, 
although variability between mRNA levels and protein transcription levels may account for 
some disparity. Statistically there was no significant difference between the cell types by 
students t-test (p=0.92). Means values would confirm this lack of difference with average 
PDL expression levels being 45pg and OGF 42pg of protein.
Figure 5.62a: GM-CSF protein levels in 5 PDL and 5 OGF lines (non-lysed)
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Figure 5.62b shows GM-CSF ELISA protein levels for lysed cell samples. Results were 
inconsistent, some values being greater and some less than those compared with non-lysed 
samples. Of four of the five samples the differences between PDL and OGF pairs remained, 
however, PDL2 was the exception where non-lysed results were the reverse of lysed. 
Statistically there was no difference between OGF and PDL cell types (p=0.53). The mean 
data columns demonstrate this more clearly; PDL expression level being 30pg and OGF 37pg 
of GM-CSF protein.
Figure 5.62b: GM-CSF protein levels in 5 OGF and 5 PDL lines (lysed)
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5.93 Transforming growth factor alpha
Table 5.63a shows results for cell culture media only, assessed in five OGF and five PDL 
populations. The results demonstrate widely varying levels of TGFa between cell samples; 
as a result, the data did not prove to be statistically significant (p=0.12). More generally, 
there were higher expression levels within OGF populations, in particular the samples 0GF9 
and OGF 15 showed a considerably higher expression level when compared with the other 
samples. OGF9 proved to be 114% higher and OGF 15 99% higher than the mean protein 
levels. This general trend was confirmed within the mean protein data levels for which PDL 
was found to be 30pg and OGF 213pg, OGF protein levels being increased on average 610% 
compared with PDL.
Figure 5.63a: TGF alpha protein levels in 5 PDL and 5 OGF lines (non-
lysed)
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Figure 5.63b shows TGFa protein levels for lysed samples. Lysis of cells did not produce 
consistently higher results when compared to non-lysed samples; in fact, 9 of 10 results were 
higher for non-lysed samples. Again, OGF demonstrated higher protein levels when 
compared with PDL but not to significance (p=0.08). It is apparent from both charts that 
OGF9 and OGF 15 produced considerably larger amounts of TGFa protein compared with 
other cell populations, 0GF9 being 48% higher and OGF 15 143% higher than the mean 
expression levels. The mean expression levels were found to be Ipg for PDL samples and 
21pg for OGF samples.
Figure 5.63b: TGF alpha protein levels in 5 PDL and 5 OGF lines (lysed)
picograms 
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CHAPTER SIX
DISCUSSION
CHAPTER SIX 
DISCUSSION
6.1 Introduction
The site of attachment of oral epithelium to the tooth surface consists of a unique epithelium, 
the jimctional epithelium, and only a small anatomical distance separates this JE from the 
phenotypically different oral-sulcular and oral-gingival epithelia. An alteration in the 
junctional phenotype, together with epithelial proliferation and down-growth along the root 
surface are characteristic features of periodontal disease. To date, fully adequate explanations 
are lacking as to what occurs to maintain the steady state of JE during health, or its transition 
to a migratory phenotype with the onset of periodontitis.
6.2 Pathogenesis of periodontal disease
Microbiological influences on the initiation and progression of periodontal disease have been 
much investigated (Page and Schroeder, 1976; Socransky et al., 1984 and Listgarten, 1986). 
Studies have shown that bacteria, and their metabolites, are capable of destroying the CT 
interface between tooth and gingivae, essentially instigating a wound healing response; it is 
theorised that JE then migrates into the created space (Grant et al., 1979). Goldman and 
Cohen (1980) were the first to suggest that during health, the density of periodontal ligament 
fibres inserted into the tooth prevent epithelial down-growth of JE. It may be true that the 
presence of periodontal ligament fibres plays an inhibitory role, but apical down-growth does 
not automatically occur around osseointegrated dental implants despite the lack of insertion of 
a ligament (Listgarten et al., 1991), suggesting the action of additional factors.
As p)criodontal disease undergoes periods of active migration, quiescence and even repair 
(Goodson et al., 1982 and Albandar et al., 1986) it seems unlikely that a simple epithelial 
wound healing response provides a complete explanation for periodontal disease processes. 
Certainly, it does not explain what events occur at the cellular and molecular level that 
prompts JE to (or not to) migrate into the resultant wound space (Mackenzie and Hill, 1984). 
It would appear that the role of bacteria and their metabolites on JE detachment and viability 
may be primarily indirect and act through changes in the “living conditions” of the 
periodontal cells, rather than having direct effects on the cells of the epithelial attachment 
apparatus (Overman et al., 1994). It appears that some signalling mechanism beyond that of 
simple physical barriers are required to maintain the JE during health and permit its migration 
during disease.
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Fibroblasts are capable of reacting to and synthesising an array of biological mediators that 
influence epithelial behaviour; differential expression of these factors could promote 
differences in the overljdng epithelium. Mackenzie (1984) described a model in the mouse 
that demonstrated the effect of CT on the JE phenotype. In that model, epithelia from 
different areas of the mouse oral cavity were transplanted, in an in vivo system, to areas of 
deep CT and seemed to re-differentiate producing many of the characteristics of JE. In that 
environment the epithelium was both non-migrating and adopted a new phenotype, showing 
the same pattern of reactivity for both lectins and keratins as the JE in-situ. In contrast to sub- 
epithelial CT, deep CT appeared to lack the permissive, and possibly directive, influences 
necessary for the differentiation of epithelial cells into a keratinised phenotype. It became 
apparent that an epithelial phenotype characteristic of JE could arise when oral epithelium is 
brought into contact with the “deep” CT (Mackenzie and Hill, 1984). This gave rise to the 
idea that the underlying PDL may directly control and maintain the passive nature of JE in 
health and possibly therefore the uniquely passive behavioural properties of JE can be 
explained by its interactions with a periodontal CT that has a reduced ability to produce 
cytokines and which differs fix)m that of OGF.
If non-permissiveness of PDL tissues is accepted as a working hypothesis for JE stability 
during health, the question arises as to why apical migration of the JE occurs at all during 
periodontal disease. As long as JE cells are in contact, or are adjacent to the PDL CT, they 
should remain in a non-migratory state. This is of course not the case in periodontal disease 
and it is conceivable that outgrowth or activation of different subpopulations of fibroblasts 
may cause perturbations in epithelial-mesenchymal interactions that, in turn, could modify the 
course of maturation of overlying epithelia. Schroeder and Listgarten (1977) theorised that 
such changes could be initiated by an inflammatory response and that inflammation and its 
sequelae play an important role in the circulating cytokines at the ADJ. Inflammatory 
cytokines have the potential to interact with homeostatic cytokines and modify the basic 
patterns of differentiation (Mackenzie, 1994). Reduced levels of gingival inflammation are 
associated with loss of epithelium with the typical appearance of OSE (Schroeder and 
Listgarten, 1977), and the observations of Bosch et al. (1989) indicate that inflammation 
induces expression of CK4, CK13, and CK19 (markers of non-keratinised epithelium) in 
keratinised OGE. Inflammation thus appears to produce a shift fi-om the OGE towards the 
OSE phenotype. This shift of phenotype by OSE provides further evidence that JE is different 
and that it too may be altered by inflammatory products. In the context of periodontitis, the
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gingival CTs become infiltrated with inflammatory cells that may promote CT destruction and 
loss of original spatial orientation between specialised epithelia and gingival and periodontal 
ligament CT (Mackenzie and Gao, 1993). The more superficial JE cells grow close to the 
bacterial plaque and the apical and lateral parts of the JE are likely to be influenced by the CT 
and inflammatory reaction.
6.3 Aims of the study
It is possible that a complex interplay between JE and its underlying CT exists, and that 
cytokine networks simultaneously influence both epithelial migration and repair. Therefore, 
the interaction with CT in the stabilisation and modification of epithelium is of particular 
importance in understanding the development of periodontal pockets in this unique tissue.
The hypotheses tested in this study were that differences between junctional and oral-gingival 
epithelia are associated with differing influences produced by their sub-epithelial fibroblasts. 
Further, it was hypothesised that periodontal and gingival fibroblasts differ in their 
constitutive levels of cytokine expression, and that they are integral in the maintenance of 
epithelial growth and activation to migration during disease. The aims of this study therefore 
were to elucidate, using an in vitro model of the oral-gingival and junctional epithelia, the 
extent to vdiich these tissues are stabilised by underlying mesenchymal tissues and 
specifically the role of fibroblast-cytokine networks in providing the stimuli necessary for 
epithelial growth and differentiation. Inferences could then be made as to what molecular 
signalling events may occur to alter oral phenotypes into those recognised during periodontal 
disease.
6.4 The fibroblast phenotype in vivo
Much work identifying and separating the component tissues of the periodontium has been 
conducted (Bampton et al., 1991; Matsuyama and Izumi, 1997 and McKeown et al., 2003). 
The periodontal tissues are composed of a number of discrete heterogeneous fibroblast 
populations, the two principle groups being those derived fi-om the PDL and those derived 
from the lamina propria (Hassell and Stanek, 1983; Mackenzie et al., 1993; Irwin et al., 1994 
and Schor, 1995).
C hap te r six: D iscussion  -I4Q
Alkaline phosphatase expression is regarded as being a marker that can differentiate between 
these fibroblast populations of the periodontium (Kawase et al., 1986; Somerman et al., 1988; 
Piche et al., 1989; Groeneveld et al., 1993 and Gao et al., 1999). Our work staining for the 
enzyme in ex vivo sections provided clear localisation of a high density of ALP toward the 
tooth surface (encompassing PDL and JZF zones), with rapidly diminishing intensity toward 
the oral surface (OGF zone). This sudden transition fi*om ALLP-rich to ALP-poor fibroblasts 
suggests differing phenotypes restricted to their own domain. The well-defined localisation of 
expressing and non-expressing cells defined zones that could be separated by micro­
dissection for subsequent tissue culture manipulations.
6.5 The epithelial phenotype in vivo
Oral mucosae display marked regional variations, in particular within the periodontium, 
which exhibits three structurally different epithelia within a small anatomical zone, the JE, 
OSE and OGE (Schroeder and Listgarten, 1971). The JE and OGE have been extensively 
investigated, characterised both histochemically (Morgan et al., 1986; Shabana et al., 1991; 
Mackenzie et al., 1991 and Bampton et al., 1991) and in terms of cell turnover rate (Loe and 
Karring, 1969 and Sabag et al., 1984) and JE is now regarded as a unique tissue type. Severjd 
studies have shown that JE has a highly unusual pattern of differentiation in which markers 
typical of stratifying and simple epithelia are co-expressed (Morgan et al., 1986 and 
Steffensen et al., 1987). JE has been found to be unique with respect to expression of the 
keratins 8, 18 and 19 (Mackemde et al., 1991) and in its binding of the lectin, dolichos 
biflorus agglutinin (Bampton et al., 1991).
We found that staining of ex vivo gingival cryosections using an extensive panel of 
monoclonal antibodies demonstrated several markers that allowed identification of the JE 
zone. Firstly, maikers lacking fi-om JE but expressed by the OGE/OSE phenotypes included 
the cytokeratin pairs 1/10 and 4/13. Positive markers of the JE phenotype included CK8, 18, 
19, DBA and MMP-7.
There were however, some patterns that did not conform to previously published data:
Crawford and Hopp (1990) and Gao and Mackenzie (1992) described ICAM-1 as 
providing differential staining for JE when applied to ex vivo sections of gingiva. In
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our study, there was at best extremely weak staining of the JE zone of gingival 
cryosections. Staining throughout the in vitro IHC continued to be extremely weak, 
and may represent a poor monoclonal antibody.
Desmoplakin, described by Matsuyama et al. (1997) as demonstrating “differences in 
staining patterns” of JE and OGE keratinocytes cultured in vitro, provided staining of 
cell membranes for both JE and OGE cells in vivo at equal intensity and so did not 
offer any measure o f differentiation.
6.6 The fibroblast phenotype in vitro
To enable testing of the first hypothesis the differing fibroblast and epithelial types identified 
within the periodontium were isolated fix>m human subjects. Histo- and inmnmohistochemical 
techniques determined their in vitro staining patterns and demonstrated the degree to which 
the in vivo phenotype was retained in culture.
Histochemical characterisation: Studies have shown that when fibroblasts fi-om closely 
approximated periodontal ligament and gingival connective tissues are grown in vitro, there 
exist large variations between them (Hassell and Stanek, 1983; Irwin et al., 1994 and Schor, 
1995), the predominant differentiating histochemical marker for periodontal fibroblast 
populations being alkaline phosphatase. Several studies have shown that gingival fibroblasts 
contain relatively low levels o f ALP activity compared to cells derived fi-om PDL or bone 
(Kawase et al., 1986; Somerman et al., 1988; Piche et al., 1989; Beertsen and Van den Bos, 
1991 and Goseki et al., 1995). Further work by Gao et al. (1999) found that ALP activity was 
highest in osteoblasts, moderate in PDL and lowest in OGF cells.
In vitro ALP staining of cells grown on a plastic substrate demonstrated distinct differences 
between examples of the two populations. PDL samples had between 50% and 88% of cells 
expressing ALP whilst OGF samples rarely exceeded 10% of positive cells. These figures 
suggest that two phenotypically distinct cell populations exist and that there is a degree of 
overlap. This overlap may either represent true anatomical variation of the cell types 
throughout the gingivae or, less likely, contamination during the micro-dissection procedure.
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The third population of fibroblasts, JZF, provides further evidence that intrinsic histochemical 
differences are maintained in culture. Their ALP expression levels were intermediate between 
PDL and OGF. It may of course be that these fibroblasts represent a “third” individual 
phenotype within the attachment tissues, or more likely, that there exists a spatial transition 
between PDL and OGF zones where two differing phenotypes intermingle at varying ratios. 
These consistent regional differences provide further evidence that our laboratory separation 
procedures were ^propriate for separating the fibroblast populations.
Growth-rate studies; in vitro studies have shown that PDL and OGF populations differ in 
their proliferative abilities. Mariotti and Cochran (1990) and Ogata and Niisato (1995) found 
PDL fibroblasts to proliferate at a slightly higher rate than OGF. Although not directly studied 
such a strict growth-rate difference between cultures were not identified in our culture 
conditions, but PDL fibroblasts did have a more limited replicative life span than OGF. All 
fibroblasts showed a reduced ability to proliferate with high passage, but whereas PDL 
fibroblasts rarely passaged beyond P7, OGF samples usually ceased to replicate at P9 or PIG. 
These findings suggest that the in vitro life span of PDL fibroblasts may be shorter than OGF 
and this correlates with data published by Sawa et al, (2000) who found high expression 
levels of ALP in cells deemed to have long telomeres (regarded as being “biologically” 
young) \^Mst those having short telomeres (old) showed weaker ALP activity. It is prudent to 
point out here that it was not known how many cells were plated at the initial isolation stage. 
There is the possibility that differences in passage munber attained may merely relate to 
significant fold-changes in the number of cells at PO.
6.7 The epithelial phenotype in vitro
Antibody characterisation: Differences in keratin expression have been used to demarcate 
the epithelia of the attachment zone by staining ex vivo tissue sections widi a panel of mABs. 
Several studies then focussed on finding markers that differentiate between OGE and JE in 
vivo when grown in vitro. Altman et al. (1988) isolated rat JE cells as well as gingival and 
palatal samples and found that the epithelia differed and remained distinct in tissue culture. 
Specifically they found differential expression of keratin specific antibodies AEl, AE3 and 
desmoplakin I+II between JE and gingival epithelial cells. Bampton et al. (1991) using the 
lectin dolichos biflorus agglutinin in a panning technique successfiilly isolated and cultured 
keratinocytes fi*om human JE and compared their in vitro phenotype with that of cells grown
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from the oral-sulcular and attached OGE. All cells expressed CK4, 7, 14, 18 and 19 
indicating, at least with respect to their keratin expression, that cells from the three areas of 
the gingiva appear to revert to one phenotype in culture. Other studies have hound phenotj^ic 
differences to persist including Gao and Mackenzie (1992) who demonstrated that during 
standardized in vitro culture conditions OGE lost expression of the differentiation markers 
CKl and 10 and acquired some expression of CK19, but less so than that of JE. Matsuyama 
and Izumi (1997) established a culture of human JE cells derived from epithelial tissue 
attached to the tooth surface. Again, the expression pattern of CKl 9 was observed not only 
for the junctional-type cells but also for cells from gingival tissue, however, as in Hampton’s 
work, DBA did prove to be specific in reacting only with JE cells. Clearly, these studies show 
that the JE phenotype is not entirely stable within their tissue culture environments although it 
would appear that some phenotypic markers do remain.
Within this study the panel of mAB staining was repeated on both epithelial colonies cultured 
both on plastic substrate and cell smears prepared from them. When viewed in their entirety 
the results provided clear evidence for the maintenance of phenotypic differences in vitro, 
principally by those markers previously identified in the literature CK8, 18, 19 and DBA 
antibodies all demonstrated staining localised to JE cells either uniquely or with a higher 
intensity of fluorescence (Bampton et al., 1991 and Mackenzie and Gao, 1992).
The majority of staining patterns corresponded to the in vivo work but there were some 
patterns that did not:
Cytokeratins 1 and 10, \ ^ c h  are markers of differentiated keratinocytes were evident 
in small amounts within JE samples, this may possibly imply some differentiation 
within the culture system not normally noted within the JE phenotype or some aberrant 
cross-reactivity of antibody.
There was weak staining of some flattened, apparently suprabasal OGE cells for CK4 
and 13 in vivo. These cytokeratins normally being localised to the crestal portions of the 
gingivae only. It is feasible that cells from the gingival crest were incorporated into 
cultures during the micro-dissection procedure.
C hap te r six: D iscussion '14 4
Weak in vitro staming of some OGE keratinocytes for CKl9 was evident. CKl9 is 
described as a marker of the basal cells of oral epithelia, however the positively stained 
cells were too few in number to represent the entire basal section. A number of culture 
conditions have been implicated in CKl 9 induction and will be discussed below.
Growth-rate studies: BrdU experimentation presented two observations. Firstly, that the 
OGE keratinocytes demonstrated a higher growth-rate (confined to the holoclone fraction) 
when compared with JE keratinocytes typically producing colonies of, on average, double the 
number of cells over six days. However, the BrdU uptake by the two populations was almost 
identical, the percentage of actively dividing cells being 33% for JE and 30% for OGE. As 
equal numbers of cells were plated and their BrdU uptake at a point in time were equal this 
implies either that JE cells in culture have an intrinsically slower cell-cycling (inter-mitotic) 
time with respect to OGE, a finding that corroborates data achieved by Gao and Mackenzie 
(1992), or that they suffer an increased rate of apoptosis. This provides more evidence 
perhaps to suggest that the JE phenotype is modulated by its spatial arrangement within 
tissues.
Secondly, JE samples showed a sharp decrease with passage in the ability to divide and 
colonise the dishes and so all samples failed to populate culture flasks beyond P3. OGE began 
a similar decline in proliferative ability at passages beyond P5. In both it was macroscopically 
evident that growth retardation coincided with an increase in numbers of the abortive, 
paraclono-like colonies and a reduction in the holoclone-like colonies. These differences in 
ability to proliferate under identical conditions suggest that this may represent a true in vitro 
difference between the two populations. JE may be a less robust phenotype that undergoes 
exhaustion of the proliferative fraction of its cells when asked to undergo significant increases 
in population expansion. Again, as with fibroblast isolation procedures there may have been a 
significant difference in the numbers of cells plated at PO that may have an effect on the 
subsequent number of passages and divisions the cells would undergo.
6.8 Phenotypic transition in culture
The four cell populations investigated could be accurately identified in vivo and subsequently 
separated and cultured within the in vitro environment. However, it is apparent that the 
phenotypic markers were susceptible to time-dependant changes whilst in culture.
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Fibroblasts: ALP expression by all fibroblast populations was lost within a relatively short 
number of passages; OGF cultures did not contain any ALP positive cells by P4, JZF by P6 
and PDL by P9. This implies existence of fimctional differences between the two populations 
that exist in vivo and initially in vitro, and that are lost on increasing passage (Irwin et al., 
1994b). The results support findings by Goseki et al. (1996) and more recently, Sawa et al. 
(2003) who found lowered ALP expression within aged cultures. Changes in phenotype have 
been foimd within in vitro PDL populations for other potential differentiation markers 
including; osteonectin (secreted protein, acidic and rich in cysteine/SPARC by Shiba et al. 
(2000) and osteopontin and osteonectin by Sawa et al. (2003).
These finding have implications as to the functional attributes of fibroblasts in culture at 
increasing passage numbers. In particular, it would seem to indicate that lower passage 
fibroblasts are likely to be more successful in regenerating and mimicking the in vivo 
situation. This striking example of shifting phenotype in culture may be due to limitations in 
the media and or growth conditions, or may represent reversion to a base phenotype (whilst in 
culture) that does not require the flill spectrum of three-dimensional signalling that would 
exist in the in vivo tissues.
Keratinocytes: Differences between the ex vivo and in vitro staining indicate a shift in 
cellular phenotype. The principle changes between ex vivo sections and in vitro colonies were 
in the cytokeratins CKl and 10, > ^ c h  are usually markers of keratinised, differentiated 
epithelia. The cytokeratins were evident in small amounts within JE samples implying some 
differentiation within the culture system that is not normally noted within JE in vivo.
In addition, there was weak staining of some flattened, suprabasal OGE cells for CK4 and 13 
when grown in culture, possibly representing a de-differentiation of the keratinised OGE 
phenotype toward a non-keratinising phenotype.
Weak staining of some OGE keratinocytes for CKl 9 was evident in vitro, possibly indicating 
a shift toward the JE phenotype as described by Bampton et al. (1991). Studies have been 
conducted into possible modulators, particularly retinoic acid, of cytokeratin expression by 
keratinocj^es in culture and retinoic acid is known to modulate stratified squamous epithelial 
differentiation to induce the expression of basal cell CKl 9 and the suprabasal keratins 
CKl/10 and CK4/13 (Eckert and Green, 1984 and Crowe et al., 1991). Retinoic acid has
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minor effects on the marker expression of JE but markedly enhanced expression of 
cytokeratins 8, 18, 19, vimentin and ICAM-1 within OGE (Gao and Mackenzie, 1996). These 
observations indicate that the response to retinoic acid can affect the phenotypes expressed by 
epithelia in vitro and suggest that such mechanisms may be related to the altered phenotypic 
patterns expressed by gingival epithelia in vivo (Gao and Mackenzie, 1996).
Interestingly, Breitkreutz et al. (1984) took keratinocytes that showed only a reduced 
programme of differentiation in primary culture, as indicated by ultrastructure and keratin 
composition, and foimd almost complete restoration of epidermal function was achieved after 
transplantation onto adult mice. In this in vivo environment, well-structured epithelia 
developed with restoration of both typical ultrastructure and in vivo-type keratin expression 
within 2 weeks. Thus, although keratinocytes in primary culture differ somewhat from those 
in vivo, they have not irreversibly lost the capacity for complete differentiation.
Summary: Examination of cytokeratin expression patterns within JE and OGE both in vivo 
and in vitro have provided evidence that their phenotypes are intrinsically different (Gao and 
Mackenzie, 1993). Mackenzie and Tonetti (1995) demonstrated, by mAB panel 
phenotypically indistinguishable JE reconstituted from OGE around dental implants. This 
suggests that rather than its developmental origin; the unusual JE phenotype is determined by 
the relationship of the epithelium to the tooth surface (Salonen, 1986) and underlying CT. If it 
is accepted that this geometry of physical apposition to a tooth be partly responsible for the JE 
phenotype, OGE must also intrinsically have the ability to re-differentiate into JE despite 
developing from an entirely different embryological interaction. Therefore, control of these 
cells phenotypes appears to be partly intrinsic and partly extrinsic. Altematively, of course we 
could consider the possibility that the JE formed from OGE, although showing the same mAB 
staining is not identical but may be a close simulacrum.
This positive identification of two separate fibroblast and epithelial populations in vivo and 
demonstration that these phenotypes were at least partially maintained in vitro indicated that 
the first hypothesis was tenable and allowed work to continue in testing the further 
hypotheses.
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6.9 Organotypic cultures
Co-cultures of keratinocytes on 3T3s do not correspond to the in vivo situation due to the lack 
of geometry and CT signalling. This is why organotypic cultures have been developed with a 
distinct CT layer and external environment that simulates the in vivo situation more closely. 
Culturing in combination with mesenchymal cells has been found to re-develop some of the 
histological characteristics observed within normal M l thickness skin and gingiva (Odioso et 
al., 1995; Garlick et al., 1996; Delcourt-Huard et al., 1997 and Chinnathambi et al., 2003). 
Organotypic cultures provide a valuable tool for the study of keratinocyte cell behaviour and 
mechanisms that control the spatial variation of epithelial phenotypes in an environment more 
closely resembling those found in vivo (Gao and Mackenzie, 1992).
The production of modulating growth factors is regulated by cjdokines such as interleukin-1 
that are generated by epithelial cells to form a feedback loop, in which epithelia signal 
fibroblast production of stimulatory factors which in turn act to maintain the epithelia (Maas- 
Szabowski et al., 2001). Taken together these findings demonstrate the importance of 
epithelial-connective tissue interactions, where presence of both fibroblasts and their products 
are central to development and maintenance of normal patterns of epithelial differentiation.
To test the influence of fibroblasts on epithelial morphology, expression of cytokeratin 
protein and to compare the differing abilities of periodontal ligament fibroblasts and gingival 
fibroblasts to support the growth of epithelium, we bio-engineered homotypic and heterotypic 
oral mucosae using cultured adult human cells. In five series of experiments, matrices were 
prepared containing either PDL or gingival fibroblasts and then plated with JE or OGE. 
Homotypic cultures constructed with OGE supported by OGF, and JE supported by PDL 
simulated the in vivo spatial arrangement. Heterotypic combinations, OGE supported by PDL 
and JE supported by OGF allow fibroblasts ability to direct growth and differentiation to be 
assessed.
In homotypic combinations, epithelial morphology and protein expression closely mimicked 
those in vivo. Histological sections of OGE and JE keratinocytes incorporated into the 
organotypic culture system showed consistent differences in epithelial thickness. Firstly, the 
homotypic recombinations:
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1) OGE grown upon OGF resulted in the thickest epithelixim with the most developed 
basal layer.
2) JE grown upon PDL showed little growth beyond 1-2 cell thickness.
Exact localisation of mAB staining was difficult within PDL/JE cultures due to the thin nature 
of the epithelium however patterns for both set-ups appeared to be consistent with those for 
epithelia cultured on plastic, with differentiation between JE and OGE indicated by CK8/18, 
19 and DBA.
In heterotypic combinations, the morphologies differed considerably fi"om the homotypic set­
up:
1) OGE grown upon PDL showed good stratification and maturation but a visible 
reduction in thickness compared to OGE cultured upon OGF. This would indicate 
either a reduced ability of PDL fibroblast to support its overlying epithelium or 
possibly a re-differentiation of the OGE toward a JE phenotype by the PDL 
fibroblasts. Evidence for this was sought fix>m the mAB staining which showed basal 
cells of the altered OGE expressing CKl 9 and DBA, features that were not evident in 
OGE homotypic culture.
2) Similarly, JE grown upon OGF produced an epithelium of 4-6-cell thickness that 
represented a considerable growth increase when compared with homotypic cultures 
of JE/PDL. This suggests an increased ability of OGF to dictate epithelial growth and 
development, possibly driving the JE toward a more OGE phenotype. The mAB 
staining provided some evidence for this; basal cells of the JE when cultured with 
OGF expressed low levels only of CK8/18, somewhat less than JE in homotypic 
culture. In addition, the suprabasal cells of the JE began expressing CKl3, a pattern 
not seen in previous JE staining.
These results suggest that fibroblasts within organotypic culture have some differing 
influence on keratinocyte differentiation. If the CTs have complete control of differentiation 
and growth of their overlying epithelium, an in vivo situation could arise where JE becomes 
juxtaposed to OGF (and its array of mitogens), its response may then result in a shift to a 
migratory phenotype. It is important to remember at this point that microbial interactions at
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the attachment zone have been implicated in phenotypic change of the JE (Mackenzie and 
Gao, 1993 and Mackenzie and Tonetti, 1995). It is possible that bacterial products (or the host 
response to them) bring about the initial processes that result in JE being exposed to differing 
CT influences. It may be expected that heterotypic organotypic combinations produce a more 
obvious shift in the epithelial phenotypes than was evident experimentally. This suggests that 
the intrinsic autocrine control of epithelial cells, in organotypic culture at least, is stronger 
than extrinsic regulation by mesenchymal fibroblasts.
In summary, it would appear that both the epithelial and CT components are integral in the 
growth, development and maintenance of a mature epithelium. At the morphological level 
these findings support our hypothesis that different CTs have differing abilities to support 
growth of overlying epithelia, probably because of intrinsically decreased or altered 
expression of epithelial mitogens (cytokines).
6.10 Cytokines and their maintenance of the epithelium
Cytokine networks involved in epithelial-mesenchymal interactions are slowly being 
unravelled within skin models and reports exist describing the spatial distribution of cytokines 
and their receptors that may provide a basis for understanding JE behaviour. Epidermal 
keratinocytes have been shown to produce a series of soluble proteins, both in vivo and in 
vitro, that modulate their own growth and that of other dermal and epidermal cell types 
(Maas-Szabowski and Shimotoyodome, 1999). The skin, a close approximation of the 
gingivae, has been the subject of numerous in vivo and in vitro studies of certain cytokine 
networics (Schroeder, 1995 and Wemer and Grose, 2002). However, evidence for other 
cytokines and in particular their presence within periodontal tissues, is either conflicting or 
absent.
The complexity of these interactions makes it difficult to determine which cytokines are of 
particular importance to epithelial proliferative and migratory responses seen in periodontal 
disease (Alexander and Damoulis, 1994) or even wound healing (Stephens and Thomas, 2002 
and Thomas and Harding, 2002). However, the results of both transgenic and functional 
studies indicate a central role particularly for KGF in particular, both in developmental 
interactions and in the normal maintenance and wound healing responses of adult epithelia.
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6.10.1 Fibroblast Q-PCR data
Quantitative PCR data identified mRNA for several cytokines, but provided no evidence of 
the concomitant expression of their receptors on fibroblasts. This agrees with literature 
describing the expression of cytokines by mesenchymal tissues (Finch et al., 1995b) and 
localisation of their receptors within the overlying epithelia. Fibroblast populations were 
found to express KGF, KGF2, HGF, GM-CSF and TGFa they also expressed the IL -la 
receptor.
Many studies have investigated the mitogenic effects of KGF (Finch et al., 1989, Wilson et 
al., 1993 and Sotozono et al., 1995) upon epidermal keratinocyte proliferation; however, data 
for KGF expression within oral tissues are conflicting. Mackenzie and Gao (2001) foimd that 
PDL did not express KGF whilst McKeown et al. (2003) found no significant difference 
between PDL and OGF in their production and secretion of KGF in vitro. Gron et al. (2001) 
reported that PDL produced more KGF than OGF. The Q-PCR analyses of our study showed 
that there was considerable heterogeneity within each of the three sets of fibroblasts, there 
being differences between OGF and PDL with respect to all of the proteins studied. OGF 
samples consistently expressed higher levels of cytokines when compared with PDL with 
mean levels being 2.1-fold greater for KGF, 1.5-fold for KGF2, 3.2-fold for HGF, 1.5-fold for 
GM-CSF, 1.6-fold for IL-laR  and 2.6-fold greater for TGFa.
These data indicate that PDL has the ability to produce KGF (and HGF) but at levels 
somewhat lower than the adjacent gingival CT. Evidence for production of KGF at the protein 
level was provided by ELISA techniques and they too demonstrated that PDL populations 
consistently produce lower levels when compared with OGF. Whether the varying levels of 
these growth factors released fix)m fibroblasts are sufficient for biological effect remains a 
question and it may be that that these differences in cytokine expression levels have effects in 
vivo, principally and that lower production of KGF/HGF by PDL effectively limits or 
maintains JE in its stable, non-migrating state during health. Further, these variations in 
cytokine levels may represent differences to be found throughout the cell population, possibly 
imparting upon individuals a greater or lesser risk of developing periodontitis.
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An additional unexpected finding was the identification of TGFa expression by the majority 
of fibroblast samples. It is well documented within the literature that TGFa plays a role as an 
autocrine acting epithelial mitogen (Maas-Szabowski et al., 2002 and Momose et al., 2002) 
but few studies describe production of TGFa by fibroblasts. ELISA protein production gave 
variable results with two of five OGF populations producing considerable levels. Again, this 
heterogeneity could be interpreted as a function of particular members of the population that 
may be more or less prone to periodontitis. Lowered levels of TGFa have been found in 
patients suffering chronic periodontal disease (Mogi et al., 1999) therefore the two samples 
expressing high levels may represent “protected” patients in a “low risk category” for 
stimulation to epithelial growth and hence development of periodontal disease.
JZF results were more difficult to interpret. As previously discussed (chapter 5.1), the 
anatomical origin of JZF is thought to be fix)m the CT beneath the JE. This represents a zone 
that both anatomically, and by virtue of its ALP expression, that occupies a central position 
between the PDL and OGF (table 5.1). It might be expected therefore that Q-PCR data would 
place cytokine expression levels at an intermediate value. For KGF, KGF2 and TGF this was 
the case but HGF, GM-CSF, and IL-laR  did not conform to one fibroblast type or the other, 
results actually being higher than both PDL and OGF by a minimum of 1.4-fold, 2-fold, and 
2.4-fold respectively. These results would tend to contradict the premise that there exists a 
gradual transition fix>m PDL to OGF cell-type through the gingiva and instead may signify a 
“third” fibroblast cell type. However, a possible explanation for the increased cytokine 
expression levels may rest with the anatomical positioning of these cells. Located adjacent to 
the JE attachment and close to the gingival sulcus there is likely to be bacteria with their 
metabolites perfusing the CT. These metabolites have the ability to modulate cytokine 
expression independently of the surrounding tissues (LFitto et al., 1988; Birkedal-Hanson, 
1993 and Zambon et al., 1994, Chapter 1) so may have extrinsically altered the JZF cytokine 
expression profile so that it no longer resembles its tissue of origin.
6.10.2 Fibroblast ELISA data
ELISA provided further confirmatory evidence that cytokines detected by Q-PCR were 
present at the protein level within cell samples:
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Keratinocyte growth factor: Protein was detected in all PDL and OGF samples and 
with the exception of non-lysed PDL/OGF9 sample; all OGF samples demonstrated a 
higher protein level compared with PDL. This agrees with Q-PCR data.
Granulocyte macrophage-colony stimulating factor: These data were variable and 
subsequently significant differences between PDL and OGF samples were not found. 
More evident were individual samples that produced considerably higher readings; 
OGF9 and PDL 14 in particular showed upward of 10-fold higher expression levels 
compared with their counterparts.
Transforming growth factor alpha: These results demonstrate widely varying 
levels of TGFa between cell samples; generally, there were higher expression levels 
within OGF populations, within the samples OGF9 and OGF 15 showing a 
considerably higher expression level compared to the other samples. This may 
represent a particular phenotype present within individuals and it is interesting to note 
that the OGF9 and OGF 15 samples also provided the highest levels of KGF recorded.
6.103 Keratinocyte Q-PCR data
There were also large differences between the data for OGE and JE. The epithelial data in 
contrast to that for fibroblasts, demonstrated the presence of receptors to KGF, HGF and GM- 
CSF within both JE and OGE. Interestingly, OGF populations exhibited higher levels of 
known epithelial mitogens whereas JE keratinocytes demonstrated increased levels of their 
receptors. JE samples expressed 2.5-fold higher levels of HGFR and 6.5-fold higher GM- 
CSFR; this increased expression level of receptors was imexpected and more difficult to 
interpret. JE would be expected to express lower levels o f receptors in its non-migratory 
(healthy) state in response to the lower levels of stimulatory cytokines provided by the 
adjacent PDL fibroblasts. However, the converse may well be true, with higher receptor levels 
being a physiological response to the normally low levels o f circulating cytokines expressed 
by the underlying PDL. Further, these receptors may become operational and in part explain 
the JE subsequent ability to migrate with the onset of periodontal disease. It should be noted 
here that keratinocytes are cultured in an artificial in vitro environment and as such are 
stimulated by media constituents EGF and cholera toxin so cannot be regarded as entirely 
normal.
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A significantly increased 4.0-fold level of IL -la  was noted for JE samples. IL-1 regulates the 
production of other stimulatory c)4okines by fibroblasts within CTs such that feedback loops 
are generated (Braulcb et al., 1994) and these feedback loops signal fibroblast production of 
stimulatory factors that in turn act to maintain the epithelia (Maas-Szabowski et al, 2001). It 
was found that epidermis (and presumably CXjE) stimulates CT production of KGF/HGF (and 
other cytokines) via an IL -la  dependant pathway. Therefore, with the increased IL -la  
mRNA level found within JE, it reasonable to expect that JE could readily upregulate 
KGF/HGF expression by PDL and react by migrating. Clearly, this is not the case during 
health where epithelial homeostasis is maintained. This presents two possibilities:
1) Firstly, that PDL fibroblasts intrinsically lack the ability to respond to the IL-la 
message. Q-PCR data showing reduced KGF/HGF expression by PDL fibroblasts would 
corroborate this.
2) Secondly, that IL -la protein production is not complete and/or there exist inhibitors of 
the IL-1 pathway that if lost may result in the progression to destructive periodontitis. Of 
course, these results took place in vitro as stated by the above caveat.
It is known that the recombination of keratinocytes and fibroblasts in vitro can result in 
epithelial acquisition of a new phenotype (Cunha et al., 1985) and it is possible to presume 
that the junctional phenotype is controlled in vivo by circulating epithelial-mesenchymal 
interactions. More specifically that the ALP-positive phenotype of PDL CT is inextricably 
linked to the overlying JE phenotype. Further, factors associated with bacterial inflammation 
can substitute for permissive factors produced by dermal cells or could perhaps act to favour 
selective outgrowth of fibroblasts of a permissive phenotype. These epithelial-mesenchymal 
interactions would then be implicated in the progression fi*om health to disease during the 
onset of periodontitis.
6.11 General discussion
Previous studies (Dabelsteen and Wandal, 1997 and McKeown et al., 2003) have inferred that 
there is distinct heterogeneity between periodontal fibroblast populations; our study 
confirmed that at least two distinct periodontal fibroblast populations could be cultured and 
differentiated histochemically. A similar finding was elucidated for the oral epithelia involved
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in periodontal disease, namely the JE and its anatomically adjacent OGE. JE was found to 
express, at the RNA level, greater levels of receptors to a variety of epithelial mitogens.
The intimate anatomical nature of the gingival attachment zone has made investigations of 
intrinsic levels of c)^okines expressed by fibroblasts and epithelial cells in this region 
difficult, making any conclusions as to the nature of the epithelial regulation during health 
and disease difficult to draw. The ability to successfully separate, culture, expand and 
characterise these cells in vitro has helped elucidate certain detailed characteristics. This study 
provides data to show differences of several key epithelial mitogens between two very closely 
opposed tissue types of the periodontium at the mRNA and protein level.
Further, the study assessed a number of approaches for preparing organotypic cultures and has 
successfiilly developed a method that can produce patterns of stratification comparable to that 
of the oral mucosa. The differences observed in epithelial mAB staining patterns in vitro 
indicate that the phenotype of JE is intrinsically different to that OGE. When recombined into 
homotypic culture the OGE phenotype is maintained, so much so that the epithelium stratifies 
and matures. Heterotypic culture however shows partial deviation of the phenotype toward 
that dictated by the CT component of origin. Taken together, these findings highlight the 
importance of keratinocyte-fibroblast interactions during establishment of epithelial patterns 
of differentiation, and the roles played by cytokines in this biological process. The results are 
consistent with the hypothesis that the sub-epithelial CT influences the phenotype of the JE, 
as well as other epithelia (Hill and Mackenzie, 1984 and Mackenzie, 1987), and that changes 
in these influences can lead to changes of the epithelial phenotype and the acquisition of new 
patterns of behaviour.
6.12 Future considerations
It seems unlikely that one factor could attribute to the stability or otherwise of the JE, 
therefore it is important that future studies be directed toward dissecting the role of cytokine 
networks in both normal epithelial maintenance and disease. It would be advantageous to 
repeat the quantitative assays with further populations of cells to enable greater statistical 
significance. Statistically significant changes would add weight to the argument that differing 
cytokine networks are responsible for the maintenance of phenotype in vivo. It would also be 
pertinent, if possible, to repeat such studies on populations of cells derived fi*om diseased sites
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where it may be expected that cytokine levels would differ, it would be interesting to see if 
once removed from their inflammatory in vivo location whether the phenotype would revert in 
culture.
Changes in constitutive cytokine expression levels may be altered by the host response to the 
bacterial micro-flora associated with progression of periodontitis. Our examination of 
baseline cytokine measurements could be compared with epithelia exposed to a series of such 
bacterial derived factors. Further, the serum levels within the media may affect the baseline 
expression levels in vitro and future modifications and refinements to epithelia media 
including omission of PBS may provide cells that are more representative of the in vivo state. 
As specific cytokines become implicated in epithelial-mesenchymal interactions and more 
becomes known of their role recombinant cytokines could be added to the organotypic system 
with the view to inducing or abrogating epithelial growth.
Finally, if cytokine changes prove to be linked with epithelial migration, this may have 
implications for therapeutic techniques. Altering an adverse cytokine balance may favour a 
more resilient epithelial phenotype.
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APPENDIX I 
CONSENT FORM
Consent Form
Research Project to Study Dental Tissues
I am to have a tooth removed from my mouth as part of my dental treatment and I have been 
asked whether I will allow this tooth and a small piece of the adjacent gum to be used in a 
research study.
1 have been given the sheet headed "Information about a research project to study dental 
tissues” and this explains what the research is about. Any questions I have about this project 
have been discussed to my satisfaction with my surgeon. I understand that if I participate in 
this study all information about me will be kept confidential and that my name will not be 
known to the people doing the research. I also imderstand that I am entirely free to choose 
whether or not I give permission to use my tissue and that my choice will not in any way 
affect my treatment.
I give permission for my tissue to be used in this research study.
Name of patient: ......
Signature of patient: 
Name of Surgeon: ... 
Signature of Surgeon:
Name of witness: ......
Signature of witness:
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Information about a research project to study dental tissues
What is the research project? The gums are attached to the teeth by a small piece of special 
tissue called “junctional epithelium”. In some people, this tissue becomes inflamed and grows 
down the root of the tooth. This type of gum disease is a common cause of tooth loss and we 
are trying to find out how inflammation causes the junctional epithelium to grow and the teeth 
to become loose.
We have developed new ways of growing the cells from the gums to study them in the 
laboratory. To do this we take the cells from a small piece of gum and put them in a special 
solution that allows them to continue to grow in a plastic dish. We can then see how certain 
chemicals and other cells control the way they grow. To do these studies we need samples of 
healthy cells from the gum next to a tooth.
What are von asking me to do? As part of your dental treatment you are going to have a 
tooth removed. We would like your permission to remove a small piece of gum next to the 
tooth when it is taken out. If you say yes, the tooth will be made numb in the usual way and 
will then be removed together with a small piece of gum (about 2 x 2 x 4mm, about the size 
of a nail clipping). This is not expected to cause any problems with the way the tooth socket 
heals.
Do I have to participate? No. You are entirely free to participate or not to participate in this 
study as you choose. Your decision will not in any way influence the treatment you receive.
Will I benefit from participating in the study? The results of this research will not directly 
benefit the patients who participate. However, we do hope that the work we are doing will 
give us information that will be useful in the fixture prevention and treatment of gum diseases.
If you wish to know more about this research you are invited to discuss it with the surgeon 
A^o will take out your tooth or to contact Professor Mackenzie, Department of Adult Dental 
Health. (Telephone: 029 20746557).
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APPENDIX II 
STOCK SOLUTIONS
All trans retinoic acid (ATRA)
For use in FAD medium at an end concentration of 1 0 '\ l .  Calculations allow 100|xl of stock 
ATRA to be added to 10ml of FAD. Serially diluted in isopropanol, aliquotted into 1ml 
eppendorfs and stored at -20°C.
Ascorbic acid
For use in FAD medium at a concentration of 50pg/ml., Calculations to allow lOOpl of stock 
ascorbic acid to be added to 10ml of FAD. Diluted in DDH2O, aliquotted and stored at >20®C.
Cholera Toxin lOOOx stock
Place Img cholera toxin in 119ml o f solution A, filter sterilise and store aliquots at -20°C. 
Epidermal growth factor lOOOx stock (EGF)
Place lOOpg EGF in 10ml solution A, filter sterilise and store aliquots at -20°C.
Hydrochloric acid 4M (HCl)
To 34.3ml, concentrated HCl add 65.6ml DDH2O.
Hydrocortisone lOOOx stock
Place 4mg hydrocortisone in 10ml solution A and 1ml ETOH to dissolve producing a 
400|ig/ml solution, filter sterilise and store aliquots at 4°C.
Insulin
Dilute lOOmg in 10ml DDH2O and lOOpl of glacial acetic acid producing a lOmg/ml stock 
solution. Aliquot and store at 4°C for 3-6 months.
Tris bnlfered saline lOx stock (TBS)
To 800ml DDH2O add 60.55g TRIS, 85.2g NaCl, dissolve and make up to IL at pH to 7.6.
Fixatives
Acetone/methanol
Mixed at a ratio of 1:1 and stored at -20°C.
Paraformaldehyde 4%
To 4g Paraformaldehyde powder add 10ml DDH2O, 2 drops of 2M NaOH and heat gently to 
60®C and stir with stir bar. Once dissolved add 90ml calcium free PBS and make up to 100ml. 
pH to 7.2 using either dilute HCL or NaOH. Filter before use and store at 4°C.
Anti-fade mountant
To 10ml PBS add lOOmg p-phenylenediamine and 90ml glycerol. Store in darkened container at 
-20°C for up to 6 months.
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APPENDIX III
RNA QUANTIFICATION VALUES
Date Designation 260nm 280nm Ratio Amount Ipg
8/5/02 OGFl 0.165 0.089 1.85 330pg/ml 3.0pl
6/8/02 OGF2 0.468 0.254 1.84 936pg/ml l.lp l
22/7/02 OGF9 0.410 0.234 1.75 820gg/ml 1.2gl
6/8/02 O G Fll 0.273 0.146 1.87 546pg/ml 1.8pl
6/8/02 CX3F13 0.423 0.223 1.90 846ng/ml 1.2^1
20/6/02 OGF14 0.195 0.107 1.82 390gg/ml 2.6pl
6/8/02 OGF15 0.112 0.059 1.90 224pg/ml 4.5^1
19/12/02 OGF16 0.367 0.211 1.74 734pg/ml 1.3gl
8/5/02 PDLl 0.132 0.084 1.57 264tig/ml 3.8^1
6/8/02 PDL2 0.314 0.178 1.76 628pg/ml 1.6gl
22/7/02 PDL9 0.323 0.192 1.69 696pg/ml 1.6pl
8/5/02 PDLl 4 0.213 0.120 1.78 426ng/ml 2.4gl
12/8/02 PDLl 5 0.104 0.072 1.51 218pg/ml 4.6|al
8/8/02 PDLl 6 0.197 0.105 1.88 395pg/ml 2.5^ll
20/6/02 PDL23 0.278 0.158 1.76 555gg/ml 1.8gl
8/5/02 JZFl 0.218 0.122 1.79 436|ig/ml 2.3nl
8/8/02 JZF9 0.399 0.215 1.86 798tig/ml 1.3^1
12/8/02 JZFl 7 0.130 0.071 1.83 260|ig/ml 3.8^1
8/8/02 JZF21 0.243 0.142 1.72 486|ag/ml 2.1 pi
30/4/02 JEl 0.165 0.101 1.63 330|ig/ml 3.0pl
5/9/02 JE2 0.320 0.190 1.68 640|ig/ml 1.6pl
6/6/02 JE4 0.387 0.229 1.69 774ng/ml 1.3pl
6/6/02 JE6 0.393 0.236 1.67 785ng/ml 1.3pl
10/3/03 JE7 0.337 0.241 1.40 674gg/ml 1.5pl
10/3/03 JE8 0.407 0.272 1.50 814iag/ml 1.3pl
10/3/03 JE9 0.391 0.240 1.63 782^g/ml 1.3pl
18/3/03 JE17 0.333 0.197 1.69 666^ig/ml 1.5pl
18/3/03 JE18 0.324 0.200 1.62 648|xg/ml 1.5pl
18/3/03 JE21 0.510 0.315 1.62 1020|xg/ml l.Opl
18/3/03 JE22 0.521 0.320 1.63 1042^g/ml l.Opl
27/3/03 OGE5 0.146 0.089 1.63 292tig/ml 3.4pl
27/3/03 CX3E6 0.089 0.050 1.66 178ng/ml 5.6pl
27/3/03 CX5E7 0.153 0.092 1.67 306fig/ml 3.3pl
19/12/02 OGE8 0.046 0.029 1.59 92pg/ml 10.8pl
30/04/02 OGE9 0.396 0.278 1.42 793gg/ml 1.3pl
5/9/02 0GE14 0.167 0.090 1.86 334|ag/ml 3.0pl
Highlighted results indicate poor mRNA retrieval values. These samples subsequently provided error prone Q-PCR results 
and were d i s c a r d e d . _________________________________________________________________
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APPENDIX IV 
EXAMPLE 96 WELL SET-UP FOR Q-PCR
1 2 3 4 5 6 7 8 9 10 11 12
UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN
A O G FlO a OGFIO b OGFIO c (X iF ll a (X iF ll b (X5F11 c (X3F12a 0 G F 12b 0G F12C (X iF13a CX}FI3b 0G F I3C
HGFR HGFR HGFR HGFR HGFR HGIR HGFR HGFR HGFR HGFR HGFR HGFR
UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN
B 0 G F 1 4 a 0G F 14b 0G F14C O G F lS a OGFl 5 b O G F l5 c G F7a G F7b G F7c G F 9a G F9b G F9c
HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR
UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN
C PDLl a PDLl b PDLl c PD L9a PDL9b PDL9C PD LISa PDLl 5 b PD Ll5 c
HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR
UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN
D PD L16a PDLl 6 b PDL16C PDL23 a PDL23 b PDL23 c JZFl a JZFl b JZFl c IZF2 a JZ F2h JZF2c
HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR
UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN GAPDH GAPDH GAPDH
E JZ F9a JZF9b JZF9C JZF14a JZ F U b JZ F U c JZF21 a JZF21b JZF21c (XJFIO O G Fll 0GF12
HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR HGFR
GAPDH GAPDH GAPDH GAPDH GAPDH GAPDH GAPDH GAPDH GAPDH GAPDH GAPDH GAPDH
F OGFl 3 0GF14 0GF15 GF7 GF9 PDLl PDL2 PDL9 PDLl 5 PDLl 6 PDL23 JZFl
STD al (SOOpg) STD a2 (SOOpg) S T D bl (50pg) STD b2 (50pg) STD cK Spg) STD c2 (5pg) STD dl (SOOfg) STD d2 (SOOfg) STD el (SOfg) STDe2 (SOfg) STD n  (5fg) STD f2(5fg)
c 50000000 50000000 5000000 5000000 500000 500000 50000 50000 5000 5000 500 500\3
IL laR IL laR IL laR IL laR IL laR IL laR IL laR IL laR IL laR IL laR IL laR 1 IL laR
STD gl (500ag) STD g2(500ag) STD hi (50ag) STD hi (50ag) N TCa N TC b N TCc N TCd GAPDH GAPDH GAPDH GAPDH
50 50 5 5 H2O HjO H2O H2O JZF2 JZF9 JZFl 4 JZF21
H IL laR IL laR IL laR IL laR 300F:300R 300F; 300R 300F; 300R 300F: 300R
ISOnM HGFR ISOnM HGFR ISOnM HGFR ISOnM HGFR
00
CO
APPENDIX V
GENE EXPRESSION STUDIES
Reverse-transcription amplification buffer master mix
Component RT Master mix (pi) Working Concentration |
PCR buffer (lOX) 2 Ix 1
MgCl2 (25mM) 3 3.75mM
DNTP’s (lOmM) 5 2mM
Random Hexamer Primers (0.5pg/p,L) 2 4
Dithiothreitol (1 OOmM) 2 lOmM
PCR amplification master mix
Component PCR Master mix (pi) Working Concentration |
PCR Buffer (lOx) 5 Ix
MgCl2 (25mM) 4 2mM
dNTP’s(lOmM) 4 0.8mM
3’ Primers (20pM) 1.25 0.5pM
5’ Primers (20pM) 1.25 0.5pM
Taq polymerase (5U/pL) 0.25 0.025U/pl
Nuclease-free H2O 34.25
Total volume: SOpl
Q-PCR amplification master mix
Component Unknown GAPDH Standards NTC’s
TaqMan™ buffer A 2.5pl 2.5pl 2.5pl 2.5pl
MgCb (25mM) 5.5pl 5.5pl 5.5pl 5.5pl
DNTP’s (lOmM) 4pl 4pl 4pl 4^1 .............
Probe (150nM) Ipl Ipl Ipl Ipl
3’ Primer (300nM) Ipl Ipl Ipl Ipl
5’ Primer (300nM) l^ l Ipl Ipl Ipl
Amplitaq Gold 0.25pl 0.25pl 0.25pl 0.25pl
cDNA (0.5pg/pl) Ipl Ipl 2pl Pre-made dilutions Nil
Nuclease-free H2O 8.75pl 8.75pl 7.75pl 9.75pl
Total volume: 25pl 25pl 25pl 25pl
Appendices 1 89
Tris-borate-EDTA buffer 5x (TBE buffer)
Add contents o f packet to 1 litre of DEPC H2O.
TBE ninning buffer
Ix TBE buffer 200ml
DEPC H2O 800ml
Ethidium Bromide (1 Omg/ml) 1 Opl
2% Agarose gel
Agarose 2.0g
Ix TBE buffer 100ml
Ethidium Bromide 4pl
Blue/orange agarose gel loading buffer 6x
Provided in a premixed, ready-to-use form. The dye is used for loading DNA samples into gel 
electrophoresis wells and tracking migration during electrophoresis. In a 2.0% agarose gel in 
0.5x TBE xylene cyanol FF migrates at approximately 4kb, bromophenol blue at 
approximately 300bp, and orange G at approximately 50bp.
0.4% orange G 
0.03% bromophenol blue 
0.03% xylene cyanol FF 
15%Ficoll®type400 
10mMTris-HCl(pH7.5)
50mM EDTA (pH 8.0)
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APPENDIX VI 
CYTOKINE PRIMER AND PROBE SEQUENCES
Target
template
Accession
number
PCR Primer sequence Primer
length
Product
size
(amplicon)
Keratinocyte 
growth factfM* 
(Fibroblast 
growth factor
7)
(KGF)
M60828 FORWARD
PRIMER 5’GAAATCAGGACAGTGGCAGTTG3’ 22
199bp
PROBE 5’TCTGGAAAACCATTACAACACATATGCATCAGC3’ 33
REVERSE
PRIMER 5’CAAACAnTCCCCTCCGTTGTG3’ 22
Keratinocyte 
growth factCH' 
receptor 
(KGFR)
M80634 FORWARD
PRIMER 5’TCTGTTCAATGTGACCGAGG3’ 20
104bp
PROBE 5’TTGGCCTGCCCTATATAATTGGAGACCTTACA3’ 32
REVERSE
PRIMER
5’GnTTGGCAGGACAGTGAGC3’ 20
Keratinocyte 
growth factcM’ 
2
(Fibroblast 
growth factw 
10)
(KGF2)
NM004465 FORWARD
PRIMER 5’GATACTGACACATTGTGCCTCAGC3’ 24
248bp
PROBE 5 ’CTGCTnriGTTGCTGTTCTTGGTGTCTTCC3 ’ 31
REVERSE
PRIMER 5’TGGTGAAAGAGAATAGCTTTCTCCA3’ 25
Granulocyte
macrcqihage
coliMiy
stimulating
facttM"
(GMCSF)
Ml 1220 FORWARD
PRIMER 5’GAGTGAGACCGGCCAGATGA3’ 20
181bp
PROBE 5’AGGTCCAGGCCACTCCCACCATGGCT3’ 26
REVERSE
PRIMER 5’TTCCCATTCTTCTGCCATGC3’ 20
Granulocyte
maCTophage
coltmy
stimulating
factor receptor
(GMCSFR)
M73832 FORWARD
PRIMER 5’CCCAGGCTCAGTAACAACGAAT 3’ 22
181bp
PROBE 5’CCTCAAATGTGACTCCTTCATGCAGACAAATTT3’ 33
REVERSE
PRIMER 5’CCGCATTGTAGATGAAACAGGAG3’ 23
Interieukin-1-
alpha
(IL-la)
M28983 FORWARD
PRIMER 5’GAATGAC GCCCTCAATC AAAGTATA3’ 25
181bp
PROBE 5’AATGATCAGTACCTCACGGCTGCTGCA3’ 27
REVERSE
PRIMER 5’TTGGGCAGTCACATACAATTGAGT3’ 24
IntCTleukin-1- 
alpha recqitOT 
(IL-laR)
M27492 FORWARD
PRIMER 5’TCCAACAGACAGGGCCTAGCT3’ 21
181bp
PROBE 5’AGCAGGGATGTCACGTCTTGAAAAGCCTATT3’ 31
REVERSE
PRIMER 5’AAATTGGCTTGCTTTCTTAGCACTAT3’ 26
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Hepatocyte
growth
facttMyScatter
factor
(HGF)
XM168542 FORWARD
PRIMER 5’CTGTCAATACCATTTGGAATGGAAT3’ 25
181bp
203bp
226bp
PROBE 5’1TGGGA1TCTCAGTATCCTCACGAGC3’ 26
REVERSE
PRIMER 5’ TAGCCAACTCGGATGTTTGGAT3’ 22
26
Hq)atocyte 
growth 
factor/Scatter 
factor recq>tor 
(HGFR)
XM048918 FORWARD
PRIMER 5’CAmTGGTTGTGTATATCATGGGAC 3’
PROBE 5’TGCTGTGAAATCCTTGAACAGAATCACTGACA3’ 32
REVERSE
PRIMER 5’ACCAGCGGAGACCCTTCACT3’ 20
Transfonning 
growth factxM* 
alpha 
(TGF-a)
M31172 FORWARD
PRIMER 5’AAATGGTCCCCTCGGCTG 3’ 18
PROBE 5’GCCAACACAATACCCAGAGCGAACAGG3’ 27
REVERSE
PRIMER 5’GCTGGCTTGTCCTCGTGC3’ 18
GlycCTalddiytfe-
3-phosphate
(khydrtrgenase
(GAPDH)
M33197 FORWARD
PRIMER 5’GCGAGATCCCTCCAAAATCAA 3’ 21
176bp
PROBE 5’ TCGTGGAGTCCACTGGCGTCTTCA3’ 24
REVERSE
PRIMER 5’CTTCTCATGGTTCACACCCATG3’ 22
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APPENDIX VII 
BrdU STAINING: RAW DATA
JE DAY 2 Cell line JE DAY 4 Cell line
JE
2
JE
4
JE
6
JE
8
JE l
8
AVE
(%)
JE
2
JE
4
JE
6
JE
8
JE l
8
AVE
(%|
Colony type number/50 HOLO 32 22 33 37 40 66 Colony type number/50 HOLO 24 17 27 28 25 48
MERO 14 27 20 12 15 35 MERO 15 12 14 16 18 30
PARA 4 1 0 6 1 5 PARA 11 5 14 15 13 23
Average colony cell number HOLO 13 9 13 12 18 13 Average colony cell number HOLO 30 24 27 29 30 28
MERO 16 12 16 13 13 14 MERO 28 16 18 20 22 21
PARA 23 5 14 14 11 13 PARA 29 7 20 21 17 19
Average number of BrdU+ve cells/colony HOLO 4 4 3 5 3 4 Average number of BrdU+ve cells/colony HOLO 13 5 10 7 9 9
type MERO 4 2 2 3 4 3 type MERO 8 2 5 4 6 5
PARA 4 0 0 0 4 2 PARA 6 0 5 4 2 3
Average % of BrdU+ve cells/colony type HOLO 31 44 23 42 17 31 Average % of BrdU+ve cella/colony type HOLO 43 21 37 24 30 31
MERO 25 17 13 23 31 22 MERO 29 13 28 20 27 23
PARA 17 0 0 0 36 11 PARA 21 0 25 19 12 15
JE DAY 6 Cell line
HOLO
JE
2
JE
4
JE
6
JE
8
JE1
8
AVE
{%)
Colony type number/50 15 11 17 18 20 32
MERO 11 17 16 14 22 32
PARA 24 22 27 28 20 48
Average colony cell number HOLO 12
3
70 10
7
98 80 96
MERO 78 29 56 67 49 56
PARA 46 14 22 29 27 28
Average number of BrdU+ve cella/colony 
type
HOLO 48 11 40 32 30 32
MERO 10 4 11 10 6 8
PARA 2 0 2 2 0 1
Average % of BrdU+ve cella/colony type HOLO 39 16 37 33 38 32
MERO 13 14 20 15 12 15
PARA 4 0 9 7 0 4
CO
CjO
>■O
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APPENDIX VII 
BrdU STAINING RAW DATA
OGE DAY 2 Cell line
OGE
5
OGE
6
OGE
7
OGE
9
0GE1
4 AVE (%)
Colony type number/50 HOLO 36 32 38 40 31 70
MERO 7 17 10 16 12 25
PARA 7 1 7 6 3 10
Average colony cell number HOLO 14 16 18 15 15 16
MERO 16 17 17 19 13 16
PARA 7 21 18 17 8 14
Average number of BrdU+ve 
cells/colony type
HOLO 5 6 3 4 7 5
MERO 7 4 4 4 4 5
PARA 0 2 2 0 0 1
Average % of BrdU+ve cells/colony 
type
HOLO 36 38 17 27 47 33
MERO^ 44 24 24 21 31 29
PARA 0 10 11 0 0 4
OGE DAY 4 Cell line
OGE
5
OGE
6
OGE
7
OGE
9
0GE1
4 AVE {%)
Colony type number/SO HOLO 26 20 22 29 30 51
MERO 9 12 13 10 10 22
PARA 15 18 16 17 18 34
Average colony cell number HOLO 31 33 38 42 26 34
MERO 22 25 28 30 26 26
PARA 7 18 21 16 13 15
Average number of BrdU+ve HOLO 7 17 12 16 7 12
cells/colony type MERO 3 7 8 10 2 6
PARA 0 3 5 4 0 2
Average % of BrdU+ve cells/colony HOLO 23 52 32 38 27 34
type MERO 14 28 29 33 8 22
PARA 0 17 24 25 0 13
OGE DAY 6 Cell line
OGE
5
OGE
6
OGE
7
OGE
9
0GE1
4 AVE (%)
Colony type number/50 HOLO 22 25 22 26 27 49
MERO 6 7 16 10 10 20
PARA 22 18 12 14 13 32
Average colony cell number HOLO 166 187 154 177 203 177
MERO 32 33 45 29 36 35
PARA 8 19 20 13 17 15
Average number of BrdU+ve HOLO 68 54 44 50 46 52
celle/colony type MERO 4 4 5 1 4 4
PARA 0 2 3 2 3 2
Average % of BrdU+ve celle/colony HOLO 41 29 29 28 23 30
type MERO 13 12 11 3 11 10
PARA 0 11 15 15 ___ 18^ 12
CD
QUANTITATIVE-POLYMERASE CHAIN REACTION: RAW DATA
Data highlighted in green not included in statistical analysis 
PE = Pipetting error
UNOET « Undetected
OQf A £
0GF1 20233 21313 15167 18904
0QF2 7023 24935 2364 11441
OQFS 840S 3914 29405 13909
0GF11 35824 35133 21304 30766
0GF13 2901 £ 49311 41376 39903
0GF14 5587 664C 6284 6170
0GF16 3482 3492 812 2596
AVE 15684 20678 16673 17668
A t £ A ia
62 183 40 95
464 252 46 254
127 4 117 83
112 237 461 270
UNOET 6 3 4
560 656 866 695
673 834 583 697
285 311 302 300
i t £ A ia
75886 21984 30541 42804
57756 11102 PE 34429
34634 43666 34523 56411
34534 54556 44544 44544
52176 22156 99484 57935
46567 39876 54666 47035
17025 29161 62376 
4551ll 317841 46591
57935
48729
i £
95017 79786 51698 75600
108306 74294 71701 84765
11696 8464 10873 10342
234717 205516 246906 229047
114958 157331 183373 151887
29681 34933 39247 34620
144100 139096 14431C 142503
105497 99915 106873 104095
A E £ A ia OOF
28 60 107 64 OGFl
206 82 12 IOC 0GF2
51 16 96 55 0GF8
326 255 220 265 OGFll
60 93 98 84 OGFl 3
424 816 532 593 OGFl 4
1691 1876 1686 1751 0GF18
395 457 393 415 AVE
PDLl 8313 718 2066 3700
PDL2 7823 8396 8461 8227
PDL6 12822 10680 5860 9787
PDL14 5576 5231 5806 5536
PDLie 6465 1097d 5205 7547
PDL23 4121 3830 5634 4525
AVE 7520 6638 5506 6555
0 UNOET UNOET 0
8 23 22 15
166 412 21 200
UNOET 66 UNOET 22
59 UNOET UNOET 20
50 351 352 251
47 142 66 85
16386 30472 26927 24595
26571 46262 11087 27973
54646 45785 75674 58701
11096 21897 12126 15041
1009 45677 33345 40015
15946 55927 15136 43505
20942 41003 20050 34972
3729 3986 3503 3740
52861 57281 68883 59675
14172 11352 9357 11627
2262G 19777 19896 20765
140158 12934C 125036 131511
21723 20026 21563 21105
42544 40295 41373 49685
7 26 13 P0L1
16 77 36 45 P0L2
885 62C UNOET 502 P0L9
44 67 UNOET 37 P0L14
656 97 8 255 P0L18
404 671 878 650 P0L23
335 258 159 250 AVE
JZFl 4906 9845 235C 5701
JZF6 10444 10464 16766 12558
JZFl 7 8718 4791 8764 7424
JZF21 4593 5194 3737 4508
AVE 7166 7574 7904 7548
17847(PE) 902 UNOET 0
66 UNOET 3 23
UNOET C 63 21
147 88 UNOET 78
53 248 1^ 31
20461 32966 15891 23108
86626 242SC 42666 51180
24526 72616 51908 49685
2804 4356 5467 4209
33605 33548 28983 32045
213821 189226 198962 200670 39C 376 311 360 JZFl
87428 97756 86177 90454 246 226 104 193 JZF6
148362 157281 147264 150968 1 92 274 123 JZFl 7
133422 123924 98268 118538 267 107 26 134 JZF21
145758 142048 132688 140158 228 201 180 203 AVE
00 £ A B C AVE
0GE5 14 132 6 51
0GE6 14761 15386 8666 12939
0GE7 323 279 111 238
0GE6 676 226 278 394
0GE14 22 27 6 18
AVE 3160 3210 1814 2728
A B £ AVE
2635 5862 4317 4271
18777 18106 19682 18858
24248 23561 7406 18406
4252 3456 4456 4055
8688 7867 8102 8219
11720 11770 8793 10761
A B £ AVE
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
0 ( ( 0
A B AVE
UNOET UNOET 2S8000000(XX MtQtmtn
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
0 0 ITMMtOCOa MtOMOMNt
A E £ AVE QSE
19796 21687 37243 26243 0GE5
220052 262796 327241 270031 0GE6
6324C 76551 74686 71493 0GE7
66276 61231 5988C 62463 0GE6
110567 123427 111990 115325 0GE14
95986 109139 122209 109111 AVE
JEl 1 4 1 3
JE2 3077 2491 2897 2823
JE4 382 274 577 411
JE6 397 276 3 228
JE7 C 1 C 0
JE6 75 84 47 69
JE6 55 131 84 90
JEl 7 154 416 1386 654
JEl 8 29 210 17q 137
JE21 19 17 19 18
JE22 97 20 15 44
AVE 390 357 473 407
2200 2210 3942 2784
35160 26226 28997 30128
8852 3990 4555 5799
7627 6206 6996 6944
UNDET UNDET UNDET 0
2591 4052 4225 3623
7086 7506 3745 6113
1408 6272 7066 4915
6295 9140 7061 7499
25882 46621 39016 37174
28798 31735 27091 29208
11445 13067 12064 12199
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET c
UNOET UNOET UNOET 0
UNOET UNOET UNOET c
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
0 C C 0
UNOET UNOET UNOET 0
0 UNOET UNOET 0
UNOET UNOET UNOET 0
0 UNOET UNOET 0
<3800 SSIOOOOOC UNOET imiiioi
UNOET UNOET UNOET 0
0 UNOET UNOET 8
UNOET 1 UNOET 0
5532 UNOET UNOET 1844
UNOET UNOET UNOET 0
UNOET UNOET UNOET 0
6312 n n n n 0 irtiiiM
59491 50806 52887 5439d JEl
508097 42362C 281516 404412 JE2
116947 147835 171044 145208 JE4
462946 581201 352574 465578 JE5
56316 52616 78552 62498 JE7
185266 120542 170016 158610 JE8
79951 98911 97841 92234 JE9
157000 667316 590956 471758 JEl 7
233212 267815 268842 256623 JEl 8
442476 305655 254391 334178 JE21
373654 317951 353856 348488 JE22
243215 275828 242953 253998 AVE
CD
cn
Unrellttole results for this RNA
OGFl 5 9853 3816 26540 13403
P0L15 UNOET 493 53824 18108
0GE6 UNOET UNOET UNOET C
5 16 1O0 40
UNDET UNOET INOET 0
UNOET UNOET UNDET 0
23623W7! 11362 6 MUNMT
UNOET UNOET UNOET 0
UNOET UNDET UNDET 0
28100000 2400000Q 28800000 84881081
UNOET UNOET UNOET 0
C UNOET 896 298
4 6 28 13 OGFl 5
£ 4 90 33 P0L1£
UNOET UNOET UNOET C 0GE6
QUANTITATIVE-POLYMERASE CHAIN REACTION -  RAW DATA
Data highlighted in green not included in statistical analysis 
PE = Pipetting error
UNDET = Undetected
OQF A B £ AVB
0GF1 SOS 1908 868 1098
0GF2 25096 3152C 42952 33168
0GF9 4284 692S 7604 6271
0GF11 635S 3444 303S 4261
0GF13 103S 1444 2648 1710
0GF14 5046 1630C 19295 13848
0GF16 327C 1925 59S 1931
AVE 6618 9067 11000 6861
A B c AVE
UNOET UNDET UNDET 0
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
UNDET UNDET 114 38
UNDET UNDET 19394 6468
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
C 0 2767 928
A B £ AVE
UNDET UNDET 71 24
64 8 UNDET 23
UNDET UNDET 18 8
6 UNDET 28 10
UNDET UNDET 1218 408
18 UNDET UNDET 8
UNDET UNDET UNDET 0
13 1 190 68
A B £ AVE
6842 7600 9570 8004
13202 7718 6408 9108
9701 7697 880C 6733
9858 7957 8564 8792
5457 9324 10494 6428
9358 7450 11468 9424
20571 1525S 11842 18691
10712 9000 9892 9766
A B C AVE
712238 862731 721916 806808
697827 438116 20468 386470
172974 u n d e k p e ; 8969(PE; 172974
791546 7512M 742427 761788
24429 745266 997631 889178
153S 6678 9201 6472
180568 198311 164709 161198
368732 318277 379807 371978
PDLl 168 94 458 240
PDL2 327 1159 662 716
PDL9 10076 6930 6690 8632
PDL14 6768 5685 6365 6278
PDL16 1017S 8201 1658 6748
PDL23 9578 11248 15222 12014
AVE 6188 8883 8876 8771
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
0 C C 0
UNDET UNDET UNDET 0
UNDET UNDET 61 27
160 UNDET UNDET 83
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
UNDET 688 92S 839
27 0 168 103
155S 247E 1062 1700
2060 1635 2134 1980
4474 6555 4647 8228
9248 9572 667S 9232
40608 25710 47148 37821
6805 6275 6065 7088
10798 8704 11993 10497
3429 35733S 3555 121441
UNDET(PE) u n d e t (p e : UNDET(PE) 0
262 184 3372 1279
266670 6E 4657 90839
0(PE) 661645 66793 378219
668417 662878 9(PE) 668647
186800 283688 13396 280828
JZFl 52518 47468 56748 82243
JZF9 6292 6091 6696 6360
JZFl 7 1695 2658 4778 3110
JZF21 3079 3012 4198 3430
AVE 18891 14887 18108 16286
UNDET UNDET UNDET 0
366474 13300000 UNDET 4888491
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
91819 3328000 0 1138873
64 UNDET UNDET 21
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
16 0 0 8
1670S 9066 1132C 12369 KPEi 645141 UNDEKPEi 648141
44567 38043 81211 47940 4(PE: 188068 68665 128366
20764 37548 26578 28296 UNDEKPEl 160365 318927 239646
16304 12260 12653 13739 183892 u n d e k p e ; UNDEKPE) 183892
24886 24229 27941 28886 48973 248393 96898 299261
A B C AVE
0GE5 271 207 80 186
0GE6 48 58 166 90
0GE7 26S 287 243 266
0GE9 22 245 105 124
0GE14 43 28 11 27
AVE 130 168 121 139
A B C AVE
414S 44(PE) UNDEKPE) 4149
6363 6364 863S 7122
9558 6461 1315 8778
2248 2678 2781 2869
578S 6473 5567 8943
8621 4398 3660 8112
A E £ AVE
20118 20100 21107 20442
143261 161933 164268 186467
43284 42165 3988E 41779
45833 3978C 5cx)oe 46207
98768 10078C 109790 103113
70283 72982 77012 73406
A B £ AVE
4 UNDET UNDET 1
0 7 44 17
48 25 UNDET 24
0 20 C 7
11 44 14 23
12 19 12 14
A B £ AVE
25218 6039 14633 18297
123577 100347] 123255 118726
24518 37502 22721 28247
99870 8949C 97895 98782
120342 132568 176547 143182
78708 73189 87010 79638
JEl 25 25 S 20
JE2 5 8 28 14
JE4 25 IS 38 27
JE6 28 42 3 24
JE7 1032 92 UNDET 376
JE8 49 27 18 31
JES 18 8 UNDET 8
JE17 1429 2236 1129 1698
JE18 564 732 1071 789
JE21 1 23 12 12
JE22 51 32 2 28
AVE 293 298 210 266
Unreliable results for this RNA
CDOi
OGFl 5 241 289 1180 870
PDL15 2828 2288 1516 2211
OGEE UNDET UNDET UNDET 0
6211 2958 47752 18974
8481 7825 39332 18846
22658 32017 36826 30800
58817 68452 75531 67600
60968 16239 15583 30929
9348 32411 67976 36878
11412 14180 20440 18344
216261 93594 147730 182826
20538 2348 15378 12784
13917 3474S 36707 28486
37487 66338 9450 37786
42372 33737 46610 40906
3 UNDET UNDET 1
UNDET UNDET UNDET] 0
undeV UNDET UNDET 0
74189 22521 80674 89128
651596 127012 228461 338690
120195 385430 68547S 397038
677836 95661 945920 873139
537732 461266 72138 387048
51230 151597 199597 134141
66074 54130 35904 82036
39350 447793 402730 296624
40677S 325223 10767 247890
73805 412347 336150 274101
396793 18149S 299848 292713
281416 242228 299768 274476
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
UNDET UNDET UNDET 0
33 2 11 16
67 53 194 106
188 253 158 199
224 168 848 413
143 20 3 58
17 222 331 190
58 4S 20 43
57 193 884 378
327 0 1 109
0 318 50S 276
S9S 358 0 319
188 149 269 191
3121 3978 3158 3419
UNDET UNDET 748 373
UNDET UNDET UNDET 0
693260 630000 628525 680896
600000 599751 600222 899991
86418 104431 86283 92377
123782 174032 150002 149272
631S 5288 7127 6248
77716 39988 40434 82712
1731S 17738 16068 17040
384392 359850 232668 328637
300582 42218E 262500 328424
189433 230877 233067 217792
114111 164608 113207 130641
238787 249886 218464 233702
209868 7465 10 72446
330363 392603 67288S 465286
UNDET UNDET UNDET 0
>■D
o
32
30
28
26
24
22
20
18
16
14
12
QUANTITATIVE POLYMERASE CHAIN REACTION: EXAMPLE STANDARD CURVE
Standard Curve
CD Log CO
Detector; IL1A receptor, Slope: -3 .372578, Intercept: 39 .457359 , R2: 0 .997644  
Document: run 6 (Fibs GMCSF) results post analysis 17-1-03
>■D
T3
(D
c
d:
CO
0
Q
QUANTITATIVE-POLYMERASE CHAIN REACTION: TYPICAL AMPLIFICATION PLOT
Delta Rn vs Cycle
1.0e+001
1.0e+000 -
1 .0e-001-----   -  \ —  -------------
1.0e-002
1.0e-003
1.0e-004
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
I  Cycle Number
Selected Detector: IL1A receptor; Start: 4; End: 16; Threshold: 0.12107900 
Well(s): A1-H12
Document: run 3 (Fibs KGF) results post analysis b 18-12-02
l!PPENBnnff^ TnsrFRnTEIOSSWTOWW!T[KGTT
>
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s
STANDARDS
STD2
<D
CD
\9  RUN1
\9  RUN2
\9  RUN3
39 RUN1
39 RUN2
31 RUN3
:9 RUN1
19 RUN2
19 RUN3
D9 RUN1
D9 RUN2
D9 RUN3
E9 RUN1
E9 RUN2
E9 RUN3
F9 RUN1
F9 RUN2
F9 RUN3
G9 RUN1
G9 RUN2 
G9 RUN3
H9 RUN1 
H9 RUN2 
H9 RUN3
1.414
1.427
1.433
1.425
0.976
0.989
0.996
0.987
0.627
0.641
0.651
0.64
0.367
0.377
0.386
0.377
0.258
0.261
0.274
0.264 STD
0.17
0.17
0.17
0.17
0.147
0.152
0.161
0.153
0.121
0.126
0.134
0.127
PDL VALUES
PDL2 A PDL2B PDL2 0 AVE
A3 RUN1 0.247 A4 RUN1 0.245 A5 RUN1 0.256 0.249
PDL 9 A PDL9 B PDL 9 0
B3 RUN1 0.443 B4 RUN1 0.457 B5 RUN1 0.48 0.46
PDL14 A PDL14 B PDL 14 0
03 RUN1 0.342 04 RUN1 0.333 05 RUN1 0.337 0.337
PDL 15 A PDL 1 5 B PDL 15 0
Y3 RUN1 0.178 Y4 RUN1 0.16 Y5 RUN1 0.186 0.175
PDL16 A PDL1 6 B PDL 16 0
Z3 RUN1 0.313 Z4 RUN1 0.233 Z5 RUN1 0.295 0.28
OGF VALUES
OGF 2 A 0 G F 2 B OGF 2 0 AVE
E3 RUN3 0.792 E4 RUN3 0.786 E5 RUN3 0.778 0.785
OGF 9 A 0 G F 9 B OGF 9 0
F3 RUN3 0.407 F4 RUN3 0.359 F5 RUN3 0.406 0.391
OGF IS A O GF1 5 B OGF 15 0
H3 RUN3 0.895 H4 RUN3 0.997 H5 RUN3 0.828 0.907
OGF 14 A OGF 14 8 OGF 14 0
Y3 RUN3 0.394 Y4 RUN3 0.38 Y5 RUN3 0.424 0.399
OGF 16 A OGF16 B OGF 16 0
Z3 RUN2 0.518 Z4 RUN2 0.513 Z5 RUN2 0.524 0.518
1.425
0.987
0.64
0.377
0.264
0.17
0.153
0.127
PG OF KGF
2000
1000
500
250
125
62.5
37
PDL LYSED VALUES
PDL2 A LYD PDL2 B LYD PDL2 0  LYD AVE
A6 RUN1 0.44 A7 RUN1 0.42 A8 RUN1 0.414 0.425
PDL 9 A PD L9B PDL 9 0
B6 RUN1 1.264 B7 RUN1 1.259 B8 RUN1 1.195 1.239
PDL 14 A PDL14 B PDL 14 0
06 RUN1 0.685 07 RUN1 0.666 08 RUN1 0.671 0.674
PD LISA PDL 1 5 B PDL 15 0
Y6 RUN1 0.323 Y7 RUN1 0.271 Y8 RUN1 0.295 0.296
PD LISA PDL 16 B PDL 16 0
Z3 RUN1 0.363 Z4 RUN1 0.309 Z5 RUN1 0.391 0.354
OGF LYSED VALUES
STANDARD CURVE
y = 0.0007x+0.1862 
R2 = 0.9663
1,600
1.400
1.000
S 0.800 
^  0.600
■ Series 1
•Linear (Seriesi)
0.400
0.000
0 500 1000 1500 2000 2500
DATA POINTS CONVERTED TO PICOGRAMS
OGF 2 A LYD OGF 2 B LYD OGF 2 0  LYD AVE
E6 RUN3 1.587 E7 RUN3 1.564 E8 RUN3 1.527 1.559
OGF 9 A LYD OGF 9 B LYD OGF 9 0  LYD
F6 RUN3 2.668 F7 RUN3 2.59 F8 RUN3 2.621 2.626
OGF 15 A LYD OGF 15 B LYD OGF 15 0  LYD
H6 RUN3 2.622 H7 RUN3 2.505 H8 RUN3 2.604 2.577
OGF 14 A LYD OGF 14 B LYD OGF 14 0  LYD
Y6 RUN3 1.235 Y7 RUN3 1.25Y8 RUN3 1.267 1.251
OGF 16 A LYD OGF 16 B LYD OGF 16 0  LYD
Z3 RUN1 0.692 Z4 RUN1 0.584 Z5 RUN1 0.605 0.627
PDL2 PDL9 PDL14 PDLl 5 PDLl 6
0.249 0.46 0.337 0.175 0.28
90 391 215 80 134
PDL2 LYD PDL9 LYD PDL14 LYD PDLl 5 LYD PDLl 6 LYD
0.425 1.239 0.674 0.296 0.354
341 1504, 697 157 240
0GF2 0GF9 OGFl 5 0GF14 OGFl 6
0.785 0.391 0.907 0.399 0.518
855 293 1030 304 474
0GF2 LYD 0GF9 LYD OGFl 5 LYD OGFl 4 LYD OGFl 6 LYD
1.599 2.626 2.577 1.251 0.627
2018 3489 3415 1521 630
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STANDARDS
SIB_______
A1 RUN1
A1 RUN2
A1 RUN3
B1 RUN1
B1 RUN2
B1 RUN3
C1 RUN1
C1 RUN2
C1 RUN3
D1 RUN1
01 RUN2
Dl RUN3
rooo
El RUN1
El RUN2
El RUN3
FI RUN1
FI RUN2
FI RUN3
Gl RUN1
Gl RUN2 
Gl RUN3
HI RUN1 
HI RUN2 
HI RUN3
1.514
1.531
1.546
1.530
0.914
0.937
0.948
0.933
0.516
0.544
0.554
0.538
0.284
0.304
0.312
0.300
0.255
0.242
0.236
0.244 STD
0.198
0.185
0.179
0.187
0.136
0.146
0.151
0.144
0.084
0.09C
0.094
0.089
PDL VALUES
PDL 2 A PD L2B PD L2C AVE
A3 RUN3 0.209 A4 RUN3 0.183 A5 RUN3 0.162 0.185
PDL 9 A PDL9B PD L9C
B3 RUN2 0.231 B4RUN2 0.195 B5 RUN2 0.182 0.203
PDL 14 A PDL 14 B PDL 14 C
03 RUN2 0.299 C4RUN2 0.257 05 RUN2 0.356 0.304
PDL 15 A PD L15 B PDL 15 0
Y3 RUN1 0.172 Y4 RUN1 0.128 Y5 RUN1 0.116 0.139
PDL 16 A PDL16 B PD L1 6 C
Z3 RUN3 0.142 Z4 RUN3 0.150 Z5 RUN3 0.139 0.144
OGF VALUES
OGF 2 A 0 G F 2 B 0 G F 2 C AVE
E3 RUN1 0.119 E4 RUN1 0.092 E5 RUN1 0.107 0.106
O G F16 A O G F16 B O G F16 C
G3 RUN2 0.210 G4 RUN2 0.143 G5 RUN2 0.138 0.164
OGF 9 A 0 G F 9 B 0 G F 9 C
F3 RUN2 0.374 F4 RUN2 0.356 F5 RUN2 0.299 0.343
OGF 15 A O GF15 B O G F1 5 C
H3 RUN2 0.182 H4 RUN2 0.152 H5 RUN2 0.130 0.155
OGF 14 A OGF 14 B O G F14 C
Y3 RUN1 0.172 Y4 RUN1 0.178 Y5 RUN1 0.170 0.173
1.530
0.933
0.538
0.300
0.244
0.187
0.144
0.089
PG GMCSF
1000
62.5
31.2
PDL LYSED VALUES
PDL 2 A LYD PDL 2 B LYD PDL 2 C LYD AVE
A6 RUN2 0.167 A7 RUN2 0.160 A8 RUN2 0.158 0.162
PDL 9 A LYD PDL 9 B LYD PDL 9 C LYD
B6 RUN2 0.155 B7 RUN2 0.183 B8 RUN2 0.210 0.183
PDL 14 A LYD PDL 14 B LYD PDL 14 C LYD
06 RUN1 0.286 C7 RUN1 0.225 C8 RUN1 0.192 0.234
PDL 15 A LYD PDL 15 B LYD PDL 15 C LYD
Y6 RUN1 0.166 Y7 RUN1 0.148 Y8 RUN1 0.146 0.153
PDL 16 A LYD PD L16 B LYD PDL 1 6 CLYD
Z3 RUN1 0.165 Z4 RUN1 0.154 Z5 RUN1 0.154 0.158
OGF LYSED VALUES
STANDARD CURVE
y»0.0014x+0.1393 
RJ = 0.9927
Seriesi 
Linear (Seriesi)
0.400
DATA POINTS CONVERTED TO PICOGRAMS
OGF 2 A LYD OGF 2 B LYD OGF 2 C LYD AVE
E6 RUN2 0.241 E7 RUN2 0.209 E8 RUN2 0.194 0.215
OGF 16 A LYD OGF 16 B LYD OGF 16 C LYD
G6 RUN2 0.187 G7 RUN2 0.157 08 RUN2 0.149 0.164
OGF 9 A LYD OGF 9 B LYD OGF 9 C LYD
F6 RUN2 0.202 F7 RUN2 0.181 F8 RUN2 0.170 0.184
OGF 15 A LYD OGF 15 B LYD OGF 15 C LYD
H6 RUN2 0.239 H7 RUN2 0.202 H8 RUN2 0.143 0.195
OGF 14 A LYD OGF 14 B LYD OGF 14 C LYD
Y6 RUN1 0.199 Y7 RUN1 0.210Y8 RUN1 0.186 0.198
PDL2 PDL9 PDL 14 PDL 15 PDL 16
0.185 0.203 0.304 0.139 0.144
33 46 118 1^ 16
PDL2 LYD PDL9 LYD PDL14 LYD PDLl 5 LYD PDL 26 LYD
0.162 0.183 0.234 0.153 0.158
16 31 68 16 17
0GF2 OGFl 6 0GF9 OGFl 5 0GF14
0.106 0.164 0.343 0.155 0.173
6 18 146 17 24
0GF2 LYD OGFl 6 L 0GF9 LYD OGFl 5 LYD 0GF14 LYD
0.215 0.164 0.184 0.195 0.198
54 18 32 40 42
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STANDARDS
STD
NJO
M RUN1
M RUN2
RUN3
31 RUN1
31 RUN2
31 RUN3
:i RUN1
Cl RUN2
Cl RUN3
Dl RUN1
01 RUN2
Dl RUN3
El RUN1
El RUN2
El RUN3
FI RUN1
FI RUN2
FI RUN3
Gl RUN1
Gl RUN2 
Gl RUN3
1.223
1.232
1.229
1.228
0.716
0.734
0.732
0.727
0.354
0.341
0.364
0.353
0.223
0.225
0.228
0.225
0.171
0.168
0.174
0.171
0.128
0.125
0.129
0.127
0.074
0.073
0.074
0.074
STD
PDL VALUES
PDL2A PDL2B PDL2C AVE
A3 RUN1 0.113 A4 RUN1 0.116 A5 RUN1 0.119 0.116
PDL9A PDL9B PDL9C
B3 RUN1 0.715 B4RUN1 0.758 B5 RUN1 0.727 0.733
PDL14 A PDL14 B PDL14 C
C3 RUN1 0.100 C4 RUN1 0.107 C5 RUN1 0.103 0.103
PDLISA PDLl SB PDLl 5 C
Y3 RUN1 0.104 Y4 RUN1 0.105 Y5 RUN1 0.106 0.105
PDLl 6 A PDLl 6 B PDLl 6 C
Z3 RUN1 0.097 Z4 RUN1 0.091 Z5 RUN1 0.099 0.096
OGF VALUES
0GF2 A 0G F2B 0G F2C AVE
E3 RUN1 0.144 E4 RUN1 0.144 E5 RUN1 0.132 0.140
0GF9 A 0G F9B 0G F9C
F3 RUN1 2.079 F4 RUN1 2.247 F5 RUN1 2.244 2.190
O GFll A 0GF14 B 0GF14 C
H3 RUN1 2.091 H4 RUN1 2.010 H5 RUN1 2.017 2.039
OGFl 5 A OGFl SB OGFl SC
Y3 RUN1 0.428 Y4 RUN1 0.412 Y5 RUN1 0.404 0.415
OGFl 6 A OGFl 6 B 0GF16C
Z3 RUN1 0.589 Z4 RUN1 0.525 Z5 RUN1 0.561 0.558
1.228
0.727
0.353
0.225
0.171
0.127
0.074
PG OF TGF
250
125
62.!
31.2
15.6
7.8
PDL LYSED VALUES
PDL2 A LYD PDL2 B LYD PDL2 C LYD AVE
A6 RUN1 0.081 A7 RUN1 0.085 A8 RUN1 0.083 0.083
PDL9 A LYD PDL9 B LYD PSL16CLYD
B6 RUN1 0.090 B7 RUN 1 0.089 B8 RUN 1 0.087 0.089
PDL14 A LYD PDL14 B LYD PDL14 C LYD
C6 RUN1 0.087 C7 RUN1 0.083 C8 RUN1 0.084 0.085
PDLISA LYD PDLl 5 B LYD PDL15CLYD
Y6 RUN1 0.074 Y7 RUN1 0.071 Y8 RUN1 0.076 0.074
PDL16 A LYD PDL16 B LYD PDL16 C LYD
Z3 RUN1 0.078 Z4 RUN1 0.070 Z5 RUN1 0.076 0.075
OGF LYSED VALUES
STANDARD CURVE
y = 0.0046x+0.0883 
R> = 0.99541.400
1200
1.000
0.800
Saties 1
I Linear (Seriesi)g  0.600 
0.400
0.000
0 10050 150
PO/ml
200 250 300
DATA POINTS CONVERTED TO PICOGRAMS
0GF2 A LYD 0GF2 B LYD 0GF2 C LYD AVE
E6 RUN3 0.122 E7 RUN3 0.122 E8 RUN3 0.122 0.122
0GF9 A LYD 0GF9 B LYD 0GF9 C LYD
F6 RUN1 0.229 F7 RUN1 0.238 F8 RUN1 0.231 0.233
0GF14 A LYD 0GF14 B LYD 0GF14 C LYD
H6 RUN1 0.328 H7 RUN1 0.320 H8 RUN1 0.314 0.321
0GF15ALYD 0GF15BLYD 0GF15CLYD
Y6 RUN1 0.130 Y7 RUN1 0.118 Y8 RUN1 0.119 0.122
0GF16 A LYD OGFl 6 B LYD OGFl 6 C LYD
Z3 RUN1 0.140 Z4 RUN1 0.133Z5 RUN1 0.132 0.135
PDL2 PDL9 PDL14 PDLl 8 PDL9
0.116 0.733 0.103 0.105 0.096
2 140 3 4 2
PDL2 LYD PDL9 LYD PDL14 LYD PDLl 5 LYD PDL9 LYD
0.083 0.089 0.085 0.074 0.075
1 C 2 1 1
0GF2 0GF9 OGFl 4 OGFl 5 OGFl 6
0.140 2.190 2.039 0.415 0.558
11 457 424 71 102
0GF2 LYD 0GF9 LYD 0GF14 LYD OGFl 5 LYD OGFl 6 LYD
0.122 0.233 0.321 0.122 0.135
7 31 51 7 10
APPENDIX XII 
SUPPLIERS
ABgene®
ABgene House, Blenheim Road, Epsom, KT19 9AP, UK.
Phone: +44 (0) 1372 723456 
Fax: +44 (0) 1372 741414 
Web site: http://www.adbio.co.uk
• Eppendorf nuclease fiee 200pl Cat No. AB0622
• Eppendorf nuclease free 500pl Cat No. AB0489
Ambion® (Europe) Ltd
Spitfire Close, Ermine Business Park, Huntingdon, Cambridgeshire, PE29 6XY, UK
Phone: 01480 373020
Fax: 01480 373010
Web site: www.ambion.com
• Glycogen, nuclease fi^e Cat No. 9510
• RNAwiz™ Cat No. 9736
Applied Biosystems
Lingley House, 120 Birchwood Boulevard, Warrington, WA3 7QH, UK.
Phone: +44 (0) 1925 825650
Fax: +44 (0) 1925 282502
Web site: http://www.appliedbiosvstems.com
• ABI PRISM Optical adhesive cover starter kit Cat No. 4313663
• Micro Amp Optical 96-well reaction plate Cat No. 4326659
• TaqMan™ PCR core reagent kit Cat No. N808-0228
Autogen-Biociear
Holly Ditch Farm, Mile Elm, Caine, Wiltshire, SNl 1 OPY, UK.
Phone: +44 (0) 1249 819008
Fax: +44 (0) 1249 817266
Web site: http://www.autogen-bioclear.co.uk
• Plasmocin™ (InvivoGen) Cat No. ant-mmp
BDH Ltd (VWR International LTD)
Merck House, Poole, Dorset, BH15 ITD, UK.
Phone: +44 (0) 1202 660444 
Fax: +44 (0) 1202 666856 
Web site: http://www.bdh.com
• Methanol Cat No. 101586B
• Acetone Cat No. 100034Q
Becton-Dickinson (BD) UK Ltd
Between Towns Road, Cowley, Oxford, 0X4 3LY, UK.
Phone: +44 (0) 1865 748844 
Fax: +44 (0) 1865 781635 
Web site: http://www.bd.com
• Biocoaf"^ deep 6-well plate Cat no: 355467
• Falcon™ 3pm pore cell culture inserts Cat No. 353092
Suppliers 2 0 2
Bibby Sterilin Ltd
Tilling Drive Stone, Stafifordshire, ST 15 OS A, UK.
Phone: +44 (0) 1785 812121
Fax: +44 (0) 1785 815066
Web site: http://www.bibbv-sterilin.co.iik
• 6 well plates Cat No. 3810-006
• Centriftige tubes 15ml (Iwaki) Cat No. 2320-015
• Centrifuge tubes 50ml (Iwaki) Cat No. 2347-050
• T25/74 Tissue culture flasks (Iwaki) Cat No. 3103-025/075
Bioline Ltd.
16 The Edge Business Centre, Humber Road, London, NW2 6EW, UK.
Phone: +44 (0) 20 8830 5300+44 
Fax: +44 (0) 20 8452 2822 
Web site: www.bioline.com
• Agarose multipurpose molecular grade Cat No. Bio-41026
DakoCytomation Ltd
Denmark House, Angel Drove, Ely, Cambridgeshire CB7 4ET, UK.
Phone: +44 (0) 1 353 66 99 11
Fax+44 (0) 1 353 66 89 89
Web site: www.dakocvtomation.co.uk
• Anti-BRDU antibodies (Clone Bu20a) Cat No. M0744
• P ^ p e n  Cat No. S2002
• Rabbit anti-mouse Immunoglobulins FITC Cat No. F0261 
Eppendorf UK Limited
Endurance House, Vision Park, Cambridge, CB4 9ZR, UK.
Phone: 01223 200 440 
Fax: 01223 200 441
Web site: http://www.eppendorf.com/uk
• Phase lock gel™ heavy 1.5ml Cat No. 0032 007.953
Greiner Bio-One Ltd
Unit 5, Stroudwater Business Park, Brunei Way, Stonehouse, Gloucestershire, GLIO 
3SX, UK.
Phone: +44 (0) 1453 825 255
Fax: +44 (0) 1453 826 266
Web site: http://www.greinerbioone.com
Invitrogen™ Ltd Life Sciences (incorporating Gibco™)
3 Fountain Drive, Inchinnan Business Park, Paisley, UK.
Phone: 0141 814 6100
FAX: 0141 814 6260
Web site: http://www.invitrogen.com
• Antibiotic/antimycotic 10,000U/ml penicillin G sodium, 10,000pg/ml 
streptomycin sulphate, 25pg/ml amphoteracin B (AA) Cat No. 15240-062
• Dulbecco’s modified Eagle’s medium high glucose with phenol red, containing 
2mM L-Glutamine (DMEM) Cat No. 41965-039
Suppliers 2 0 3
• Foetal bovine serum (PBS) Cat No. 10106-169
• Newbom calf serum (NBCS) Cat No. 16010-084
• Nutrient mixture F-12 (Ham’s F-12) Cat No. 21765-029
• Trypsin 0.25% Cat No. 15050065
• Trypsin/EDTA (0.05% (w/v) trypsin/0.53mM ethylenediaminetetraacetic acid) 
Cat No. 25300-054
ISL
PO Box 120, Paignton, TQ4 7XD, UK.
Phone: +44 (0) 1803 526556 
Fax: +44 (0) 1803 526776
• Fast Read cell counting chambers Cat No. BUS 100
Lamb Ltd
Units 4 & 5 Parkview Industrial Estate, Alder close, Loflbridge, Eastboume, East 
Sussex, BN23 6QE, UK.
Phone: +44 (0) 1323 737000 
Fax: +44 (0) 1323 733000 
Web site: http://www.ralamb.co.uk
• Cork disks 20mm Cat No. E7.15/CD
• Harris’s haematoxylin Cat No. 033-D
Millipore
Billerica Massachusetts, 290 Concord Road, Billerica, MA 01821, USA.
Phone: (978) 715-4321
Web site: http://www.millipore.com
• Stericup Filter Units Vacuum-operated filtration and storage system Cat No. 
SCGVUIORE
• Millex Filter Units 25 mm Syringe-driven filter units with PVC housing Cat No. 
SLGPR25LS
Nalgene®
Nalge Europe Ltd, Unit la, Thom Business Park, Hereford, HR2 6JT, UK.
Phone: +44 (0) 1432 263933
Fax: +44 (0) 1432 376567
Web site: www.nalgenelabware.com
• Cryo 1°C Freezing Container, "Mr. Frosty" Cat No. 5100
Promega UK Ltd
Delta House, Chilworth Research Centre, Southampton SO 16 7NS, UK.
Web site: http://www.promega.com
• DL-Dithiothreitol, MB grade (DTT) PI 171
• DNA ladder (lOObp) Cat No. G2101
• Deoxynucleotide triphosphates (dNTP’s) Cat No. U 1511
• Ethidium bromide Cat No. H5041
• Human genomic DNA Cat No. G3041
• Blue/orange Loading buffer 6x Cat No. Gl 881
• Moloney murine leukaemia virus reverse transcriptase (MMLV-RT) Cat No. 
M3681
Suppliers 2 0 4
• Random primers Cat No. Cl 181
• RNasin® Inhibitor 2500U Cat No. N2111
• Taq DNA polymerase Cat No. M1661
•  TaqMan buffer A Cat No.Ml90A
Qbiogene c/o Excel] Biotech
Oakland Park Road, Oakland Business Park, Livingstone, Scotland, EH53 OTG, UK. 
Website: http://qbiogene.com 
Phone: +44 (0) 800 328 8401 
Fax: +44 (0) 800 0853090
• MiniCuve 8.10 Electrophoresis Unit
R&D Systems Europe Ltd
19 Barton Lane, Abingdon Science Park, Abingdon, Oxon, 0X14 3NB, UK.
Phone: +44 (0) 1235 529449
Fax: +44 (0) 1235 533420
Web site: http://www.mdsvstems.com
• Human GM-CSF Quantikine ELISA Kit DGMOO
• Human KGF/FGF-7 Quantikine ELISA Kit DKGOO
• Human TGF-alpha Quantikine ELISA Kit DTGAOO
Roche Dii^nostics Ltd (Boehiinger Mannheim)
Bell Lane, Lewes, East Sussex BN7 ILG, UK.
Phone: 01273 480444 
FAX: 0808 100 99 98
Web site: http://www.roche-applied-science.com
• Collagenase A fix>m Clostridium histolyticum Cat No. 49271620
• Amplitaq Gold Cat No. AP 4311806
Sigma-Aldrich Company Ltd
Dorset, England, UK.
Phone: +44 (0) 1202 733114
Fax: +44 (0) 1202 715460
Web site: http://www.sigmaaldrich.com
5-Bromo-2’-deoxyuridine (BrdU) Cat No. B9285 
5-Bromo-4-chloro-3-indolyl phosphate p-toluidine salt (BCIP) B5655 
Albumin bovine serum, lyophilised powder (BSA) A2153 
Chloroform MB grade C2432
Cholera toxin vibrio cholerae, lyophilised powder C3012 
Diethyl pyrocarbonate (DEPC) D5758 
DMEM xlO D2429
Epidermal growth factor human (EGF), lyophilised powder E9644 
Ethanol absolute 200 proof, MB grade E7023
Ethylenediaminetetraacetic acid 0.02% solution Ca^^/Mg^^ free (EDTA) E8008 
Hoechst stain solution 33258 Cat No. H6024 
Hydrocortisone, cell culture tested H0888 
Insulin from bovine pancreas, lyophilised powder I I882 
Isopropanol, MB grade 19516 
Mitomycin-C M4287
Suppliers 2 0 5
Nystatin suspension 10,000U/ml N1638 
Parafomialdehyde P6148 
Pronase Cat No. P6911 
Retinoic acid all trans (ATRA) R2625 
RNase Zap R2020
Sigmaclean water bath treatment S5525 
Sodium hydroxide standard solution IN (NaOH) S2770 
Sucrose S7903
Tris-borate-EDTA buffer 5x (TBE buffer) T3913 
SorvalKD
Kendro Laboratory Products Pic, Stortford Hall Park, Bishop's Stortford, 
Hertfordshire, CM23 5GZ, UK.
Phone: +44 (1279) 82 77 00 
Fax: +44 (1279) 82 77 50 
Web site: http://www.sorvall.com
• Biofuge Fresco bench top ultracentrifuge
Swann-Morton Limited
Owlerton Green, Sheffield, S6 2BJ, UK.
Phone: +44 (0) 114 234 4231
Fax:+44(0) 114 231 4966
Web site: http://www.swaim-morton.com
• Disposable No. 10 Scalpel blades Cat No. 0501
Thermo Shandon
Rimcom, Cheshire, WA7 IPR, UK.
Phone: +44 (0) 1928 562600 
Fax: +44 (0) 1928 562627 
Web site: httD://www.thermo.com
• Cryomatrix™ Cat No. 6769006
Vector Laboratories Ltd
3, Accent Park, Bakewell Road, Orton Southgate, Peterborough, PE2 6XS, UK.
Phone: (01733) 237999
Fax: (01733) 237119
Web site: http://www.vectorlabs.com
• 3,3’-diaminobenzidine (DAB) Substrate Kit, Cat No. SK-4100
• Vectastain Elite ABC kit Cat No. PK-6200
Suppliers 2 0 6
